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The phytochemistry of Ochna serrulata (Hochst.) Walp. was investigated for the first 
time; two new dimeric chalcones (5-deoxyurundeuvine C and serrulone A) and two 
new biflavonoid derivatives (4,4’,7-tri-O-methylisocampylospermone A and 4”’-de-O-
methylafzelone A) were isolated. These compounds were isolated along with the 
known compounds lophirone A, afzelone B, campylospermone A, 
isocampylospermone A, ochnaflavone, 2”,3”-dihydroochnaflavone, lophirone C, 
psilosin, 3’-O-methylpsilosin, a cyanoglucoside, epicatechin, (2’,4’-
dihydroxyphenyl)acetic acid, methyl (2’,4’-dihydroxyphenyl)acetate, irisolone 4’-
methyl ether, iriskumaonin 3’-methyl ether, 3',4'-dimethoxy-6,7-
methylenedioxyisoflavone, lophirone L, syringaresinol and 16α,17-dihydroxy-ent-
kauran-19-oic acid. 
 
The growth inhibitory effect of these compounds was evaluated against three cancer 
cell line panel of TK 10 (renal), UACC62 (melanoma) and MCF7 (breast) using a 
sulforhodamine B (SRB) assay. Ochnaflavone and 3’-methoxypsilosin demonstrated 
selectivity and only inhibited the growth of melanoma cancer cells. However, 
ochnaflavone showed higher activity by totally inhibiting the growth of melanoma 
cancer cells at 12.91 µM, whereas, 3’-O-methylpsilosin has this effect at a 
concentration of 14.11 µM. Lophirone C, a dimeric chalcone, demonstrated the 
highest cytotoxic activity amongst all isolated compounds against renal, melanoma 
and breast cancer cells with TGI at 35.63 µM, 11.67 µM and 30.35 µM, respectively. 
Lophirone A, a rearranged biflavonoid, showed TGI against these cancer cells at 
58.96 µM, 26.23 µM and 40.01 µM, respectively. The rest of the compounds showed 
no significant cytotoxicity against the three cancer cells. 
 
The new biflavonoid, 4,4’,7-tri-O-methylisocampylospermone A demonstrated the 
highest antimalarial activity against chloroquine-resistant strains of Plasmodium 
falciparum (FCR-3) with IC50 of 11.46 µM, followed by ochnaflavone (17.25 µM). 
iv 
 
Serrulone A (26.52 µM), lophirone A (29.78 µM), 5-deoxyurundeuvine C (31.07 µM), 
lophirone C (35.31 µM), 4”’-de-O-methylafzelone A (38.43 µM), afzelone B (39.54 
µM), irisolone 4’-methyl ether (40.72 µM) and syringaresinol (42.66 µM) were 
moderately active. The following compounds exhibited the lowest antimalarial activity, 
2”,3”-dihydroochnaflavone (61.86 µM), iriskumaonin 3’-O-methyl ether (93.69 µM),3’-
O-methylpsilosin (106.35 µM) and16α,17-dihydroxy-ent-kauran-19-oic acid (106.48 
µM). 
 
Owing to the observed and reported biological/pharmacological activity, ochnaflavone 
(an ether-linked biflavone consisting of apigenin and luteolin moieties) was selected 
for synthetic studies. An older method, nucleophilic aromatic substitution (SNAr) was 
successfully applied in the construction of the diary ether. Oxidative ring cyclization of 
the ether-linked dimeric chalcone was achieved by using heated pyridine and iodine. 
The two methods can be extended further in the synthesis of other novel biflavones 
with ether linkage.  
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1.1 Novel Drugs Derived from Plant Natural Products 
 
Since time immemorial, humans have relied on plants for the provision of 
medication, food, clothing, shelter and transportation (Cragg and Newman, 2009). 
For thousands of years plants have been the foundation of traditional medicine 
systems where the knowledge on the plants has been passed on from generation 
to generation (Koehn and Carter, 2005). In African, Indian and Chinese 
communities, plants have formed the main ingredient of traditional medicines 
(Gurib-Fakim, 2006; Magassouba et al., 2007).  
 
Over 80% of the population residing in developing countries were estimated by 
WHO in 2008 to be depending directly on plants for their primary medical 
requirements (WHO, 2008); this is attributed to the fact that plant-derived 
medicines can be easily accessed and are also cheap (Amin and Mousa, 2007; 
Ramawat and Goyal, 2008; WHO, 2008). Even the people of the developed world 
are also dependent directly or indirectly on plants for their health care. In the 
United States, 25% of the prescriptions given from community pharmacies 
consisted of plant extracts or active ingredients of plant origin (Cragg and 
Newman, 2005). In Dar es Salaam (the biggest city in Tanzania), 21% of patients 
who visited public hospitals have consulted a traditional healer before they come 
to hospital (de Boer et al., 2005). Plant-derived medicines are offered/taken in the 
form of tinctures, teas, poultices and powders, depending on the knowledge of the 
use and application method of a particular plant for a given ailment (Balunas and 
Kinghorn, 2005; Fennell et al., 2004).  
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Plants produce compounds of varying diversity as a means of defence against 
bacteria, fungi, pests and predators, hence the plants are efficient natural chemical 
factories, producing compounds of various structures that result in different 
physiological effects in the body once ingested (Edeoga et al., 2005). In 1985, 
Farnsworth et al. estimated that at least 119 substances isolated from plants were 
used as important drugs in one or more countries and that 74% of these 
compounds were discovered as a result of phytochemical studies on plants used 
for medicinal purposes (Farnsworth et al., 1985). The development of some 
synthetic drugs also uses plant-derived structures as leads (Ganesan, 2008; 
Vuorela et al., 2004). An analysis of the origin of new drugs that came onto the 
market during the period 1981-2006 indicated that only 37% of 974 new chemical 
entities were devoid of natural origin (i.e., purely synthetic) and that the remaining 
drugs are either a natural product or have a natural origin by having 
pharmacophores derived from a natural product (Newman and Cragg, 2007). 
 
The isolation and characterisation of natural products began over 200 years ago, 
when morphine (1) was first isolated from Papaver somniferum L. by a 21-year-old 
pharmacist’s trainee called Friedrich Sertürner. This was the first plant-derived 
pure compound with biological activity to be isolated and it formulated a foundation 
for alkaloid chemistry which consequently resulted in the development of more 
effective analgesic agents (Ramoutsaki et al., 2002). After this discovery, an era 












In 1820, the French researchers, Caventou and Pelletier isolated quinine (2), an 
antimalarial drug, from the bark of Cinchona L. trees (Guerra, 1977). The bark of 
these trees has been used by indigenous people of the Amazon region for the 
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treatment of fevers and in the early 1600s the bark was first introduced into 
Europe for the treatment of malaria. The bark was not only used for malaria 
treatment but also for treatment of lupus and arthritis. Nocturnal leg cramps was 
known to be treated by quinine, however, recently the FDA has regarded this kind 
of treatment as uncertain (FDA, 2010). The discovery of 2 laid the foundation for 
the synthesis of chloroquine (3) and mefloquine (4), which were commonly used 
antimalarial drugs for several years. The more effective antimalarial drug 
artemisinin (5) was first isolated from Artemisia annua L. (Quinhaosu), a plant that 
has long been used as a remedy for fever in Chinese traditional medicine. 
Artemisinin (5) then served as a lead structure for the development of the 

















































6  R= CH3
7  R= CH2CH3  
 
Strychnine (8), a colourless crystalline alkaloid was isolated from the seed extract 
of Strychnos L. species (Loganiaceae) native to India and Southeast Asia by the 
French botanist Leschenault de la Tour (1773-1826). The powdered seeds and 
decoction have been used by Hindu physicians in the treatment of certain types of 
cancer, digestive disorders, and diseases of the nervous system, heart diseases, 
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respiratory and circulatory problems and in the treatment of cutaneous diseases 
(ulcers infested with maggots). The plant has long been used as an arrow poison 
in Java, Indonesia. The structure of 8 was first elucidated by Sir Robert Robinson 
(Robinson, 1945) and its total synthesis was first accomplished in 1954 by Robert 
W. Woodward (Woodward and Brehm, 1948; Woodward et al., 1947; Woodward 
et al., 1954). Small doses of 8 help in improving appetite and provide a generally 
strong and hopeful feeling. When dosage is increased, 8 is known to quicken and 
deepen the respiration and to increase pulse and blood pressure. At poisonous 
dosages (30 to 120 mg.Kg-1), 8 affects the nervous system, particularly the spinal 











The genus Strophanthus DC. (Apocynaceae) is found in tropical Africa and Asia, 
where for hundreds of years the natives have used the seeds of these plants to 
make poisonous arrow heads for hunting. The isolation of G-strophanthin (9) (also 
known as milk for the ageing heart) and its formulation into a cardiotonic agent 
established a remedy for cardiac diseases. G-strophanthin is a steroidal glycoside 
isolated from the dried ripe seeds of Strophanthus species (Apocynaceae). The 
compound is known to strengthen contraction of cardiac muscles and has 
predominant systolic action, therefore an excellent remedy for patients with 





















Salicylic acid (10) was first isolated from the trees of the genus Salix commonly 
called willow trees, but later the compound was also isolated from the flowers of 
Filipendula ulmaria (L.) (meadowsweet). The meadowsweet plant has been used 
as a remedy for flu, rheumatism, arthritis and fevers in some communities of 
western Asia and Europe. The plant is also known to have anti-ulcerogenic, anti-
tumour, anti-microbial, anti-carcinogenic, antioxidant and anti-coagulant activities. 
Salicylic acid, the active principle of the meadowsweet flowers has a disagreeable 
irritating taste when taken orally and its side effects, which limits its usage. The 
acetate derivative of 10, acetylsalicylic acid (11), was first synthesized in 1850 and 
this has become the prototypical aspirin of today (Vane and Botting, 2003; Yildirim 






10 11  
 
The antihypertensive agent, reserpine (12), an indole alkaloid, was developed 
from the traditionally-used medicinal plant Rauwolfia serpentine Benth. The plant 
is locally used in Ayurvedic medicine for the treatment of snakebites. Reserpine 
(12) has been used for a long time as an anti-psychotic and anti-hypertensive 
drug. However, due to its side effects and the evolution of better drugs for the 






















In 1887, an alkaloid ephedrine (13) was first isolated from Ephedra sinica Stapf. 
(Ma Huang), a plant with a history of being used for the treatment of the common 
cold, hay fever and asthma in Chinese traditional medicine. Ephedrine (13), an 
appetite suppressant in combination with herbs containing caffeine, is known to 
enhance weight loss and/or to improve athletic performance. Structurally, 13 is 
similar to its semi-synthetic derivatives amphetamine and methamphetamine. The 
structure of 13 as a bronchodilator, has laid the foundation where anti-asthma 
compounds (beta agonists) were synthesized, viz. salbutamol (14) and salmeterol 





















14 15  
 
A benzylisoquinoline, tubocurarine (16), was isolated from Chondrodendron Ruiz 
& Pav. species. The compound is a neuromuscular-blocking drug or skeletal 
muscle relaxant and it is used in anaesthesia to provide skeletal muscle relaxation 
during surgery. Chondrodendron species have long been used by the indigenous 

















A large number of chemotherapeutic agents used in cancer treatment are derived 
from natural products. Similarly, several laboratories throughout the world have 
directed considerable efforts towards discovering new chemotherapeutic agents of 
natural origin. Vinblastine (17) and vincristine (18), also called vinca alkaloids, 
were first isolated from Catharanthus roseus L. (Madagascar periwinkle). These 
compounds were discovered during a search for potential sources of 
hypoglycaemic drugs; this was due to the fact that the plant was traditionally used 
for the treatment of diabetes. Vinca alkaloids are known to bind to tubulin dimers 
thereby inhibiting the assembly of microtubule structures and hence affect cell 
division of all rapidly dividing cells including cancer cells (Gigant et al., 2005; 
















18   R=CHO  
 
Podophyllum (L.) (meaning ‘shield-formed’) species, also known as May apples, 
are originating from the Himalayan region where several other medicinal plants are 
found. The plants have been used locally for the treatment of skin cancers, warts, 
and as a purgative and emetic for several hundreds of years (Alam et al., 2008). 
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The roots of the plants were used both as a medicine and poison by Asians, in 
some cases they were used as a suicide agent (Alam et al., 2008). Two 
compounds, epipodophyllotoxin (19) and podophyllotoxin (20) are non-alkaloidal 
toxic lignans isolated from the roots and rhizomes of Podophyllum species. These 
compounds have anticancer activity by arresting mitotic division of the cell, 
however, the clinical use of 20 was largely affected by its undesirable 
gastrointestinal toxicity (Damayanthi and Lown, 1998). Due to this side effect, the 
synthetic glycosides of Podophyllum lignans and the semisynthetic derivatives of 
20, viz. etoposide (21) and teniposide (22) were discovered (Canel et al., 2000; 
Cragg and Newman, 2005). 
 
Compounds 21 and 22 have a unique mechanism of action, they are DNA topo-
isomerase II inhibitors and hence arrest the growth of cancer cells by causing 























However 20, which is the parent compound, has no inhibitory effect against DNA 
topoisomerase II, but is a potent inhibitor of microtubule formation and thereby 
inhibit cell division (Canel et al., 2000; Cragg and Newman, 2005; Gordaliza et al., 






































21 22  
 
Paclitaxel (23) (Taxol®) was isolated from the bark of Taxus brevifolia Nutt., T. 
canadensis Marsh. and T. baccata L. These species are known to be used by 
Native Americans for treatment of noncancerous conditions. Paclitaxel (23) is a 
diterpenoid alkaloid with anticancer activities; the compound is known to disrupt 
the microtubule functioning and hence inhibit the process of cell division. The 
compound is effective in the treatment of cancers of the ovary, breast, lung, 
oesophagus, bladder, endometrium and cervix (Chan and Yang, 2000; Takimoto 
























Like any other growing cell, cancer cells rely on a developing vasculature to meet 
their needs in terms of oxygen, nutrients and depuration. This implies that if the 
vascular bed that has developed within the tumoural mass can be made to 
collapse, then tumoural growth can be significantly hampered. The 
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combretastatins (24 and 25) act as anticancer agents by shutting down the 
vascular systems in tumour cells thereby causing tumour necrosis. These 
compounds were isolated from Combretum caffrum (Eckl. & Zeyh.), a Zulu 
medicinal plant locally called South African bush willow. Sodium phosphate salt of 
24 and 25 were developed to overcome the problem of their insolubility in water. 
The sodium phosphate form 26 act as a prodrug which when subjected to 






















In search of more efficient anticancer drugs, a considerable number of compounds 
were synthesized based on the combrestatin skeleton (Cragg and Newman, 2005; 
Holwell et al., 2002; Li and Sham, 2002; Pettit and Lippert, 2000; Tozer et al., 
2002; Tron et al., 2006; West and Price, 2004). 
 
Ancistrocladus korupensis (D. W. Thomas & Gereau) (Ancistrocladaceae), a plant 
native to Korup National Park in Cameroon is the main source of michellamine B 
(27). The compound is an anti-HIV naphthalene-tetrahydroisoquinoline alkaloid 
and the leaves of this plant are the only known source of the compound. 
Michellamine B (27) is known to inhibit HIV-1 in its early T-lymphocyte viral 
infection phase and also inhibits HIV-2 in MT-2 cells. The studies done on dogs 
showed that the effective anti-HIV in vivo concentration of the compound is 
reached close to its neurotoxic concentration level. Thus, despite its in vitro activity 
against a wide range of HIV-1 and HIV-2 strains, the small difference between the 
toxic concentration and the concentration required for efficient antiviral activity has 
resulted in the discontinuation of further studies designed for its clinical 
development (Alves and Rosa, 2007; Cheng et al., 2008; McMahon et al., 1995; 

















(+)-Calanolide A (28), an anti-HIV coumarin derivative, was isolated from the 
leaves and twigs of Calophyllum lanigerum Miq., a rare plant found in Sarawak, 
Malaysia. The compound act by inhibiting HIV-1 reverse transcriptase and has 
been chosen for preclinical trials by the US National Cancer Institute. However, 
the sources of 28 from plant material are problematic since the original population 
of plants was destroyed (Flavin et al., 1996; Spino et al., 1998). Other populations 
of the same species yielded only a small amount of 28. However, the latex of 
another species, C. teysmanii with major anti-HIV activity, contained (–)-calanolide 
B (30) as the active ingredient. Although 30 was slightly less active than 28, it was 
regarded as a better alternative due to the availability of the plant and because the 
latex can easily be obtained by just making small slashes on the mature tree bark 
without harming the plant. The studies focused on the isolation of active 
compounds from Calophyllum species yielded two enantiomers of calanolide A (28 
and 29), two enantiomers of calanolide B (30 and 31) and (-)-dihydrocalanolide B 




































Homalanthus nutan (G. Forst.) Guill. is a plant found in Samoa where it is locally 
known as the mamala tree. Indigenous people use a concoction made from the 
bark for the treatment of hepatitis. Research has lead to the isolation of a protein 
kinase C activator prostratin (33) from the plant. The compound is a phorbol ester, 
but unlike other phorbol esters (viz. phorbol myristate acetate (34)), 33 is not a 
tumour promoter (Gustafson et al., 1992). The antiviral activity of 33 was 
discovered during research on the traditional knowledge of Samoan healers in 
Falealupo village by ethnobotanist Paul Cox. Prostratin (33) showed antiviral 
activity against severe infection by numerous strains of HIV and also it activates 
gene expression of the virus from the latently infected cells (Anderson et al., 2006; 






























To conclude, many compounds with medicinal value have been isolated from 
plants that are traditionally used for medicinal purposes. Some of these 
compounds are currently in use clinically or have established a base for the 
synthesis of other compounds with better activities. 
 
1.2 Aims of the Study 
 
This investigation is aimed at studying the structures, biological activities and 
synthesis of the compounds present in the Zulu medicinal plant, Ochna serrulata 
Hochst.) Walp.  
 
The main aims of this project were: 
•  To isolate and characterise the compounds from the stem, leaves and roots 
of O. serrulata. 
•  To establish antimalarial and anticancer activities of the isolated 
compounds. 
•  To develop a synthetic methodology for the synthesis of the most active 
compound. 
 
The isolation and characterisation of the compounds from the stem and leaves are 
discussed in Chapter 3 of this thesis, whereas Chapter 4 discusses compounds 




The biological activities of the isolated compounds are reported in Chapter 5, and 
the synthesis of the most potent compound is reported in Chapter 6 of this thesis. 
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The observed resistance of pathogens and unwanted side effects exhibited by 
currently used drugs, necessitate a continuous search for new drugs against a wide 
variety of ailments (Verschaeve and Van Staden, 2008). It has been shown in 
Chapter 1 that many compounds with medicinal value are derived from traditionally 
used medicinal plants. In this Chapter, an overview of the documented traditional 
uses of plants from the family Ochnaceae, will be presented together with the 
compounds isolated from this family and their biological/pharmacological activities.  
 
2.2 Distribution, Economic Importance and Medicinal Uses of  
Ochnaceae plants 
 
The family Ochnaceae is mainly comprised of trees and shrubs with about 30 genera 
and 450 species which are highly distributed around the globe. Tropical Africa, Asia, 
Australia, Madagascar, the Mascarene islands and America as shown in the map 
below (Fig 2.1), are the regions where these species are mostly found (Coates, 2002; 
Mabberley, 2008). Species of the family Ochnaceae flourish in areas ranging from 
open to semi-open and in evergreen forests, they are characterized by evergreen 
petiole leaves which sometimes becomes leathery, specifically for the genus Ochna 




Fig 2.1: Distribution of Ochnaceae plant species 
(Map: http://www.discoverlife.org/mp/20q?search=Ochna&guide=Guianas_flora) 
 
The two genera, Brackenridgea and Ochna are commonly found in South Africa, 
Zimbabwe and Mozambique, with a total of 32 native species. For the genus 
Brackenridgea, about 12 species are known to be native to Southern Africa including 
Zimbabwe and Mozambique and 20 species of the genus Ochna occur in this area 
(Coates, 2002; Mabberley, 2008). 
 
Economic importance of members of Ochnaceae 
Some species of the family Ochnaceae are known to have economic value. Since 
species of the genus Ochna are known to have very attractive yellow flowers and 
beautiful fruits, the genus have been cultivated for ornamental purposes. Members of 
the genus Sauvagesia are used for making tea in Lesser Antilles, whereas members 
of Ouratea and Lophira are used as a source of a valuable oil, commonly called meni 
oil, from their seeds. Meni oil has gained popularity in Nigeria and some other West 
African countries where it is used for cooking, as a remedy for lice and as a hair 
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lotion. The seeds of these species also serve as food, regardless of their bitter and 
caustic taste. Lophira species found in West Africa are an excellent source of 
commercially valuable timber known by different names such as African oak, azobe, 
ekki, bongossi or red ironwood. The yellow dye from the bark of Brackenridgea 
zanguebarica Oliv. is used for dying mats to give a beautiful bright yellow colour 
(Lohlum et al., 2010; Mabberley, 2008; Moller et al., 2006; Rosalina, 2006). 
 
Medicinal uses 
In various traditional medicine systems, members of the family Ochnaceae are 
popularly used as medicines for different ailments. The species of the genus Lophira 
also known as Meni oil trees, locally called beung in Chamba language and namijin 
kadanya in Hausa language, are known to be helpful to pregnant women during 
labour. The leaves of Lophira plants are boiled in water and the resulting extract is 
used for drinking and washing for an easy labour. The inner bark of these plants is 
used for pain relieving purposes, especially for the treatment of headaches. The bark 
decoction is reported to be used to stop vaginal discharge and also for the treatment 
of diarrhoea, ovarian cyst and typhoid fever where one small cup is consumed three 
times a day (Jiofack et al., 2010; Lohlum et al., 2010). 
 
The genus Ouratea is used in Brazil and many West African countries in traditional 
medicine systems, where the leaves extracts are used for the treatment of upper 
respiratory tract infections, dysentery, and diarrhoea and as pain-relieving agents, 
especially for treatment of tooth ache. The extracts from the epicarp fruit commonly 
called folha-de-serra (Brazil) are used for the treatment of liver and skin infections  
(Brandão et al., 2011; Pegnyemb et al., 2005). 
 
The genus Brackenridgea is important as part of East African traditional medicine 
systems where the plants are used for the treatment of anaemia. The powdered roots 
of these species have been used to treat swollen parts of the body and for mental 
illnesses and worms. The powdered stem bark of these plants have been applied on 
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wounds and a decoction of the bark of these species is used as an eye wash. It is 
also effective against conjunctivitis and a decoction can be used in porridge 
preparation for a person with jaundice to drink in overcoming jaundice. The roots of 
the Brackenridgea plants are known as mumino in Muda (Mozambique) and are 
macerated in water and taken orally for the treatment of diarrhoea, to induce or to 
speed up the delivery process, miscarriage and treatment of venereal diseases 
(Bruschi et al., 2011; Moller et al., 2006). 
 
2.3 Genus  Ochna: Local Uses 
 
More than 85 plant species are known to belong to the genus Ochna. The genus 
comprises of trees and shrubs which are distributed worldwide from tropical Africa, 
Asia to America. In Southern Africa Ochna species are found in South Africa 
(Limpopo, Mpumalanga, KwaZulu-Natal and Eastern Cape provinces), Swaziland, 
Zimbabwe and Mozambique. The genus was named by Linnaeus in 1753, the name 
Ochna originated from a Greek word, Ochne, which means “wild pear”; this is 
because the leaves of these species resemble those of the wild pear. Species of this 
genus are usually known as Ochnas or mickey mouse plants, this name is a result of 
the appearance of their black drupelets fruits sitting on a red receptacle mimicking the 
face of mickey mouse as shown in Fig 2.2 below (Coates, 2002; Mabberley, 2008). 
 
Ochna species, also called ‘sunari’ or ‘yerra juvvi’ in Indian traditional medicine 
systems, are regarded as one of the important drugs used in the treatment of different 
ailments such as constipation, ulcers, sores, cancers, epilepsy, menstrual complaints, 
lumbago, asthma, and as an antidote to snake bites in India. While the root bark of 
the plant is used as a digestive tonic, the boiled leaves are considered to be a key 
element in the treatment of lumbago and ulcers. The decoction of the roots of these 
plants in Indian traditional medicine are used in the treatment of menstrual complaints 





Fig 2.2: Ochna serrulata leaves and fruits 
(Photo: http://www.biodiversityexplorer.org/plants/ochnaceae/ochna.htm) 
 
Ochna integerrima Merr. is a common plant which is widely distributed in Thailand, 
where in their traditional medicine systems, the bark of this plant is used as a 
digestive tonic. In Indonesia an infusion of the roots and leaves are used as an anti-
dysenteric and an antipyretic agent. The flowers are the most celebrated flowers in 
Vietnam.  During “Tet” festivals, Vietnamese New Year festivals, the bright yellow 
flowers of the plant are used for decoration. In Vietnamese culture it is regarded as a 
must to grow plants for “tet” celebrations, bringing good luck and prosperity to the 
family (Kaewamatawong et al., 2002; Likhitwitayawuid et al., 2001). 
 
In Swazi traditional medicine systems, the bark of Ochna arborea Burch. Ex DC, also 
called Cape Plane Tree or sifubasenkhala in siSwati, is used for healing bone 
fractures and pain relieving especially for the cure of headaches. For the same 
healing purpose, O. gamostigmata (Bird's-eye Bush), O. holstii Engl. (red ironwood, 
umthelelo), O. natalitia Meisn. Walp. (Natal plane, lincedza) and O. serrulata 
(Carnival bush, umvuma) are also used. Ochna arborea is used to make handles and 
carved sticks to support old people and the plant is thought to be a protective charm 
to drive off evil spirits. Ochna natalitia is suspected to hybridize with O. serrulata in 




The indigenous people of Central Africa use the stem bark of O. calodendron for pain 
relieving purposes and for the treatment of liver infections and dysentery (Messanga 
et al., 2001). In Zimbabwe, the mature leaves of O. pulchra Hook., also called 
‘umnyelenyele’ or ‘muparamhosva’ in their vernacular language, is assumed to be 
good for cattle feeding, but its juvenile leaves are believed to be poisonous to cattle. 
In Zimbabwean traditional medicine systems, the plant is extensively used to treat 
blood parasites and various skin diseases (Sibanda et al., 1990). The Pare society of 
Kilimanjaro in Tanzania use the wood of O. holstii, locally known as ‘kitakwa’, for 
making handles, spears and firewood (de Boer et al., 2005). 
 
O. afzelii is a common tree of West Africa where it has various names in different 
West African countries. In Ghana the plant is locally known as adangme or 
okoliawatso, in Senegal as mandingbambara or mananitiana and in Togo as Tem or 
fanam. Various parts (leaves, roots, wood, bark) of the plant are used by the natives 
to treat different health problems including female sterility, menstrual complaints, 
jaundice, lumbago and dysentery (Bouquet, 1969). 
 
The stem bark of O. lanceolata, a semi-evergreen tree found widely in central and 
peninsular India is commonly used as an abortifacient and also for treating gastric 
complaints and menstrual disorders (Mathew, 1981; Muthukumarasamy et al., 2003). 
The Zulu people in South Africa use a decoction of the root of Ochna serrulata which 
is commonly known as fynblaarrooihout (Afr.), Umbomvane (Zulu), iliTye (Xhosa) for 
the treatment of bone diseases and gangrenous proctitis (Hutchings et al., 1996; 
Hutchings and Van Staden, 1994). 
In New South Wales and southern Queensland, Australia, O. serrulata has been 
declared a noxious weed, class 4. The plant is described to be a tough and adaptable 
weed which grows in areas ranging from sunny and open positions to the shade of 
deep forest. It is believed to cause the disappearance of some indigenous species 
due to its adaptability nature and easy spread. The plant has been widely cultivated 
outside South Africa as an excellent ornamental garden plant (Wolff, 1999).  
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2.4 The Genus Ochna: Phytochemistry and Biological Activities  
 
From the previous phytochemical studies on the genus Ochna, it has been revealed 
that the genus is rich in phenolic biflavonoids (Khalivulla et al., 2008; Likhitwitayawuid 
et al., 2001; Pegnyemb et al., 2001, 2003b). Flavonoids, an abundant class of plant 
constituents, are acknowledged to exhibit numerous biological/pharmacological 
activities such as anticancer, antibacterial, antiviral, anti-inflammatory, 
immunomodulatory activities, antimalarial and anti-HIV activities (Ichino et al., 2006; 
Murakami et al., 1991a; Murakami et al., 1991b; Murakami et al., 1992; Reutrakul et 
al., 2007).  
 
The rearranged biflavonoids, calodenone (35), lophirone A (36) and afzelone D (37), 
were isolated for the first time from the methanol extracts of the stem bark of O. 
calodendron, Lophira lanceolata and O. afzelii, respectively (Ghogomu et al., 1987; 
Messanga et al., 1992; Pegnyemb et al., 2003a). The compounds represent a very 
unusual skeleton of a biflavonoid (Ghogomu et al., 1987). Lophirone A (36) has been 
reported to be an inhibitor of Epstein-Barr virus and has shown inhibitory properties 
against tumor promotion. To date there are many reports on the isolation of 36 from 
Ochna species (Anuradha et al., 2006; Kaewamatawong et al., 2002; Kittisak et al., 
2005; Pegnyemb et al., 2003b). There are no filed reports on the biological activities 
of 35 and 37.  
Dimeric chalcones have also been isolated from the genus Ochna, the report filed by 
Messanga and co-workers indicated the isolation and characterization of lophirone K 
(38) and lophirone C (39) from Lophira lanceolata. Calodenin A (40) and calodenin B 
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The other dimeric chalcones reported from O. afzelii are isolophirone C (42) and 
dihydrolophirone C (43). The roots of Lophira lanceolata yielded three dimeric 
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It is of interest to note that the relative configuration of lophirone C (39), G (45) and F 
(44) are known but the absolute configurations have not been determined. There are 


































































From the stem bark of O. integerrima, a derivative of lophirone B (47a), 6'''-
hydroxylophirone B (47b) was isolated together with an O-glucosylated chalcone  6'''-
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The stem bark of O. afzelii, a plant commonly found in tropical Africa, yielded two 
biflavonoids, namely a flavanone/chalcone hybrid, afzelone A (49) and a biflavanone, 
afzelone B (50) (Pegnyemb et al., 2001, 2003b). The biological activities of these 



















The aerial parts of Ochna squrrosa yielded an ether-linked biflavone, ochnaflavone 
(51) (Okigawa et al., 1976). The compound has also been isolated from aerial parts of 
Lonicera japonica (Caprifoliaceae) (Kun et al., 1992). Derivatives of ochnaflavone 
have been isolated from other plant species, these are 7-methoxy-2,3-
dihydroochnaflavone (52) and  2,3-dihydroochnaflavone (53) from the leaves of O. 
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2’’,3’’-Dihydroochnaflavone (54), another ochnaflavone derivative, was isolated from 
the leaves and twigs of O. integerrima (Likhitwitayawuid et al., 2001). Ochnaflavone 
(51) has a broad range of biological/pharmacological activities including anti-
inflammatory, anticancer, anti-HIV and anti-atherogenic activities (Suh et al., 2006a; 
Suh et al., 2006b; Suh et al., 2006c). 
 
Reutrakul and group reported the isolation and anti-HIV activity of the derivatives of 
51 viz. 7''-methoxyochnaflavone (55) and 7”-methoxy-2'',3''-dihydroochnaflavone (56). 
The compounds were isolated from the leaves of O. integerrima and were found to 
exhibit a potent anti-HIV activity with EC50 values of 2.0 and 0.9 µg/mL, respectively 
(Reutrakul et al., 2007). The two compounds 55 and 56 were also found to inhibit the 
HIV-1 reverse transcriptase (RT) enzyme with IC50 values of 2.0 and 2.4 µg/mL, 
























O. integerrima yielded prenylated and glucosylated flavonoids with significant anti-HIV 
activities. These compounds include 6-γ,γ-dimethylallyldihydrokaempferol 7-O-β-D-
glucoside (57), 6-γ,γ-dimethylallylquercetin 7-O-β-D-glucoside (58), 6-(3-hydroxy-3-
methylbutyl)taxfolin 7-O-β-D-glucoside (59),  6-(3-hydroxy-3-methylbutyl)quercetin 7-
O-β-D-glucoside (60).  The anti-HIV activities of these compounds range from EC50 14 
























































Potent antimalarial activities have been shown by isocampylospermone A (61) and 
campylospermone A (62); these compounds are diastereomers isolated for the first 
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time from the stem bark of O. integerrima. Biflavanoids 61 and 62 have shown to be 
significantly active against Plasmodium falciparum multidrug resistant strains (K1) at  
0.08 and 5.2 µg/mL,  respectively, and multidrug sensitive strains (FCR3) at 0.26 and 
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Kaemferol 3-O-α-rhamnoside (63) and ruixianglangdusu B (64) were isolated from the 
leaves of O. lanceolata (Khalivulla et al., 2008; Kun et al., 1992), there are no filed 

























In 1987, Kamil et al. reported the isolation of tetrahydroamentoflavone (65) and 
amentoflavone 7''-O-methyl ether (66) from the leaves and twigs of O. pumila (Kamil 
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From the roots of O. pulchra (Ochnaceae), a woody plant found in southern and 
central Africa, Sibanda and co-workers reported the isolation of vismiones from the 
genus Ochna for the first time. The compounds isolated from the plant were 
ochnabianthrone (67) together with vismiones L (68), M (69), D (70), acetylvismione 
D (71) and 3-O-geranylemodinanthrone (72) (Sibanda et al., 1990, 1993). The 
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Members of the family Ochnaceae are widely used in traditional medicine systems of 
different cultures in the treatment of dysentery, liver infections and blood parasites. 
The family is also known for its use in curing toothaches, lumbago, ulcers, menstrual 
complaints, cancer and sores. Conditions like constipation, asthma and epilepsy are 
known to be cured by the use of Ochnaceae plants. There is a large diversity in the 
compounds that have been isolated from Ochnaceae species ranging from simple 
flavonoids to complex flavonoids. However, only the relative configuration of these 
compounds is known and the absolute configuration has not been determined. The 
biological/pharmacological activities of these compounds isolated from Ochnaceae 
species have up to now not received enough attention. This thesis therefore intends 
to report the isolation, structural elucidation as well as biological activities of the 
compounds from O. serrulata. In the next chapter, the isolation and characterization 
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The phytochemistry of some species of Ochna has been studied as discussed in 
Chapter 2 of this thesis. However, the phytochemistry of O. serrulata has not been 
investigated, therefore, in Chapter 3 and 4 of this thesis, the structures of the 
compounds present in the stem, leaves and roots of O. serrulata are reported for 
the first time. 
 
3.1.1 Ochna serrulata 
 
O. serrulata is a plant with bright yellow flowers accompanied by a very unusual 
persistent calyx that enlarges and becomes bright red when in fruit. The fruits are 
also colourful with black drupelets sitting on a bright red, open receptacle (Golding, 
2002). The species name of the plant is derived from the Latin word serrula 
meaning "little saw", referring to its fine-toothed leaf margins (Simpson, 1979). 
 
O. serrulata is a small shrub mostly growing to a height of 1 to 2 m; occasionally 
the plant may become a small tree of up to 6 m high. Its leaves are narrow and 
shiny green with fine toothed serrations along its edges. In spring, the fragrant 
yellow flowers of the plant blossom but the petals have a tendency of dropping 
soon after they bloom and five or six fruits grow together attached to the sepals. 
During the fruit development, the sepals tend to enlarge and its colour changes to 
bright red (Mark, 1999). In Southern Africa, O. serrulata are found in South Africa 
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(Limpopo, Mpumalanga, KwaZulu-Natal and Eastern Cape), Swaziland, Zimbabwe 
and Mozambique (Golding, 2002).  
The aims of this Chapter are: 
 
•  To report the isolation of the compounds from the stem bark and leaves of 
O. serrulata 
•  To report the structures of the isolated compounds from the stem and 
leaves of the plant. 
 
3.2 Results and Discussion 
 
The EtOAc extracts of the pulverized stem and leaves of O. serrulata afforded a 
rearranged biflavonoid lophirone A (36), lophirone C (39), three biflavonoids 
afzelone B (50), ochnaflavone (51), 2”,3”-dihydroochnaflavone (54), a mixture of 
isocampylospermone A (61) and campylospermone A (62), methyl (2’,4’-
dihydroxyphenyl)acetate (73), (2’,4’-dihydroxyphenyl)acetic acid (74), epicatechin 
(75), 5-deoxyurundeuvine C (76), two C-glucosylated flavones psilosin (77) and 3’-
O-methylpsilosin (78) and a cyanoglucoside (79). Compounds 61 and 62 were 
also isolated from the roots of the plant and their structural elucidation will be 
discussed in Chapter 4. 
 











In the 1H NMR and 1H, 1H COSY spectra of 73 (Plate 1a and 1b) an ABX aromatic 
spin system at δH 6.28 (d), 6.23 (dd) and 6.87 (d) was identified. Methylene 
protons resonated at δH 3.48 (s, 2H) and a methoxy group was observed at δH 3.64 
(s, 3H).  
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The 13C NMR spectrum (Plate 1c) showed the presence of nine peaks 
corresponding to nine carbons, consistent with the proposed structure. Two peaks 
at δC 157.3 and 156.1 are characteristic of aromatic carbons bonded to oxygen 
atoms and the peak at δC 173.8 suggesting the presence of an ester carbonyl 
carbon. The peak at δC 50.7 correlated with the methoxy protons in the HSQC 
spectrum. Furthermore, the HMBC spectrum (Plate 1d) pointed out the correlation 
between the methoxy group and the carbonyl at δC 173.8, confirming the presence 
of a methyl ester group. The long-range correlations between the methylene 
protons and C-1’ of the aromatic ring implied that the methylene group is linked to 
C-1’ of the aromatic ring. 
 
The HMBC spectrum indicated 1H/13C correlations shown in Fig. 3.1 confirmed the 












73    
Fig. 3.1: HMBC correlations in structure 73  
 
The compound was isolated for the first time from Madhuca pasquiery and later 
from the seeds of Ilex aquifolium. It is reported to have antioxidant activity at 2.55 
x 10–3 mg.mL-1 (Nahar et al., 2005; Taylor et al., 2011). This is the first report on 
the isolation of methyl (2’,4’-dihydroxyphenyl)acetate from Ochna species. 
 










Careful observation of the 1H NMR and 1H, 1H COSY spectra of 74 (Plate 2a and 
2b) showed the presence of an ABX aromatic spin system at δH 6.34 (d), 6.28 (dd) 
and 6.87 (d) as well as methylene protons which resonated at δH 3.42 (s, 2H). 
Essentially, 74 showed same features in the NMR spectra as 73, with the only 
difference being the absence of a methoxy group in 74. 
 
The 13C NMR spectrum showed the presence of eight carbons consistent with the 
proposed structure, where the peak at δC 177.2 signified the presence of a 
carbonyl group and the two oxygen-linked aromatic carbons resonated at δC 156.3 
and 157.6. A DEPT-135 experiment (Plate 2f) established the presence of a 
methylene carbon at δC 36.6. The correlations between the methylene protons and 
carbons resonating at δC 177.2 (C-1), δC 156.3 (C-2’), δC 130.9 (C-6’) and δC 113.3 
(C-1’) showed that the methylene carbon is linked to the aromatic ring and at the 
same time to the carbonyl carbon resonating at δC 177.2. 
 











Structures 74 and 74a will give the same splitting pattern in their NMR spectra but 
74a is not the correct structure since the downfield resonance of the carbonyl 
carbon at δC 177.2 is not consistent with the presence of a lactone functionality 
(Iqbal et al., 1995). The 1H/13C correlations from the HMBC spectrum (Plate 2e) 
















Fig. 3.2: HMBC correlations in structure 74 
 
This compound has previously been identified as a constituent of a spider (Nephila 
clavata) toxin; it acts by inhibiting binding of L-glutamic acid to the brain synaptic 
membranes and hence causes paralysis of the prey (Kim et al., 1998; Pan-Hou et 
al., 1987; Taylor et al., 2011). The compound was also isolated from the seeds of 
Ilex aquifolium by Nahar and co-workers who reported an antioxidant activity at 1.5 
x 10-3 mg.mL-1 for the compound (Nahar et al., 2005). In the Ochnaceae, the 
compound was isolated for the first time from the MeOH extract of the branches of 
Ouratea hexasperma (de Carvalho et al., 2008). The observed difference between 
the NMR data of the reported compound and the one reported in this thesis is 
attributed by different solvents used for NMR experiments. The isolation of (2’,4’-
dihydroxyphenyl)acetic acid from an Ochna species is reported here for the first 
time. 
 














The 1H NMR (Plate 3a) and 1H, 1H COSY (Plate 3b) spectra showed the presence 
of an ABX aromatic spin system at δH 6.96 (d, J=1.9 Hz), 6.78 (dd, J=1.9, 8.1 Hz) 
and 6.70 (d, J=8.1 Hz). The presence of a tetrasubstituted aromatic system was 
revealed by the two m-coupled protons at δH 5.93 and 5.91 for H-6 and H-8, 
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respectively, of a flavonoid derivative. Two chemically different methine protons 
were present at δH 4.79 (H-2) and 4.16 (m, H-3) (H-2 was overlapping with the 
solvent signal in 1H NMR spectrum but its chemical shift was obtained from the 
HSQC spectrum).  Methylene protons resonated at δH 2.84 (J =17.0, 4.6 Hz, H-4) 
and 2.72 (J=17.0, 4.6 Hz, H-4) in 1H NMR and 1H, 1H COSY spectra. 
 
In the 13C NMR spectrum (Plate 3c) there were fourteen signals and the peaks at 
δC 157.9, 157.6, 157.3, 145.9 and 145.7 are in agreement with the presence of five 
oxygen-linked aromatic carbons in the proposed structure. The absence of peaks 
at δC 170-190 showed the absence of carbonyl carbons in the compound. In the 
HMBC spectrum (Plate 3e), the long-range correlations between H-2’, H-6’ and C-
2 implied that the ABX aromatic ring system was connected to the pyran ring at C-
2. The two m-coupled aromatic protons at δH 5.91 (1H, d, J=2.4 Hz) and 5.93 (1H, 
d, J=2.4 Hz) showed long-range 1H/13C correlations [HMBC spectrum (Plate 3e)] 
with C-7, C-4a and C-8a at δC 157.3, 100.1 and 145.7, respectively, confirmed the 
presence of the benzopyran system of the flavonoid unit. The connectivity of the 





















Fig. 3.3: HMBC correlations in structure 75  
 
The pseudo-molecular ion peak [M+Na]+ at m/z 313.0688 in the positive-ion mass 
spectrum is consistent with the molecular formula of C15H14O6. Based on the 
spectroscopic evidence, compound 75 was assigned as epicatechin.  
 
Epicatechin (75) is known for its antioxidant and anticarcinogenic  activities, it is 
also an anti-artherogenic and antitumor agent (Xu et al., 2004). The compound 
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was initially called kakaool due to the fact that it is found in large quantities in 
cacao beans (Freudenberg et al., 1932). There are several reports on the isolation 
of this compound from Ochna species (de Carvalho et al., 2008; Rao et al., 1997; 
Reddy et al., 2008). 
 




























A yellow amorphous solid, compound 36, produced a characteristic red coloured 
spot when stained with anisaldehyde/sulfuric acid and heat. Structural 
determination of 36 was achieved by careful analysis of 1D (1H, 13C) and 2D 
(HMBC, HSQC, COSY) NMR spectra. 
 
The 1H, 1H COSY (Plate 4b) and the 1H NMR spectra (Plate 4a), showed the 
presence of two p-substituted aromatic rings and two trisubstituted phenyl ring 
systems. A singlet at δH 8.28 is characteristic of H-2 of a 3-substituted benzopyran-
4-one moiety (such as an isoflavone) and the peaks at δH 6.15 and 4.79 revealed 
the presence of an AX system. The large coupling (J=12.1 Hz) observed between 
the latter two protons suggested that they are in an antiperiplanar conformation. 
 
In the 13C NMR spectrum (Plate 4c) there are 22 peaks corresponding to 26 
carbons with chemical shifts between δC 100 to 170 implying the presence of four 
aromatic ring systems in addition to the pyran-4-one ring. The methine carbons at 
δC 53.6 and 44.1 were correlated to protons at δH 4.79 and 6.15, respectively, in 
the HSQC spectrum (Plate 4d). The two carbonyls resonated at δC 204.7 and 
175.4 and the up-field resonance of the later carbonyl suggested that it is part of a 
4-pyrone system. 
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The position of the two p-substituted aromatic ring systems (AA’XX') was 
unambiguously assigned by to the long-range heteronuclear correlation [HMBC 
spectrum (Plate 4e)] between H-β2 at δH 4.79 and C-1A2 and C-1A1 at δC 135.8 
and 134.7 of ring A1 and A2, respectively, indicative of the connection of both rings 











Fig. 3.4: HMBC correlations in partial structure 36a 
 
The 1H NMR spectrum showed the presence of a singlet at δH 11.67 signifying that 
one of the trisubstituted aromatic rings has a hydroxy group peri to a carbonyl 
group. The downfield resonance of  H-6B1 (at δH 7.94) shows its close proximity to 
the carbonyl and therefore, the second trisubstituted aromatic ring (ring B1) is not 
substituted at C-5 (Abraham et al., 2003). 
 
The presence of a singlet at around δH 8.28 (H-β1) evidenced that C-2 of the 
benzopyran moiety is not substituted. The long-range correlation between H-α2 (at 
δH 6.15) and C-α1 (at δC 122.3) confirms that C-α2 is linked to the benzopyran 
moiety through C-α1. The position of the first trisubstituted aromatic system was 
confirmed by the long-range correlations between H-6B1 (at δH 7.94) and the 
carbonyl at δC 175.4 suggesting that this particular ring (B1) is part of a benzopyran 
moiety and therefore forms ring A of a flavonoid skeleton.  
 
Long-range correlations between H-6B2 (δH 8.33) and a carbonyl at δC 204.7 (C-2) 
suggested the connectivity of the second trisubstituted aromatic ring to this 
carbonyl, which in turn was also correlated to H-α2 as shown in partial structure 
36b (Fig. 3.5).  
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The assignment of 36 as lophirone A was confirmed further by the positive ion 
mass spectrum which exhibited a pseudo-molecular ion peak [M+Na]+ at m/z 533, 
in agreement with molecular formula of C30H22O8. The compound was previously 
isolated from the stem bark of Lophira lanceolata Van Tiegh Keay (Ochnaceae) by 
Ghogomu and coworkers. The NMR data of 36 was in agreement with those 
reported for lophirone A (Ghogomu et al., 1987). The proposed structure of 36 is 
rather unusual as a biflavonoid since common biflavonoids have two C6-C3-C6 





















Fig. 3.5: HMBC correlations in the partial structure 36b 
 
Lophirone A (36) has been reported to be an inhibitor of Epstein-Barr virus and 
has also shown inhibitory properties against tumor promotion. To date there are 
many reports on the isolation of 36 from Ochna species (Anuradha et al., 2006; 
Kaewamatawong et al., 2002; Kittisak et al., 2005; Pegnyemb et al., 2003). In an 
attempt to determine the absolute configuration of the compound at C-α2, 
Murakami et al. have reported the crystal structure of a p-bromobenzoate 
derivative of 36, but they could not determine the absolute configuration because 
racemic crystals were obtained (Murakami et al., 1991).  
 
The biosynthesis of 36 (Fig. 3.6) is believed to involve a rearrangement of a 
dimeric flavanone. The first step is the protonation of the oxygen atom of the 
benzopyran system followed by the formation of a phenol (in red) and a new bond 
(in red) between the p-hydroxy aromatic ring and one of the methine carbons. The 
second step is marked by the removal of a hydrogen atom from the C-3 of the 
remaining benzopyran system, thereby resulting into the breaking of the bond 
between the p-hydroxy aromatic system and the benzopyran system hence a total 
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shift of the ring and formation of the 3-substituted benzopyrone unit (in red) 
(Masatake et al., 1984). 
 
It is interesting to note that from the stems and roots of O. serrulata, dimeric 
flavanones (campylospermone type) and lophirone A have both been isolated 



























Fig. 3.6: Proposed biogenesis of 36 (Masatake  et al., 1984) 
 



















The structural determination of 39 was achieved through a combination of different 
spectroscopic techniques including MS, 1H, 13C, COSY, HMBC and HSQC. 
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Careful examination of the 1H, 1H COSY (Plate 5a) and the 1H NMR spectra (Plate 
5b) showed the presence of a p-hydroxy aromatic ring and three trisubstituted 
aromatic ring systems together with an α,β-unsaturated carbonyl moiety at δH 7.72 
(1H, d, Jα1, β1 =15.4 Hz, H-β1) and 7.51 (1H, d, Jα1, β1 =15.4 Hz, H-α1). In addition, 
the spectra showed the presence of two vicinal methine protons at δH 6.09 and 
5.31, each integrating for one proton. 
 
The 13C NMR (Plate 5c) spectrum showed the presence of 30 carbons with peaks 
at δC 167.7, 166.6, 163.7 (2C) and 159.3 (2C) indicating the presence of six 
oxygen-linked quaternary aromatic carbons. The signal for the C-α2 could not be 
observed in the 13C NMR spectrum. The signal for H-α2 was disappearing with 
time, while that of H-β2 was changing from doublet to singlet over time. However, 
the compound was isolated as a clean sample from the plant. The 1H/13C 
correlation present in HMBC spectrum (Plate 5e) between H-6B1 and the carbonyl 
at δC 193.4 confirms that a 2,4-dihydroxy aromatic ring system (ring B1) is linked to 
this carbonyl (C1). The mentioned carbonyl was in turn correlated to the H-α1 and 
H-β1 at δH 7.51 and 7.72, indicating the linkage of these sp2 carbons to the 
mentioned carbonyl as shown in the proposed structure. Furthermore, these 
protons attached to sp2-hybridized carbons correlated to C-1A1 (at δC 129.1), C-
2A1 and C-6A1 (at δC 126.9 and 132.5 respectively), verifying the linkage of the 
second trisubstituted aromatic ring system (ring A1) to the two sp
2 carbons (C-α1 



















Fig. 3.7: HMBC correlations in partial structure 39a 
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The carbonyl at δC 201.7 (C2) correlated with the methine proton attached to the 
sp3 carbon at δH 6.09 (H-β2). The mentioned carbonyl was further correlated to H-
6B2 at δH 7.74 indicating that the third 2,4-dihydroxyphenyl ring (ring B2) was linked 
to it as shown in the proposed structure 39b.  
 
The presence of a benzofuran instead of a benzopyran moiety was evidenced by 
the downfield resonance of the carbonyl at δC 201.7; if the carbonyl was present in 
a ring as in the 4-pyranone systems, the resonance would have been around δC 
180-190 (Pegnyemb et al., 2001). 
 
The 1H/13C correlation between H-β2 and C-1A2 (of AA’XX’ system) as well as the 
correlation between H-2, 6A2 at δH 7.21 and C-β2 at δC 89.2 pointed out the 
connectivity of p-hydroxyphenyl ring to C-β2. Thus the NMR data allowed 




















Fig. 3.8: HMBC correlations in partial structure 39b 
 
The negative ion mass spectrum exhibited a pseudo-molecular ion peak [M-H]- at 
m/z 510, in agreement with a molecular formula of C30H22O8. The NMR data of the 
compound correlated with that reported for lophirone C, previously isolated from 
the stem bark of Lophira lanceolata Van Tiegh Keay (Ochnaceae) (Pegnyemb et 
al., 2001). Biosynthetically, 39 is proposed to originate from 2’,4’,4-
trihydroxychalcone (39c). After conjugate addition of 2’,4’,4-trihydroxychalcone on 
itself to form a dimer (39d), cyclization of the intermediate 39e gives the 

































Fig. 3.9: Proposed biogenesis of 39 (Ghogomu et al., 1989; Shimamura et al., 
1996) 
 
There are no filed reports on the biological activities of lophirone C (39). It is of 
interest to note that the relative configuration of 39 is known but the absolute 
configuration has not been reported.  
 




















The presence of two p-hydroxy aromatic systems, one trisubstituted aromatic 
system and a pentasubstituted aromatic ring system were established from the 
detailed analysis of 1H NMR (Plate 6a) and 1H, 1H COSY (Plate 6b) spectra. 
These spectra also depicted two vicinal diaxial protons as part of a pyrano ring at 
δH 5.84 and  4.62 and an AMX spin system at δH 3.03 and 2.61 for H-3, and 5.27 
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for H-2, indicating the presence of two flavanone moieties, one of which 
substituted at C-3”. 
 
Twenty-four signals were observed in the 13C NMR spectrum (Plate 6c) 
corresponding to 29 carbons as per proposed structure, the signal for C-3” could 
not be detected in the spectrum, but could be observed in HSQC spectrum. The 
presence of seven oxygen-linked quaternary aromatic carbons was evidenced by 
the peaks at δC 166.7, 165.7, 163.9, 159.17, 159.16 and 158.8 (2C), consistent 
with the proposed structure.  
 
The connectivity of the above-mentioned systems was established by 1H/13C 
correlations present in HMBC spectrum (Plate 6e). The correlation between H-2 
(δH 5.27) and C-2’,6’ (δC 129.2) indicated that one of the p-hydroxy aromatic 
system was linked to the benzopyran system through C-2 as expected in 
flavanones. 
 
The substitution in the pentasubstituted aromatic system can be according to 
structure 50a, 50b or 50c below, where all three structures will give the similar 



































A singlet at δH 5.80 belongs to the pentasubstituted aromatic ring and the high-field 
resonance indicated that the proton is not peri to the carbonyl because if it were, 
then it would have had a lower field resonance at around δH 7.5-8.0. This was 
further supported by the presence of the hydrogen-bonded proton at δH 11.8 which 
showed that C-5 was hydroxy substituted and therefore structure 50b is not the 
correct structure for 50 (Abraham et al., 2003). NOE correlation observed between 
H-2, H-3” (at δH 5.27, 4.62) and the aromatic singlet H-8 (at δH 5.80) supports the 
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presence of a proton on C-8. The above-mentioned facts confirm that partial 



























Fig. 3.10: HMBC correlations in partial structure 50a 
 
The position of the second p-substituted aromatic system was assigned to be 
linked to C-2” due to the 1H/13C long-range correlations between H-2" (δH 5.84) 
and C-2’”,6’” (δC 130.1) as expected in flavanones (Fig. 3.10). The ABX aromatic 
system was part of the benzopyran system thereby forming the second flavanone 
unit as was established by  the long-range correlations between H-5” at δH 7.75 
and C-4a” at δC 115.1, C-4” at δC 194.6.  
 
The interflavanoid linkage involved C-3” of ring C and C-6 of the pentasubstituted 
aromatic ring was supported by the long-range correlations between H-3” at δH 
4.62 and C-5, 6 and 7 at δC 159.16, 106.2 and 166.7 respectively, according to 





















Fig. 3.11: HMBC correlations in partial structure 50d 
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Relative configuration of this molecule was established by observations in the 1H 
NMR spectrum where a large coupling constant was observed between H-2” and 
H-3” (J=13.0 Hz) indicating that they are in trans-diaxial positions as indicated in 
the structure 50. The configuration was supported by the weak NOE interaction in 
NOESY spectrum (Plate 6f) between H-2” and H-3”. NOE interaction between H-2, 
H-3” and H-8 confirmed the position of the pentasubstituted aromatic ring as 
indicated in the structure. These NOE interactions are as summarized in Fig. 3.12. 
 
The negative ion mass spectrum of 50 exhibited a pseudo-molecular ion peak [M-
H]- at m/z 526, which is in agreement with C30H22O9 as the molecular formula of 
the compound. The compound was isolated previously from the stem bark of 
Ochna afzelii (Ochnaceae) (Pegnyemb et al., 2003), none the less, the biological 




























Fig. 3.12 NOE Interactions in structure 50 
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76  R= H
80  R=OH  
 
The structure of compound 76 was characterized based on MS and 1D (1H, 13C) 
and 2D (COSY, HMBC, HSQC) NMR analysis. The 1H NMR (Plate 7a) and 1H, 1H 
COSY (Plate 7b) spectra showed the following aromatic systems: one p-
substituted benzene ring and three protons in a benzene ring showing an ABX 
spin system. Furthermore, a trisubstituted alkene and two vicinal methine protons 
were identified by the singlet peak at δH 7.24 for olefinic proton and two trans-
coupled doublets at δH 4.99 and 4.34 (J=7.9 Hz) (Bandeira et al., 2003). 
 
In the 13C NMR spectrum (Plate 7c) the presence of six oxygen-linked quaternary 
aromatic carbons (δC 166.9, 166.6, 166.3, 166.2, 161.4 and 157.8) and two 
carbonyls at δC 206.2 and 200.0 were observed. The chemical shifts of the 
carbonyls indicated that neither of them was part of a pyran-4-one ring because if 
they were, their resonances would be around δC 180-190 ppm. The heteronuclear 
multiple bond correlation (HMBC) spectrum (Plate 7e) displayed 1H/13C 
correlations between H-7 at δH 7.24 (s) and a carbonyl at δC 200.0 (C-9), C-2 at δC 
133.1, C-8 and C-1 at δC 125.3, signifying that one of the three trisubstituted 
aromatic systems is linked to both C-7 and C-7’’.  
 
The linkage of the second ABX aromatic system to a carbonyl was established by 
the long-range 1H/13C correlations between H-6’ at δH 7.68 and the carbonyl (C-9) 
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Fig. 3.13: HMBC correlations in partial structure 76a 
 
The p-substituted aromatic system was shown to be linked to C-8” due to the 
1H/13C correlations between H-7” at δH 4.34 and C-1” at δC 133.1 and C-2”, 6” at δC 
130.8. Correlations between H-8” at δH 4.99 and both carbonyls [δC 206.2 (C-9”) 
and 200.0 (C-9)], C-7 (δC 141.7), C-1” and C-2 (δC 133.1) and C-7’’ (δC 49.6) 
confirmed the position of C-8” and H-7” in the proposed structure. 
 
The link of trisubstituted ring B’ was derived from the long-range 1H/13C 
correlations between H-6”’ and the carbonyl (C-9”) at δC 206.2 which in turn was 
correlated to H-8” at δH 4.99. These correlations allowed the construction of partial 





















Fig. 3.14: HMBC correlations in partial structure 76b 
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The relative configuration of 76 was established based on the value of the 
coupling constant (J=7.9 Hz) corresponding to vicinal spin-spin interactions 
between H-8” (δH 4.99 (1H, d, J=7.9 Hz)) and H-7” (δH 4.34 (1H, d, J=7.9 Hz)) 
which is a typical axial-axial coupling (Bandeira et al., 2003). The absolute 
configuration of 76 was not determined. 
 
A pseudo-molecular ion peak [M-H]- at m/z 509 was present in the mass spectrum 
of 76 in agreement with a molecular formula of C30H22O8 for 76. 
 
Table 3.1:  13C and 1H – NMR spectral data for 76 as compared to 80 in CD 3OD 
80 
δ 13C C (state) 
76 
δ 13C C (state) δ H, m (J) 
204.7 9'' (q) 206.2 9'' (q) - 
199.2 9 (q) 200.0 9 (q) - 
166.9 4'(q) 166.9 4'(q) - 
166.4 4'''(q) 166.6 4'''(q) - 
165.9 2'(q) 166.3 2'(q) - 
165.7 2'''(q) 166.2 2'''(q) - 
157.3 4''(q) 161.4 4''(q) - 
148.7 4(q) 157.8  4(q) - 
145.2 5(q) 115.4 5(CH) 6.67 (3H, dd, J=2.3, 8.2 Hz ) 
141.6 7 (CH) 141.7 7 (CH) 7.24 (1H, s) 
135.7 6' (CH)  135.9 6' (CH) 7.68 (1H, d, J=8.8 Hz) 
134.7 1'' (q) 133.1 1'' (q) - 
134.0 6''' (CH) 134.5 6''' (CH) 7.72 (1H, d, J=9.1 Hz) 
131.4 2 (q) 133.1 2 (q) - 
130.2 2'', 6'' (CH) 130.8 2'', 6'' (CH) 7.05 (2H, d, J=8.5 Hz) 
124.8 8,1 (q) 125.3 8,1 (q) - 
117.31 6 (CH) 132.5 6 (CH) 7.18 (1H, d, J=8.2 Hz) 
116.8 3 (CH) 103.8 3 (CH) 6.27 (2H, d, J=2.3 Hz) 
116.3 3'', 5'' (CH) 116.7 3'', 5'' (CH) 6.67 (3H, d, J=8.5 Hz) 
113.4 1' (q) 114.2 1' (q) - 
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113.1 1''' (q) 114.0 1''' (q) - 
109.0 5''' (CH) 109.3 5''' (CH) 6.27 (2H, dd, J=2.3, 9.1 Hz) 
108.6 5'(CH) 108.9 5'(CH) 6.35 (2H, dd, J=2.4, 8.8 Hz) 
103.9 3' (CH) 104.2 3' (CH) 6.16 (1H, d, J=2.4 Hz) 
103.8 3'''(CH) 116.8 3'''(CH) 6.35 (2H, d, J=2.4 Hz) 
51.1 8'' (CH) 51.8 8'' (CH) 4.99 (1H, d, J=7.9 Hz) 
48.4 7'’ (CH) 49.6 7'’ (CH) 4.34 (1H, d, J=7.9 Hz) 
 
The spectroscopic data of 76 were compared to those reported in the literature for 
urundeuvine C (80) isolated from the stem bark of Astronium urundeuva Engl. 
(Anacardiaceae) (Bandeira et al., 2003). The difference between compound 76 
and 80 is that whereas 76 has three trisubstituted aromatic rings and one p-
substituted aromatic system, 80 has two trisubstituted aromatic rings, one 


































Fig. 3.15: Proposed biogenesis of 76 (Bai  et al., 2003) 
 
Biogenetically, 76 is proposed to originate from 2’,4’,4-trihydroxychalcone (39c). 
After conjugate addition of 39c on itself to form a dimer, followed by dienone- 
phenol rearrangement to yield an intermediate 76c. Cyclization of 76c gives 
compound 76 (Fig. 3.15) (Bai et al., 2003).  This compound has not been 
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described previously and this is the first report on the isolation and 
characterization of 76, which was named 5-deoxyurundeuvine C. 
 


























The presence of a p-substituted aromatic ring, a trisubstituted aromatic ring and 
two tetrasubstituted aromatic rings were established by careful examination of 1H 
NMR (Plate 8a) and the 1H, 1H COSY (Plate 8b) spectra of 51. This compound 
was clearly a biflavonoid which consisted of two flavone units. This is due to the 
presence of a singlet at δH 6.81 (2H) in the 
1H NMR spectrum which is 
characteristic of H-3 of flavones. In the HSQC spectrum this signal correlated with 
carbons resonating at δC 103.9 and 104.2 (Burns et al., 2007). 
 
In the 13C NMR spectrum (Plate 8c), the presence of two carbonyls was indicated 
by the peaks at δC 182.2 and 182.1. Furthermore, 11 peaks appearing in the δC 
165 to 140 resonance region accounting for oxygen-linked quaternary aromatic 
carbons (9 peaks) and the two β-carbons of α,β-unsaturated pyran ring system. 
The DEPT 135 (Plate 8f) spectrum showed the presence of 13 methine carbons 
with no methylene carbons in accordance with the proposed structure. 
 
The 1H NMR spectrum showed the presence of two singlets at δH 11.76 and 11.73 
indicating that 51 is a 5,5”-dihydroxybiflavonoid (Markham, 1989). This is further 
supported by peaks at δC 94.6 and 99.4 in 
13C NMR spectrum for C-6, 6” and C-8, 
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8”, respectively; these peaks are typical for 5,7-dihydroxyflavone derivatives which 
usually give a difference >4 between the resonance of C-6 and C-8 (Chari et al., 
1977).  
 
The two aromatic rings with m-coupled protons are part of the benzopyran 
moieties as indicated by the long-range correlations between H-6, H-8 (H-6”, H-8”) 
and C-4a, C-4a” (partial structure 51a and 51b). The position of the p-
hydroxyphenyl ring was derived from the long-range HMBC (Plate 8e) correlations 
between H-3” at δH 6.81 and C-1”’ at δC 124.8, confirming that p-hydroxyphenyl 
ring is linked to the benzopyran moiety at C-2”. Furthermore, the HMBC 
correlations between H-2”’,6”’ (δH 8.01) and C-2” (δC 163.2) supported partial 

















Fig. 3.16: HMBC correlations in partial structure 51a 
 
The trisubstituted aromatic ring was attached to C-2 of the second benzopyran 
moiety based on the correlations between H-6’ (δH 7.87) and C-2 (δC 163.6), also 
H-2’ (δH 7.84) correlated to C-2. Fig. 3.17 summarizes the correlations as provided 






















Fig. 3.17: HMBC correlations in partial structure 51b 
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An ether linkage between the two flavone units was proposed due to the fact that 
H-2’ showed long-range correlations with C-6’, C-3’, C-4’ and C-2; H-3”’/H-5”’ 
showed correlations with C-1”’ and C-4”’. The absence of long-range correlations 
between the protons in the p-substituted and trisubstituted aromatic rings indicated 
that the two rings are not C-C linked. This was further confirmed by MS where an 
extra oxygen atom was observed and hence confirmed the linkage. Also, the 
down-field resonance of the C-3’ signal as compared to the unsubstituted 
flavones, suggests that C-3’ and C-4”’ are involved in the interflavonoid linkage. 
 
The positive ion mass spectrum of 51 shows the presence of the pseudo-
molecular ion peak [M+Na]+ at m/z 561 consistent with the molecular formula 
C30H18O10. Therefore, 51 was identified as ochnaflavone, which was previously 
isolated from the aerial parts of Lonicera japonica (Kun et al., 1992). To date there 
are many reports on the isolation of 51 from Ochnaceae plants (Flamini et al., 
1997; Jayaprakasam et al., 2000; Rao et al., 1997). Ochnaflavone (51) has a 
broad range of biological/pharmacological activities including anti-inflammatory, 
anticancer, anti-HIV and anti-atherogenic activities (Suh et al., 2006a; Suh et al., 
2006b; Suh et al., 2006c). 
 


























The 1H NMR spectrum (Plate 9a) showed two intramolecular hydrogen-bonded 
hydroxy signals at δH 12.83 and 12.16 indicating that 54 is a 5,5”-
dihydroxybiflavonoid (Markham, 1989). Upon careful observation of the 1H NMR 
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and 1H, 1H COSY (Plate 9b) spectra, it was clear that substitution pattern of the 
aromatic rings is similar to that of ochnaflavone (51). The only difference was the 
presence of one ABX spin system of a flavanone moiety at δH 5.44 (dd, J=3.1, 
12.6 Hz) and 3.12 (dd, J=12.6, 17.8 Hz), 2.78 (dd, J=3.1, 17.8 Hz) for H-2” and 3”, 
respectively, indicating that 54 is a dihydro derivative of 51.  
 
The flavanone moiety can be linked to the other half either at C-3’ (54a) or C-4”’ 

























HMBC (Plate 9e) correlations between H-2” and C-1”’, C-2”’/C-6”’ implied that the 
p-substituted aromatic system was linked to C-2” and thereby partial structure 54b 
was supported by the NMR spectroscopic data. More proof for the linkage of p-
substituted system was provided by the correlations between H-3” and C-1”’ as 

















Fig. 3.18: HMBC correlations in partial structure 54b 
 
The trisubstituted aromatic system was found to be linked to C-2 of benzopyran 
moiety, this is due to the correlations between H-2’/H-6’ and C-2 at δC 163.8. 
Figures 3.18 and 3.19 summarize the 1H/13C correlations for partial structures 54b 
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and 54c. The flavones moiety was linked to the flavanone moiety by ether linkage 




















Fig. 3.19: HMBC correlations in partial structure 54c 
 
In the negative ion mass spectrum, the pseudo-molecular ion peak [M-H]- at m/z 
539 consistent with the molecular formula C30H20O10 was present, indicating that 
54 has two additional hydrogens as compared to 51. The compound was reported 
for the first time from the leaves of Ochna integerrima (Likhitwitayawuid et al., 
2001). The absolute configuration at C-2” and biological activities of 54 have not 
been reported. 
 
3.2.10  Psilosin (77)  
 





















The 1H NMR (Plate 10a) and 1H, 1H COSY (Plate 10b) spectra of compound 77 
were analyzed and a p-substituted aromatic ring, a pentasubstituted aromatic 
system and flavone skeleton were identified. Hydrogen bonded hydroxy group at 
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δH 13.29 were also visible in the
1H NMR spectrum, indicating that 77 is a 5-
hydroxyflavone (Markham, 1989).  
 
13C NMR spectrum (Plate 10c) gave six signals due to the C-glucoside substituent 
at δC 77.0, 75.3, 74.0, 69.7, 68.2 and 65.2, suggesting that 77 is a flavone with a 
C-glucoside moiety. Peaks at δC 164.4, 162.8, 161.2 and 160.6 established the 
presence of four oxygen-linked quaternary aromatic carbons. Furthermore, the 
spectrum showed the presence of a carbonyl at δC 170.6 correlating to a methyl 
carbon at δC 20.8 (HMBC, Plate 10e) implying the presence of an acetyl group. 
Whereas the DEPT-135 spectrum (Plate 10f) indicated the presence of a 
methylene carbon at δC 65.2 belonging to C-6” of the glucoside moiety, the DEPT-
90 spectrum pointed to the presence of 11 CH’s in agreement with the proposed 
structure. 
 
The p-substituted aromatic ring is linked to C-2 of the benzopyran moiety of a 
flavones as evidenced by the correlations between H-3 and C-1’ of the p-
substituted aromatic ring at δC 121.1, furthermore, H-2’/6’ at δH 8.30 correlated to 
C-2 at δC 164.4 (Fig. 3.20). 
 
The H-6” of the glucoside moiety correlated with the acetyl group, and therefore 
showing the linkage of the acetyl group to C-6”. The linkage of the sugar moiety to 
the aglycone in 77 was assigned to be at C-8, this being supported by the fact that 
the C-8 signal appeared at high field (at δC 104.4) and also due to the correlations 
between the anomeric proton of the sugar at δH 4.68 and C-7 (δC 162.8) and C-8a 
(δC 156.3) while the singlet proton signal (H-6) correlates with C-5 and C-7. The 































77          
Fig. 3.20: HMBC correlations in structure 77 
 
 
The pseudo-molecular ion peak [M-H]- at m/z 473 from the negative ion mass 
spectrum of 77 corresponds to the molecular formula of C23H22O11. The NMR data 
for 77 agreed with the data reported for psilosin, a compound previously isolated 
from the leaves of Crataegus pinnatifida Bge. Var. major N.E.Br (Zhang and Xu, 
2003). The isolation of 77 from the Ochnaceae has not been reported and there 
are also no filed reports on the biological/pharmacological activities of this 
compound. 
 
























The 1H NMR spectrum (Plate 11a) showed an intramolecular hydrogen-bonded 
hydroxy proton signal at δH 13.35 suggesting that 78 is a 5-hydroxyflavonoid 
(Markham, 1989). Upon examination of the 1H NMR and 1H, 1H COSY (Plate 11b), 
13C (Plate 11c), HSQC (Plate 11d) and HMBC spectra (Plate 11e), showed that 
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compound 78 is a flavone C-glucoside with an acetyl group in the sugar moiety, 
similar to 77. The only difference between these two flavones being the presence 
of a methoxy group and a trisubstituted aromatic system in 78 instead of a p-
substituted aromatic ring in 77.  
 
The trisubstituted aromatic system was linked to the benzopyran moiety at C-2 (at 
δC 164.6) as shown by the correlations between H-3 at δH 6.95 and C-1’ at δC 
121.8. Further confirmation for this attachment was provided by the correlation 
between H-2’ at δH 7.54 and C-2 at δC 164.6. The position of the methoxy group on 
the trisubstituted aromatic ring was shown by the correlations between H-2’ at δH 
7.54 and the carbon bearing the methoxy group (C-3’) at δC 148.3. 
 
A series of six peaks from δC 77.3 to δC 65.4 in the 
13C NMR spectrum was 
indicative of the presence of a C-glucoside system. The C-glycone moiety was 
linked to C-8 due to the correlations between the anomeric sugar proton and C-8a 
and C-7 of the pentasubstituted aromatic ring system. 
 






























Fig. 3.21: HMBC correlations in structure 78  
 
The pseudo-molecular ion peak [M-H]- at m/z 503 consistent with the C24H24O12 
molecular formula for 78 specified the presence of additional methoxy group as 
compared to 77. The compound was isolated from the leaves of Sarothamnus 
scoparius (Brum-Bousquet et al., 1977 ). The 3’-hydroxy derivative of 78 has been 
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isolated from the flowers of Trollius ledebouri and from the fern Odontosoria 
gymnogrammoides (Hori et al., 1987; Zou et al., 2005). Neither the isolation of 78 
from the Ochnaceae species nor the biological/pharmacological activities of the 



























Structure of 79 was established from analyses of the 1D [1H (Plate 12a), 13C (Plate 
12c) and DEPT-135 (Plate 12f)] and 2D [1H, 1H COSY (Plate 12b), NOESY (Plate 
12g), HMBC (Plate 12e) and HSQC (Plate 12d)] spectra.  
 
The 1H NMR together with 1H, 1H COSY spectra showed the presence of two 
doublets due to two olefinic protons at δH 6.18 and δH 5.92 (J=10.0 Hz), a singlet 
due to trisubstituted alkene at δH 5.71s (H-7). The presence of an O-glucosyl 
moiety was established by the overlapping multiplets between δH 3.65 to δH 2.65; 
further evidence to this was provided by the anomeric proton of the sugar which 
appeared as a doublet at δH 4.38 (d, J=7.8 Hz) and correlated to a carbon signal at 
δC 103.3 in the HSQC. The sharp absorption at 2225 cm
-1 in the IR spectrum is 
characteristic of nitriles. The long-range correlations between H-7 at δH 5.71 and 
C-8 and C-1 (at δC 117.8 and 154.3) implied the connection of the three carbons 


























Fig. 3.22: HMBC correlations in structure 79 
 
The relative configuration of the molecule was established based on observations 
in the NOESY spectrum. Strong NOE correlations between H-4, H-5 and H-6 
suggested that these protons “are on the same plane” and therefore have cis 
configuration. The structure above was further confirmed by the HMBC (Fig. 3.22) 

























Fig. 3.23: NOE Interactions in structure 79 
 
The proposed structure 79 was further confirmed by MS analysis which showed 
the presence of a pseudo-molecular ion peak [M+Na]+ at m/z 352 consistent with 
the molecular formula of C14H19O8N. The compound was first isolated from the 
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roots of Ilex species and later from Semiaqilegia species (Ranunculaceae). Its 
total synthesis was reported in 2007 (Lefebvre and Drian, 2007; Niu et al., 2006).  
Nitrile containing natural products from plants are known to be derived from amino 
acids. These acids undergo N-hydroxylation and decarboxylation to afford 
aldoximes, followed by enzymatic conversion of aldoximes to the corresponding 
nitriles (Fraiser, 1999). In plants, cyanogenic glucosides containing a cyanohydrin 
group, are known to occur widely. However, cynoglucosides bearing 
cyanomethylene group such as 79 which are non-cyanogenic, are rare (Murakami 
et al., 1993). The presence of the cyano group in 76 may indicate the defensive 
nature of the plants (Fraiser, 1999), but on the contrary, the compound did not 
show any significant cytotoxicity activity when tested. This compound has not been 




The phytochemical studies on the stem bark and leaves of O. serrulata were 
performed for the first time and one novel compound (5-deoxyurundeuvine C) was 
isolated. The isolation of a cyanoglucoside, psilosin and 3’-O-methylpsilosin is 
hereby reported for the first time from an Ochna species. The rest of the 
compounds were previously isolated from other Ochna species. O. serrulata, in 
common with other Ochna species, is rich in biflavonoids.  
 




The solvents used in the reported investigations included hexanes (mixture of 
hexane isomers), EtOAc, DCM, MeOH and acetone were of analytical grade. 
 
3.4.2 General experimental procedure 
 
For purification of fractions, centrifugal chromatography (chromatotron model 
7924, Harrison Research) was used. The circular chromatotron plates were coated 
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with preparative silica gel (2 or 4 mm thickness, Merck 7749 with gypsum binding 
agent). Silica gel 60F254, (40-63 µm, Merck) was also used for the purification of 
the compounds by column chromatography. Thin-layer chromatography (TLC) 
plates (Kieselgel 60 F254, 0.25mm) stained with anisaldehyde/ sulfuric acid and 
heat were used for monitoring separation of the isolates. The stain solution was 
made as follows: In a 1 L volumetric flask, 465 ml of methanol were cooled in an 
ice bath, while shaking to ensure homogeneity, 5 ml of acetic acid was added 
followed by addition of 17 ml of concentrated sulfuric acid and 13 ml of p-
anisaldehyde and stored in a refrigerator. 
 
Bruker Avance III 500 or Bruker Avance III 400 spectrometers were used for the 
1H, 1H, 1H COSY, HSQC, HMBC and 13C NMR spectra recording at 500 MHz/400 
MHz for 1H and 125 MHz/100 MHz for 13C. All spectra were recorded in deuterated 
solvents like chloroform, DMSO, acetone and MeOH, at 30 °C using either a 5 mm 
BBOZ probe or a 5 mm TBIZ probe. Chemical shifts (δ) are given in parts per 
million (ppm) and referenced to a residual solvent peak (e.g. DMSO-d6: 
1H, 2.50 
ppm, 13C, 39.5 ppm; CDCl3: 
1H 7.26 ppm, 13C, 77.0 ppm, methanol-d4: 
1H 3.31 
ppm, 13C, 49.1 ppm, acetone-d6 
1H 2.05 ppm, 13C, 29.9 ppm). Peak multiplicities 
are designated as s for singlet, d for doublet, m for multiplet. Coupling constants 
(J) are given in Hz. Mass spectral data were collected on the time-of-flight Waters 
LCT Premier mass spectrometer using electrospray ionization in the positive or 
negative mode. Infrared spectra were recorded on a Perkin Elmer FT-IR 
spectrometer with universal ATR sampling accessory and optical rotations were 
determined using ADP 440+ model polarimeter manufactured by Bellingham and 
Stanley. 
 
3.4.3 Plant material  
 
The stem, leaves and roots of Ochna serrulata were collected from the UKZN 
Botanical Garden in September 2009. The plant was identified by Allison Young 
from UKZN Botanical Garden, voucher specimen (NU, M. Ndoile 01) deposited at 
the University of KwaZulu-Natal herbarium. 
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3.4.4 Extraction and isolation (Stem bark) 
 
Oven–dried (30 °C) and ground stem bark of O. serrulata (0.92 kg) was extracted 
with MeOH at room temperature for 48 hours to obtain 9.7 g extract. The extract 
consisted of mixtures of polar components and was dissolved in EtOAc:H2O (8:2). 
This was followed by extraction with 3 x 100 mL EtOAc aiming at extracting 
moderately polar organic compounds and 7.0 g of the extract was obtained. 
 
The EtOAc extract (7.0 g) was fractionated in a short silica gel column eluted with 
increasing polarity of EtOAc:hexanes, where 5 fractions were obtained (1-5), the 
5th being with MeOH wash. Fraction 3 (500 mg) was fractionated on a silica gel 
column eluted with EtOAc:hexanes (1:1), where 2 fractions were obtained (3.1 and 
3.2). Fraction 3.1 was further purified on a chromatotron with EtOAc:hexanes (3:7)  
resulting in the isolation of 12 mg of 73. 
 
The remaining fractions of 3.1 and fraction 3.2 were combined with fraction 4 (1.6 
g) and the mixture was subjected to chromatography on a short silica gel column 
eluted with increasing polarity of EtOAc:hexanes, 6 fractions were obtained (4.1-
4.6). Fraction 4.3 (400 mg) was combined with fraction 4.4 (200 mg) and was 
purified repeatedly on a chromatotron with DCM:EtOAc (2:1) and resulted in the 
isolation of 60 mg of 75, 50 mg of 36, 52 mg of 39, 30 mg of 50, 28 mg of a 
mixture of 61 and 62 and 50 mg of 76. 
 
3.4.5 Extraction and Isolation (Leaves) 
 
Oven–dried (30 °C) and ground leaves of O. serrulata (1.98 kg) were extracted 
with MeOH at room temperature for 48 hours to obtain 40 g of the MeOH leaves 
extract. The extract was then fractionated by a short silica gel column eluted with 
DCM followed by EtOAc and finally washed with MeOH, yielding 8.2 g of DCM 
extract, 8.8 g of EtOAc extract and 20 g of MeOH extract. 
 
The EtOAc extract (8.8 g) was then fractionated by using a short silica gel column 
eluted with increasing polarity of hexanes:EtOAc solvent ratios to obtain five 
fractions (L1-5), the fifth being with MeOH wash. Silica gel column 
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chromatography with EtOAc:DCM (7:3) on L4 (1.0 g) followed by a chromatotron 
with MeOH:DCM (1:9) afforded 12 mg of 74 and 48 mg of 51. The remaining of 
fraction L4 were combined with L5 and purified by a silica gel column 
chromatography with EtOAc:DCM (7:3) followed by a chromatotron with 
MeOH:DCM (1:9) to afford 6 mg of 74, 16 mg of 51 and 28 mg of 54 together with 
two fractions (L5.3 and L5.4). A chromatotron ran on a combined fraction (L5.3 
and L5.4) with MeOH:DCM (1:9) afforded 18 mg of 77 and 13 mg of 78. 
 
The flow diagram for the isolation of the compounds from the stem and leaves are 
as provided in Fig. 3.24 and 3.25 respectively. 
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Fig. 3.24: Isolation of compounds from EtOAc extract of the stem back of O. 
serrulata 
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Physical data of the isolated compounds 
 
Methyl (2’,4’-dihydroxyphenyl)acetate  (73) was isolated as a yellow solid 
substance. 1H NMR (400 MHz, CD3OD): δH 6.87 (1H, d, J5’,6’=8.0 Hz, H-6’), 6.28 
(1H, d, J3’,5’=2.4 Hz, H-3’), 6.23 (1H, dd, J5’,6’=8.0 Hz, J3’,5’=2.4 Hz, H-5’), 3.64 (3H, 
s, OMe), 3.48 (2H, s, H-2) (Plate 1a). 13C NMR (100 MHz, CD3OD): δC 173.8 (CO), 
156.1 (C-2’), 157.3 (C-4’), 130.9 (C-6’), 112.0 (C-1’), 106.0 (C-5’), 101.9 (C-3’), 
50.7 (OMe), 34.5 (C-2) (Plate 1c). 
 
(2’,4’-Dihydroxyphenyl)acetic acid  (74) was isolated as a yellow non-crystalline 
solid. 1H NMR (400 MHz, CD3OD): δH 6.87 (1H, d, J5’,6’=8.2 Hz, H-6’), 6.34 (1H, d, 
J3’,5’=2.4 Hz, H-3’), 6.28 (1H, dd, J5’,6’=8.2 Hz, J3’,5’=2.4 Hz, H-5’), 3.42 (2H,s, H-2) 
(Plate 2a). 13C NMR (100 MHz, CD3OD): δC 177.2 (CO), 157.6 (C-4’), 156.3 (C-2’), 
130.9 (C-6’), 113.3 (C-1’), 106.5 (C-5’), 102.6 (C-3’), 36.6 (C-2) (Plate 2c). 
 
Epicatechin  (75) isolated as a brown non-crystalline solid. 1H NMR (400 MHz, 
CD3OD): δH 6.96 (1H, d, J2',6'=1.9 Hz, H-2'), 6.78 (1H, dd, J5',6'= 8.1 Hz, J6',2'=1.9 
Hz, H-6'), 6.70 (1H, d, J5',6'=8.1 Hz, H-5'), 5.93 (1H, d, J6,8=2.4 Hz, H-6), 5.91 (1H, 
d, J6,8=2.4 Hz, H-8), 4.79 (1H, d, J2,3=4.4 Hz, H-2), 4.16 (1H, m, H-3), 2.84, (1H, 
dd, J3,4=17.0, 4.6 Hz, H-4), 2.72 (1H, dd, J3,4=17.0, 4.6 Hz, H-4) (Plate 3a).
 13C 
NMR (100 MHz, CD3OD): δC 157.9 (C-3'), 157.6 (C-4'), 157.3 (C-7), 145.9 (C-5), 
145.7 (C-8a), 132.3 (C-1'), 119.4 (C-6'), 115.9 (C-5'), 115.3 (C-2'),100.1 (C-4a), 
96.4 (C-8), 95.9 (C-6), 78.5 (C-2), 66.3 (C-3), 29.5 (C-4) (Plate 3c). HRESIMS 
(positive ionization mode), m/z 313.0688 [M+Na]+ (calculated for C15H14NaO6 
313.0688). 
 
Lophirone A  (36) was isolated as a yellow non-crystalline solid. [α]20D= +70.9 (c 
0.4, MeOH) (lit. +74.7 (MeOH (Murakami et al., 1991)). 1H NMR (400 MHz, 
(CD3)2CO): δH 8.33 (1H, d, J5,6=8.9 Hz, H-6B2), 8.28 (1H, s, H- β1), 7.94 (1H, d, 
J5,6=8.9 Hz, H- 6B1), 7.27 (2H, d, J2,3=8.4 Hz, H-2,6A1), 7.24 (2H, d, J2,3=8.4 Hz, 
H-2,6 A2), 6.91 (1H, dd, J5,6=8.9 Hz, J3,5=2.2 Hz, H-5B1), 6.77 (1H, d, J3,5=2.2 Hz, 
H-3B1), 6.66 (2H, d, J2,3=8.4 Hz, H-3,5A1), 6.61 (2H, d, J2,3=8.4 Hz, H-3,5 A2), 
6.45 (1H, dd, J5,6=8.9 Hz, J3,6 =2.2 Hz, H-5B2), 6.21 (1H, d, J3,5=2.2 Hz, H-3B2), 
6.15 (1H, d, Jα2, β2=12.1 Hz, H-α2), 4.79 (1H, d, Jβ2, α2=12.1 Hz, H-β2) (Plate 4a).
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13C NMR (100 MHz, (CD3)2CO): δC 204.7 (C-2), 175.4 (C-1), 166.9 (C-2B2), 166.2 
(C-4B2), 163.5 (C-4B1), 158.7 (C-2B1), 156.6 (C-4A2,A1), 156.4 (C-β1) 135.8 (C-
1A2), 134.7 (C-1A1), 134.5 (C-6B2), 130.1 (C-2,6A1), 129.6 (C-2,6A2), 128.3 (C-
6B1), 122.3 (C-α1), 117.4 (C-1B2), 116.0 (C-3,5A1), 115.9 (C-5B1), 115.9 (C-
3,5A2), 114.3 (C-1B1), 109.1 (C-5B2), 103.5 (C-3B2), 103.3 (C-3B1), 53.6 (C-β2), 
44.1 (C-α2), (Plate 4c). HRESIMS (positive ionization mode), m/z 533.1235 
[M+Na]+ (calculated for C30H22NaO8 533.1212). 
 
Lophirone C  (39) was isolated as a yellow solid substance. [α]22D= -29.7 (c 0.3, 
MeOH) (lit. -16.4 (acetone) (Pegnyemb et al., 2001)). 1H NMR (400 MHz, CD3OD): 
δH 7.85 (1H, d, J6,5=9.0 Hz, H-6B1), 7.74 (1H, d, J5,6=8.9 Hz, H-6B2), 7.72 (1H, d, 
Jα1,β1=15.4 Hz Hβ1),  7.66 (1H, dd, J6,5=8.5 Hz, J2,6=1.8 Hz, H6A1), 7.51 (1H, d, 
Jα1,β1=15.4 Hz, Hα1), 7.41 (1H, d, J2,6=1.8 Hz, H-2A1), 7.21 (2H, d, J2,3=8.6 Hz, H-
2,6A2), 6.94 (1H, d, J6,5=8.5 Hz, H-5A1), 6.80 (2H, d, J2,3=8.6 Hz, H-3,5A2), 6.44 
(1H, dd, J5,3=2.3 Hz, J6,5=8.9 Hz,H-5B2), 6.39 (1H, dd J5,3=2.3 Hz, J6,5=9.0 Hz, H-
5B1), 6.35 (1H, d, J5,3=2.3 Hz, H-3B2), 6.28 (1H, d, J5,3=2.3 Hz, H-3B1), 6.09 (1H, 
d, Jα2,β2=7.2 Hz, Hβ2), 5.31 (1H, d, Jα2,β2=7.2 Hz, Hα2) (Plate 5a). 13C NMR (100 
MHz, CD3OD): δC 201.7 (C2), 193.4 (C1), 167.7 (C-2B1), 166.6 (C-2B2), 163.7 (C-
2B1, 4B2), 159.3 (C-4A1,A2), 145.2 (C-β1), 134.8 (C-6B2), 133.5 (C-6B1), 132.5 (C-
6A1), 132.4 (C-3A1), 129.8 (C-1A2), 129.1 (C-1A1), 128.8 (C-2,6A2), 126.9 (C-
2A1), 119.3 (C-α1), 116.8 (C-3,5A2), 114.8 (C-1B1),113.9 (C-1B2), 111.3 (C-5A1), 
110.0 (C-5B2), 109.5 (C-5B1), 104.1 (C-3B2), 103.9 (C-3B1), 89.2 (C-β2)  (Plate 5c). 
LRMS (negative ionization mode), m/z 510.1202 [M-H]-. 
 
Afzelone B (50) was isolated as a yellow solid. [α]24D= -22 (c 0.3, MeOH) (lit. -19.0
 
(acetone) (Pegnyemb et al., 2003)). 1H NMR (400 MHz, CD3OD): δH 7.75 (1H, d, 
J5”,6”=8.7 Hz, H-5”), 7.25 (2H, d, J2’,3’=8.5 Hz, H-2’,6’), 7.19 (2H, J2”’,3”’=8.5 Hz, H-
2”’,6”’), 6.76 (2H, d, J2’,3’=8.5 Hz, H-3’,5’), 6.63 (2H, d, J2”’,3’”=8.5 Hz, H-3”’,5”’), 6.5 
(1H, dd, J8”,6”=2.2 Hz, J5”,6”=8.7 Hz, H-6”), 6.33 (1H, d, J6”,8”=2.2 Hz, H-8”), 5.84 
(1H, d, J2”,3”=13.0 Hz, H-2”), 5.8 (s, 1H, H-8), 5.27 (1H, dd, J2,3=3.2, 13.0 Hz, H-2), 
4.62 (1H, d, J2”,3”=13.0 Hz, H-3”), 3.03 (1H, m), 2.61 (1H, m, H-3) (Plate 6a).
 13C 
NMR (100 MHz, CD3OD): δC 197.9 (C4), 194.6 (C4”), 166.7 (C-7), 165.7 (C-7”), 
163.9 (C-8a”), 159.17 (C-8a), 159.16 (C-5), 158.8 (C-4’,4”’), 131.3 (C-1’), 130.9 
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(C-1”’). 130.5 (C-5”), 130.1 (C-2”’,6”’), 129.2 (C-2’,6’), 116.5 (C-3’,5’), 115.8 (C-
3”’,5”’) 115.1 (C-4a”), 111.9 (C-6”), 106.2 (C-6), 103.9 (C-8”), 103.8 (C-4a), 96.1 
(C-8), 82.9 (C-2”), 78.1 (C-2), 42.1 (C-3) (Plate 6c). LRMS (negative mode), m/z = 
526.1120 [M-H]-. 
 
5-Deoxyurundeuvine C  (76) was isolated as a yellow non-crystalline solid 
substance. [α]23D= -5.2 (c 0.2, MeOH). 
1H NMR (400 MHz, CD3OD): δH 7.72 (1H, 
d, J5’’’,6’’’=9.1 Hz, H-6’’’), 7.68 (1H, d, J5’,6’=8.8 Hz, H-6’), 7.24 (1H, s, H-7), 7.18 
(1H, d, J5,6=8.2 Hz, H-6), 7.05 (2H, d, J2’’,3’’=8.5 Hz, H-2”,6”), 6.67 (3H, dd, J3,5=2.3 
Hz, J5,6=8.2 Hz,  H-5), 6.67 (3H, d, J2’’,3’’=8.5 Hz, H- 3”,5”), 6.35 (2H, dd, J3’,5’=2.4 
Hz, J5’,6’=8.8 Hz, H-5’), 6.35 (2H, d, J3’’’,5’’’=2.4 Hz, H-3’’’), 6.27 (2H, d, J3,5=2.3 Hz, 
H-3), 6.27 (2H, dd, J3’’’,5’’’=2.3 Hz, J5’’’,6’’’=9.1 Hz, H-5”’), 6.16 (1H, d, J3’,5’=2.4 Hz, 
H-3’), 4.99 (1H, d, J7”,8”=7.9 Hz, H- 8”), 4.34 (1H, d, J7”,8”=7.9 Hz, H-7”) (Plate 7a).
 
13C NMR (100 MHz, CD3OD): δC 206.2 (C-9”), 200 (C-9), 166.9 (C-4’), 166.6 (C-
4”’), 166.3 (C-2’), 166.2 (C-2”’), 161.4 (C-4”) 157.8 (C-4), 141.7 (C-7), 135.9 (C-6’), 
134.5 (C-6”’), 133.1 (C-1”,2), 132.5 (C-6), 130.8 (C-2”,6”), 125.3 (C-1,8), 116.8 (C-
3”’), 116.7 (C-3”,5”), 115.4 (C-5), 114.2 (C-1’), 114.0 (C-1”’), 109.3 (C-5”’), 108.9 
(C-5’), 104.2 (C-3’),103.8 (C-3), 51.8 (C-8”), 49.6 (C-7”) (Plate 7c). HRESIMS 
(negative ionization mode), m/z 509.1242 [M-H]- (calculated for C30H21O8 
509.1236). 
 
Ochnaflavone  (51) was isolated as a yellow solid substance.  1H NMR (400 MHz, 
(CD3)2SO): δH 8.01 (2H, d, J2”’,3”’=8.9 Hz, H-2”’,6”’), 7.87 (1H, dd, J5’,6’=8.9 Hz, 
J2’,6’=2.3 Hz, H-6’), 7.84 (1H, d, J2’,5’=2.3Hz, H-2’), 7.15 (1H, d, J5’,6’=8.6 Hz, H-5’), 
7.02 (2H, d, J5’’’,6’’’=8.9 Hz, H-3”’,5’’’), 6.81 (1H, s, H-3,3”), 6.48 (2H, d, J6,8=1.9 Hz, 
H-6,6”), 6.19 (2H, d, J6,8=1.9 Hz, H-8,8”) (Plate 8a).
 13C NMR (100 MHz, 
(CD3)2SO): δC 182.2 (C-4), 182.1 (4’’), 164.9 (C-7’’), 164.7 (C-7),   163.6 (C-2), 
163.2 (C-2’’), 161.8 (C-5), 161.8 (C-5’’), 161.3 (C-4’’’), 157.8 (C-8a), 157.8 (C-8a’’), 
154.1 (C-4’),  142.2 (C-3’), 128.9 (C-2’’’,6”’), 125.8 (C-6’), 124.8 (C-1’’’),  122.5 (C-
1’), 121.6 (C-2’), 118.5 (C-5’), 116.6 (C-3’’’,5”’), 104.4 (C-4a’’), 104.2 (C-3’’), 104.1 
(C-4a), 103.9 (C-3) 99.4 (C-8,8”), 94.6 (C-6,6”) (Plate 8c). HRESIMS (positive 
ionization mode), m/z 561.0796 [M+Na]+ (calculated for C30H18NaO10 561.0798). 
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2”,3”-Dihydroochnaflavone (54) was isolated as a yellow non-crystalline solid 
substance. [α]22D= +5.9 (c 0.4, MeOH) (lit. +6.8
 (MeOH) (Likhitwitayawuid et al., 
2001)). 1H NMR (400 MHz, (CD3)2CO): δH 7.88 (1H, dd, J5’,6=8.5 Hz, J6’,2’=2.2 Hz,  
H-6’), 7.80 (1H, d, J6’,2’=2.2 Hz, H-2’), 7.58 (2H, d, J2”’,3”’=8.3 Hz, H-2”’,6”’), 7.25 
(1H, d, J5’,6’=8.5, H-5’), 7.07 (2H, d, J5”’,6”’=8.3 Hz, H-3”’,5”’), 6.69 (1H, s, H-3), 6.54 
(1H, d, J6,8=2.2 Hz, H-8), 6.27 (1H, d, J6,8=2.2 Hz, H-6), 6.01 (1H, d, J6”,8”=2.1 Hz, 
H-8”), 5.99 (1H, d, J6”,8”=2.1 Hz, H-6”), 5.44 (1H, dd, J2”,3”=3.1, 12.6 Hz, H-2”), 3.12 
(1H, dd, J2”,3”=12.6, 17.8 Hz, H-3”), 2.78 (1H, dd, J2”,3”=3.1, 17.8 Hz, H-3”) (Plate 
9a). 13C NMR (100 MHz, (CD3)2CO): δC 195.9 (C-4”), 182.4 (C-4), 167.0 (C-7”), 
164.7 (C-7), 164.0 (C-5”), 163.8 (C-2), 163.2 (C-8a”), 161.8 (C-5), 158.0 (C-4”’), 
157.9 (C-8a), 153.2 (C-4’), 143.6 (C-3’), 133.4 (C-1”’), 127.7 (C-2”’,6”’), 123.9 (C-
6’), 122.8 (C-1’), 119.4 (C-2’), 117.5 (C-5’), 116.6 (C-3”’,5”’), 103.9 (C-4a), 103.9 
(C-3), 103.1 (C-4a”), 98.8 (C-6), 95.8 (C-6”), 94.8 (C-8”), 93.7 (C-8), 78.6 (C-2”), 
42.7 (C-3”) (Plate 9c). LRMS (negative mode), m/z = 539.0824 [M-H]-. 
 
Psilosin  (77) was isolated as a yellow gum. 1H NMR (500 MHz, (CD3)2SO): δH 8.3 
(2H, d, J2’,3’=8.7 Hz, H-2’,6’), 6.88 (2H, d, J2’,3’=8.7 Hz, H-3’,5’), 6.81 (1H, s, H-3), 
6.28 (1H, s, H-6), 4.68 (1H, d, J1’’,2’’=9.6 Hz, H-1’’), 4.21 (2H, m, H-5’’,6”), 4.08 (1H, 
m, H-6’’), 3.90 (1H, m, H-2”), 3.78 (1H, m, H-4’’), 3.40 (2H, m, H-3”), 1.97 (3H, s, 
Me) (Plate 10a). 13C NMR (125 MHz, (CD3)2SO): δC 182.3 (C-4), 170.6 (CO), 164.4 
(C-2), 162.8 (C-7), 161.2 (C-5), 160.6 (C-4’), 156.3 (C-8a), 129.8 (C-2’,6’), 121.1 
(C-1’), 116.2 (C-3’,5’), 104.4 (C-8), 104.2 (C-4a), 102.0 (C-3), 98.4 (C-6), 77.0 (C-
4’’), 75.3 (C-3’’), 74.0 (C-1’’), 69.7 (C-2’’), 68.2 (C-5’’), 65.2 (C-6’’), 20.8 (Me) (Plate 
10c). LRMS (negative mode), m/z = 473.0880 [M-H]-.  
 
3’-O-methylpsilosin  (78) was isolated as a yellow solid substance. 1H NMR (500 
MHz, (CD3)2SO): δH 8.23 (1H, dd, J6’,5’=8.2 Hz, J2’,6’=1.8 Hz, H-6’), 7.54 (1H, d, 
J2’,6’=1.8 Hz, H-2’), 6.95 (1H, s, H-3), 6.88 (1H, d, J5’,6’=8.2 Hz, H-5’), 6.28 (1H, s, 
H-6), 4.6 (1H, d, J1’’,2’’=9.7 Hz, H-1’’), 4.2 (2H, m, H-5’’,6”), 4.06 (1H, m, H-6’’), 3.88 
(3H, s, OCH3), 3.77 (1H, m, H-4’’), 3.4 (2H, m, H-3’’,2”), 1.97 (3H, s, Me) (Plate 
11a). 13C NMR (125 MHz, (CD3)2SO): showed the signals at δC 182.7 (C-4), 170.9 
(CO), 164.6 (C-2), 163.1 (C-7), 161.0 (C-5), 156.6 (C-8a), 151.3 (C-4’), 148.3 (C-
3’), 123.3 (C-6’), 121.8 (C-1’), 116.4 (C-5’), 110.5 (C-2’), 104.7 (C-8), 104.5 (C-4a), 
102.9 (C-3), 98.6 (C-6), 77.3 (C-4’’), 75.5 (C-3’’), 74.3 (C-1’’), 69.9 (C-2’’), 68.3 (C-
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ylidene]ethanenitrile  (79) was isolated as off-white fluffy solids. [α]20D= -136 (c 
0.4, DMSO) (lit. -148 (H2O) (Niu et al., 2006)).
 1H NMR (400 MHz, (CD3)2SO): δH 
6.18 (1H, d, J2,3=10.0 Hz, H-2), 5.92 (1H, d, J2,3=10.0 Hz, H-3), 5.71 (1H, s, H-7), 
4.56 (1H, m, H-6), 4.45 (1H, br s, H-4), 4.38 (1H, d, J1',2'=7.8 Hz, H-1'), 4.04 (1H, br 
s, H-5), 3.65 (1H, m, H-6’), 3.49 (1H, m, H-6’), 3.15 (2H, m, H-4’, 3’), 3.09 (1H, m, 
H-5'), 2.65 (1H, m, H-2') (Plate 12a).  13C NMR (100 MHz, (CD3)2SO): δC 154.3 (C-
1), 139.7 (C-3), 125.3 (C-2), 117.8 (C-8), 103.3 (C-1'), 98.9 (C-7), 76.8 (C-4'), 76.7 
(C-3'), 76.5 (C-6), 73.5 (C-2'), 70.2 (C-5’), 68.8 (C-5), 65.7 (C-4), 61.4 (C-6'), (Plate 
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The roots of plants are in contact with microorganisms in the soil and, therefore, 
the plants need to develop a defense mechanism against these organisms. Thus it 
is no surprise that antimicrobial compounds are often isolated from the roots of 
plants. Not much has been reported on the phytochemistry of the roots of Ochna 
species. In this Chapter the structures of the compounds present in the roots of O. 
serrulata are discussed.  
 
4.2 Results and Discussion 
 
The methanol extract of the roots of O. serrulata yielded three isoflavonoid 
derivatives, irisolone 4’-methyl ether (81), 3',4'-dimethoxy-6,7-
methylenedioxyisoflavone (83), iriskumaonin 3’-methyl ether (84), four biflavonoid 
derivatives [4,4’,7-tri-O-methylisocampylospermone A (85), a mixture of 
isocampylospermone A (61) and campylospermone A (62), 4”’-de-O-
methylafzelone A (86)], two dimeric chalcones [serrulone (87) and lophirone L 
(88)], a furofuran lignan [syringaresinol (89)] and a diterpene of ent-kauranoic acid 
type [16α,17-dihydroxy-ent-kauran-19-oic acid (90)]. In the following section, the 
detailed structural elucidation of these compounds will be discussed. 
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82  R= OH













The structure of 81 was determined by a combination of spectroscopic methods 
including MS and 1D [1H (Plate 13a), 13C (Plate 13c)] and 2D [COSY (Plate 13b), 
HSQC (Plate 13d) and HMBC (Plate 13e)] NMR spectra.  
 
The methylenedioxy protons exhibited a resonance at the expected position viz. δH 
6.07 (s) correlating to a 13C-signal at δC 102.1. A p-substituted aromatic system 
was observed in the 1H NMR and 1H,1H COSY spectra as two doublets at δH 7.48 
and 6.96, each integrating for two protons. A one-proton singlet at δH 6.64 
correlating in the HSQC spectrum to a carbon at δC 93.2, indicate the presence of 
a pentasubstituted aromatic ring. An indication that the compound might be an 
isoflavone was provided by a one-proton singlet at δH 7.79 in the 
1H NMR 




Inspection of the 1H NMR and HSQC spectra revealed the presence of two 
singlets due to two methoxy groups at δH 4.09 and 3.85 which correlated (HSQC) 
to carbons at δC 61.2 and 55.3. These chemical shifts suggest that the former 
methoxy group is sterically hindered and must be placed on a carbon atom where 
both ortho carbons are substituted, whereas the latter must be placed on a carbon 
atom where at least one of the ortho carbons is unsubstituted (Fleischer et al., 
1998). Therefore, the methoxy group at δC 55.3 was placed at C-4 of the p-
substituted aromatic ring while the other was placed on the pentasubstituted 
aromatic ring (ring B). 
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There are different positions where the methoxy group can be in the A-ring, the 
most likely being position 5 (81a) and position 8 (81b), both partial structures will 






























The up-field resonance of H-8 at δH 6.64 indicated that it is not peri to the carbonyl 
and therefore confirming partial structure 81a (Abraham et al., 2003). Further 
evidence for this substitution pattern is the down-field shift of the methoxy group 
resonating at δC 61.2 showing its close proximity to a carbonyl group (Kalla et al., 
1978).  
 
The singlet due to a proton on the pentasubstituted aromatic ring (ring A) was 
found to show long-range correlations with signals at δC 135.6 and 152.8, these 
carbons were in turn correlated to the methylenedioxy protons at δH 6.07. Thus, 
the methylenedioxy group was linked to the pentasubstituted aromatic ring at the 
mentioned positions as pointed out in partial structure 81c (Fig. 4.1). The 
correlation of H-8 with C-8a, C-4a confirmed that the pentasubstituted ring forms 
part of the benzopyran system and is at the same time linked to the 
methylenedioxy group. 1H/13C correlations as observed in the HMBC spectrum are 


















Fig. 4.1: HMBC correlations in partial structure 81a 
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The remaining partial structure was confirmed from the long-range 1H/13C 
correlations between the p-substituted (B ring) aromatic protons at δH 7.48 (H-2’/6’) 
and C-3 at δC 125.4, which uncovered the connection of the B-ring to the 
benzopyran ring via C-3. Further proof for this linkage was provided by the 1H/13C 
correlations between H-2 of benzopyran ring and C-1’ of the p-substituted ring. 
















Fig. 4.2: HMBC correlations in partial structure 81c 
 
The mass spectrum of 81 gave a pseudo-molecular ion peak [M+Na]+ at m/z 
349.0671 in agreement with a molecular formula of C18H14O6. Compound 81 was 
assigned as 4’-methoxyirisolone, an isoflavone previously isolated from various 
plants of the genus Iris (El Emary et al., 1980; Hiroyuki et al., 1996; Syeda et al., 
2009). The compound was also previously reported from the leaves of O. 
integerrima (Reutrakul et al., 2007). 
 



















The structure of 83 was determined by a combination of spectroscopic methods 
including 1D [1H (Plate 14a), 13C (Plate 14c), DEPT-135 (Plate 14f)] and 2D 
[COSY (Plate 14b), HSQC (Plate 14d), HMBC (Plate 14e)] NMR and MS. 
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The 1H and 13C NMR spectra exhibited signals due to two methoxy groups, a 
methylenedioxy group, a trisubstituted aromatic ring, two aromatic singlet protons 
and an isoflavone nucleus. The position of the two methoxy groups resonating at 
δH 3.94 and 3.93 was based on the correlations observed between the protons of 
the trisubstituted aromatic ring and the carbons bearing the methoxy groups. 
Further proof for the positions of the methoxy groups was provided by the absence 
of chemical shifts of sterically hindered methoxy groups which are resonating 
downfield (above δC 60), suggesting that both methoxy groups are linked to the 
trisubstituted aromatic ring.  
 
The trisubstituted aromatic ring was linked to the benzopyran system via C-3, this 
was confirmed by the 1H/13C correlations between H-2’, 6’ and C-3. A correlation 
was also observed between H-2 and C-1’, which signified the stated connectivity. 

















Fig. 4.3: HMBC correlations in partial structure 83a 
 
It was confirmed readily that the second aromatic ring (ring A) is linked to both the 
pyran ring and the methylenedioxy group by the observed correlation of the 
aromatic proton singlets (at δH 7.63 and 6.89) with C-6, C-7, C-8a and C-4a. The 
methylenedioxy protons at δH 6.12 were correlated to C-7 and C-6. The downfield 
peak for H-5 at δH 7.63 suggested its close proximity to the carbonyl. The above-





















Fig. 4.4: HMBC correlations in partial structure 83b 
 
The mass spectrum of 83 gave a pseudo-molecular ion peak [M+Na]+ at m/z 
349.0671 which is in agreement with a molecular formula of C18H14O6 for 83. The 
structure of 83 was characterized as 3’,4’-dimethoxy-6,7-
methylenedioxyisoflavone. 
 
The 5-hydroxy and 5-methoxy derivatives of 83 have been isolated from the 
leaves of O. squarrosa, these are squarrosin and 3’-O-methyliriskumaonin, 
respectively (Anuradha et al., 2006). Compound 83 was first isolated from species 
of Leguminosae family and later from Ateleia species (Veitch et al., 2003). The first 
total synthesis of the compound was reported in 1977 (Bharadwaj and Jain, 1977). 
The compound has been established to have moderate antioxidant activity (Voss 
et al., 1992). 
 





















The 1H NMR (Plate 15a) and the 1H,1H COSY (Plate 15b) spectra of 84 revealed 
the presence of three methoxy groups (at δH 3.91, 3.93 and 4.10), a 
methylenedioxy group at δH 6.08, a 1,3,4-trisubstituted aromatic system at δH 6.91 
(d), 7.21 (d) and 7.02 (dd), a pentasubstituted aromatic ring with the only proton 
resonating at δH 6.65 and H-2 of an isoflavone at δH 7.81. 
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In the 13C NMR (Plate 15c) the presence of three non-equivalent methoxy groups 
at δC 56.0, 55.9 and 61.3 was observed. The latter methoxy group has a downfield 
resonance, which is due to steric hindrance due to substituents present on both 
carbons at the o-positions. Therefore, this methoxy group could be placed at C-5 
or C-8 of the pentasubstituted ring. The down-field resonance of the signal for this 
methoxy group at δH 4.10 indicates that it is in the peri position to a carbonyl, as 
indicated in partial structure 84a (Fig. 4.5). 
 
The partial structure 84a was readily assembled due to its similarity to partial 
structure 81a (Fig. 4.1) as observed in the 1H and 13C NMR spectra. The summary 
of the 1H/13C interactions for partial structure 84a as observed in the HMBC 




















Fig. 4.5:  HMBC correlations in partial structure 84a 
 
The partial structure 84b bear similarity to partial structure 83a (Fig. 4.3). The 
1H/13C correlations for 84b in the HMBC spectrum of 84 are summarized in Fig 
4.6. The mass spectrum of the compound gave a pseudo-molecular ion peak 
[M+Na]+ at m/z 379.0786 in agreement with the molecular formula C19H16O7. Thus, 
compound 84 was identified as 3’-O-methyliriskumaonin. The compound was first 
isolated from the rhizomes of Iris species (Hiroyuki et al., 1996; Kachroo et al., 



















Fig. 4.6: HMBC correlations in partial structure 84b 
 
Compound 84 was later isolated from the leaves of Ateleia herbertsmithii, where 
the compound was reported to be the most abundant component in the leaves of 
the plant (Rahman et al., 2004; Veitch et al., 2003). Iriskumaonin 3’-methyl ether 
(84) was isolated from the leaves of O. obtusata and O. integerrima (Rao et al., 
1997; Reutrakul et al., 2007; Reynaud et al., 2005). The compound has been 
reported to exhibit anti-cholinesterase activity at 200 µg/mL and moderate 
antioxidant activity (Hacıbekiroglu and Kolak, 2011). 
 




















































Isocampylospermone A (61) was isolated from the stem bark of O. serrulata as a 
2:1 mixture with campylospermone A (62). However, the compound was also 
isolated from the MeOH extract of the root of O. serrulata. In this isolate, the ratio 
of 62 to 61 was 1:4, making it easier to assign the structure of 62 from the NMR 
spectra of the mixture. Purification of these compounds was not possible on silica 
gel since TLC (Kieselgel 60 F254, 0.25mm) showed one spot, despite the evidence 
of two compounds in the 1H NMR spectrum.  
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The two compounds were reported for the first time from the outer bark of O. 
integerrima by Ichino et al. (2006), naming them as biflavanone 1 and biflavanone 
2. Biflavanone 2 was later published as campylospermone A isolated from the 
stem bark of Campylospermum mannii (Elo Manga et al., 2009; Ichino et al., 
2006). The relative configuration of C3-C3” as assigned by Ichino et al. (2006) was 
based on optical rotation. Campylospermone A (62) had a significant specific 
rotation (+83.2 in MeOH) and is chiral, where as 61 has a very small specific 
rotation (+6) and was assigned as a meso isomer (the small specific rotation 
observed may have been the result of some epimerization of the compound). In 
analogy to chamaejasmin where the meso isomer was named isochamaejasmin, 
we herewith propose the name isocampylospermone A be assigned to compound 
61.  
 
The structures of both compounds (61 and 62) were established from MS, 1D (1H, 
13C) and 2D (COSY, HSQC and HMBC) NMR data. In the 1H NMR (Plate 16a) and 
1H,1H COSY spectra (Plate 16b) of the mixture of 61 and 62, the presence of two 
p-substituted aromatic systems and two o,p-disubstituted aromatic systems were 
observed. The flavanone skeleton of 61 and 62 was characterized by the presence 
of two doublets at δH 5.85 (J2,3=12.0 Hz, H-2, 2”) and 2.66 (J2,3=12.0 Hz, H-3, 3”) 
each integrating for two protons. Both compounds were observed to be highly 
symmetrical dimers, showing only one set of signals in their NMR spectra. The 1H 
NMR spectrum of 61 did not show the peaks for two C-ring protons at 30 °C, this 
might be due to the restricted rotation (fixed conformation) at the mentioned 
temperature, as was also reported by Ichino et al. The presence of a downfield 
doublet signal in the 1H NMR spectra of both compounds illustrated both 
compounds to be 5, 5”-deoxybiflavonoids. 
 
The 13C NMR spectrum (Plate 16c) indicated the presence of three peaks due to 
oxygen-linked aromatic carbons at δC 166.8, 165.2 and δC 159.6 for C-7,7”, C-8a, 
8a” and C-4’,4”’ respectively; confirming both compounds to be phenolic. The two 
carbonyls were observed at δC 193.8. The HMBC spectra (Plate 16e) of both 61 
and 62 showed 1H/13C correlations between H-2’,6’ and the C-2’; between H-2,2” 
and C-1’,1”’ indicating the attachment of the two p-substituted aromatic systems to 
 94 
the benzopyran system through C-2 forming ring B of the flavonoid moiety as 
shown in Fig. 4.7.  
 
The two o,p-disubstituted aromatic rings were linked to the pyran ring and 
therefore form a benzopyran system of the flavonoid moiety; this was due to the 
1H/13C  correlations between H-5, 5” and the carbonyls. The interflavonoid bond for 
62 was found to involve the two C-rings; this was provided by the long-range 






























61 & 62  
Fig. 4.7: HMBC correlations in structure 61 and 62 
 
From the large value of coupling constant (12.0 Hz) between H-2, 2” and H-3, 3”; 
the relative configuration of 62 was deduced to be trans-trans. 
 
The negative ion mass spectra of both compounds exhibited a pseudo-molecular 
ion peak [M-H]- at m/z 509, confirming C30H22O8 to be the molecular formula of 
both 61 and 62. The NMR data of both 61 and 62 are in agreement with those 
reported by Ichino et al. for the two compounds (Ichino et al., 2006). 
Isocampylospermone A (61) is a meso compound, campylospermone A (62) is 
chiral but the absolute configuration is not known. As discussed in Chapter 2 of 
this thesis, isocampylospermone A (61) with IC50 of 0.08 µg/mL was significantly 
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more active than campylospermone A (62) with IC50 of 5.2 µg/mL against malaria 
parasites (Ichino et al., 2006).  
 





























The 1H NMR (Plate 17a) and 1H,1H COSY (Plate 17b) spectra of 85 revealed the 
molecule to be a 3,3”-biflavanone. Two p-substituted aromatic rings  signified by 
peaks centred at δH 7.21 and 6.98 (4H each), two trisubstituted aromatic rings as 
illustrated by signals at δH 6.59, 6.28, 7.77 and 7.80, 6.65, 6.38, respectively, and 
three methoxy groups at δH 3.84 and 3.82, the latter signal represents two 
methoxy groups, were also observed in the 1H NMR and COSY spectra. The 
signals of H-2 and H-3 of the two flavanone moieties were observed as unresolved 
broad signals which almost disappear into the base line. The appearance of these 
signals was similar to the heterocyclic proton signals of isocampylospermone A 
(61). This is probably due to restricted rotation at 30 °C (Ichino  et al., 2006). The 
presence of downfield proton doublets at δH 7.80 and 7.77 indicated that both 5 
and 5” positions are unsubstituted. 
 
The 13C spectrum (Plate 17c) exposed the presence of two carbonyls at δC 190.7 
and 190.5, six oxygen-linked quaternary aromatic carbons at δC 167.2, 165.4, 
164.3, 164.3 and 161.6 (for two carbon atoms) consistent with the proposed 
structure of 85. 
 
The two p-substituted aromatic rings were linked to C-2 and C-2” of the two 
benzopyran systems as expected for flavanone dimers; this was due to the 
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correlations observed in the HMBC spectrum (Plate 17e) between H-2’/2’” and C-
2, 2”. 
 
Of the three methoxy groups observed in the 1H NMR spectrum, two have the 
same chemical shift value indicating similar chemical environments, indicating that 
both might be linked to the two trisubstituted aromatic rings or, alternatively, to C-
4’/C-4”’ of the B-rings. 1H/13C correlations (HMBC) between these methoxy 
protons and C-4’/C-4’’’ at δC 161.6 signified their connectivity to these carbon 
atoms and therefore confined the remaining methoxy group to one of the A-rings. 
The position of this methoxy group was derived from the long-range correlations 
observed in the HMBC spectrum between H-6 (at δH 6.65), H-8 (at δH 6.38) and 





















Fig. 4.8:  HMBC correlations in partial structure 85a 
 
Long-range correlations observed between H-5/H-5” of the A-rings and the two 
carbonyls, C-4a implied that the trisubstituted rings are linked to the pyran rings 
and therefore form the A-rings of the flavonoid units. The above discussed 























Fig. 4.9:  HMBC correlations in partial structure 85b 
 
The molecular composition of 85 was found to be C33H28O8 by mass spectrometry 
which gave a molecular ion peak [M-H]- at m/z = 551. The structure of 85 was 
assigned as 4,4’,7-tri-O-methylisocampylospermone A (or its antipode), which is a 
new compound. 
 
4.2.6  4”’-De- O-methylafzelone A (86)  
 
86         R= OH























The structure of 86 was determined by 1D and 2D NMR spectroscopy together 
with MS and IR. The IR spectrum of the compound gave a very broad absorption 
band extending from 2800- 3700 cm-1suggesting that 86 is a phenolic compound 
and absorption at 1650 cm-1 established the presence of a ketone carbonyl.  
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The 1H (Plate 18a) and 1H,1H COSY (Plate 18b) spectra pointed out evidence of 
an aliphatic AB system at δH 5.75 (1H, d, J=5.7 Hz, H-β) and 5.22 (1H, d, J=5.7 
Hz, H-α) and the ABX spin system at δH 3.15 (1H, m) and 2.72 (1H, m) for H-3 and 
δH 5.39 (1H, m) for H-2 confirming the presence of a flavanone moiety. The two 
NMR spectra also exposed the presence of two p-substituted phenyl rings, one 
o,p-disubstituted aromatic ring and a pentasubstituted benzoyl system.  
 
Thirty peaks were observed in the 13C NMR spectrum (Plate 18c). Two carbonyls 
at δC 202.7 and 198.5 (Cc, C-4) and seven oxygen-linked aromatic carbons at δC 
170.3, 167.5, 167.4, 166.5, 160.2, 159.5 and δC 159.2 are consistent with the 
proposed structure. A DEPT-135 experiment uncovered the presence of one CH2 
at δC 44.0, and sixteen CHs, the remaining thirteen carbons were quaternary 
carbons. 
 
The presence of the furan ring instead of pyran ring was favored by the fact that 
the carbonyl that experienced strong correlations with the aliphatic AB protons had 
a pronounced downfield resonance at δC 202.7. The pyrone carbonyl resonates at 
around δC 190 to 199 ppm, consistent with the resonance of C-4 of the flavanones 
(Pegnyemb et al., 2003). The absence of a downfield proton signal below ca. δH 
7.5 indicated that C-5 of the pentasubstituted ring is substituted and therefore 
confine the signal at δC 6.06 to H-8. 
 
The connectivities in this compound were confirmed by the HMBC spectrum (Plate 
18e). The pentasubstituted aromatic ring is linked to the furan ring as well as pyran 
ring, based on correlations observed between H-8 and C-8a, C-4a, C-7. Further 
evidence for the position of the furan ring was provided by the long-range 
correlations of H-α and C-β, C-1”’, C-5, C-6, C-7 and C-c, eliminating the 
possibility that the structure is the angular isomer as in partial structure 86a. 
Structure 86a was also unlikely due to the fact that there were no correlations 












The p-substituted aromatic system was found to be linked to C-2 of the 
benzopyran system due to correlations observed between H-2 and C-1’ at δC 























Fig. 4.10: HMBC correlations in partial structure 86b 
 
The second p-substituted aromatic ring was shown to be linked to C-β of the furan 
ring by the long-range correlation observed between H-β and C-1”’ at δC 131.9, 
also H-2”’,6”’ at δH 7.17 and C- β at δC 92.3. The carbonyl at δC 202.7 correlated to 
H-α which was in turn correlated to the o,p-disubstituted aromatic system and 
therefore confirm the position of o,p-disubstituted aromatic system to be linked to 
the mentioned carbonyl.  The summary of these correlations in partial structure 


























 Fig. 4.11: HMBC correlations in partial structure 86c 
 
Compound 86 had a molecular formula of C30H22O9 in agreement with a pseudo-
molecular ion peak [M-H]- at m/z 525. Based on this data, the structure of 86 was 
assigned as 4”’-de-O-methylafzelone A, a derivative of afzelone A (Pegnyemb et 
al., 2003). Compound 86 is hereby reported for the first time.  
 
A 5-deoxy analogue of compound 86 has been isolated from the stem of 
Caesalpinia ferrea (Pau-Ferro) found in Middle and South America. It is reported 
to be the active ingredient in the stem of the plant having inhibitory effect on type II 
DNA topoisomerase and as a result, the compound inhibits cell growth and 
induces apoptosis (Hiroshi et al., 2009). 
 




























Analysis of the 1H (Plate 19a) and 1H,1H COSY spectra (Plate 19b) of 87 indicated 
the presence of two p-substituted aromatic rings due to doublet signals at δH 7.39, 
6.83, 7.20 and 6.59 (2H each), two trisubstituted rings (protons with o-, o/m-, and 
m-coupling) and an array of four methine protons constituting a tetrahydrofuran 
ring having a substituent on each carbon. Signals for two strongly hydrogen-
bonded hydroxy protons were observed at δH 12.5 and 12.47, indicating their peri-
position to the carbonyl and therefore belong to the hydroxy groups at C-2’ and C-
2”’. 
 
The 13C NMR spectrum (Plate 19c) of 87 uncovered the presence of two carbonyls 
at δC 202.5 (c) and 201.1 (c’), six aromatic carbons that are oxygen-linked at δC 
167.1 (C-2’), 166.4 (C-4’), 166.2 (C-2”’), 165.7 (C-4”’) 157.8 (4”), and δC 157.7 (C-
4) as per proposed structure. The 1H/13C correlations (HMBC spectrum, Plate 19e) 
between H-2/H-6 at δH 7.39 and C-β at δC 85.7 lead to the unambiguous linkage of 
one of the two p-oxygenated aromatic rings to this carbon viz. C-β. In the same 
spectrum, the connection of one of the o,p-dioxygenated aromatic rings to the 
carbonyl which in turn correlated to H-α at δH 5.47 was observed leading to the 
conclusion that the o,p- dioxygenated system must be linked to carbonyl which in 
turn linked to C-α. The above discussed correlations led to the confirmation of 






















Fig. 4.12: HMBC correlation in partial structure 87a 
 
The second p-oxygenated phenyl ring was unambiguously established to be linked 
to C-β’ due to the HMBC correlations between H-2”, 6” at δH 7.20 and C-β’ at δC 
85.7 (Fig 4.13). The second disubstituted benzoyl ring was bonded to the carbonyl 
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at δC 202.5 (c’) which in-turn had a long-range correlation with H-α’ at δH 4.51, thus 

























Fig. 4.13: HMBC correlations in partial structure 87b 
 
Compound 87 exhibited a pseudo-molecular ion [M-H]- peak at m/z 527 in the 
mass spectrum consistent with a molecular formula of C30H24O9. Based on the 
spectroscopic data discussed, six possible structures (Table 4.1) were possible for 
this compound. 
 
Table 4.1: Possible structures for 87 from the observed NMR data 





OHHO HO OH  
cis-cis-cis-isomer 












OHHO HO OH  
trans-cis-trans-isomer 





































































In Table 4.13, the first four structures are symmetrical (expected to show 13 
carbon signals) and therefore could not be the structure of 87 which is not 
symmetrical (it showed 26 carbon signals). This reduces the possibilities to the last 
two structures are the only options for 87. It was observed that the spectroscopic 
data of 87 are not in agreement with those of lophirone F (44), isolated from the 
stem bark of Lophira lanceolata (Tih et al., 1990). Therefore, the only possibility 
remaining for 87 is the last structure with a cis-cis-trans configuration around the 
furan ring. The structure of 87 was therefore assigned as cis-cis-trans-3,4-bis(2,4-
dihydroxybenzoyl)-2,5-bis(4-hydroxyphenyl)furan and is given the common name 
serrulone A. The absolute configuration of 87 has not yet been established and the 
isolation and characterization of 87 have not been previously reported. 
 



























Comparison of the 1H, 13C NMR and MS of 87 and 88, indicated that the two 
compounds are isomers. The only difference was that 88 is symmetrical while 87 
is not. The 1H (Plate 20a) and 1H,1H- COSY (Plate 20b) spectra of 88 showed the 
presence of two symmetrical p-oxygenated phenyl rings (AA’XX’ system), two 
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symmetrical trisubstituted aromatic rings and a set of protons belonging to a 
symmetrical furan ring substituted on each carbon.  
 
The 13C NMR spectrum of 88 has 15 carbon signals and revealed the presence of 
a carbonyl at δC 202.7 and three oxygen-linked aromatic carbons at δC 166.7, 
166.5 and 158.8 suggesting that both p-substituted and trisubstituted aromatic 
rings are phenolic (oxygen-linked). The linkage of p-substituted aromatic system to 
C-β was confirmed by the 1H/13C correlations observed (HMBC spectrum, Plate 
20e) between the mentioned carbon viz. C-β and H-2, 6 at δH 7.36 (Fig. 4.14). The 
protons of the trisubstituted aromatic ring (δH 6.07, 6.03, 7.36) had a strong 
correlation to the carbonyl at δC 202.7, which was in turn correlated to H-α at δH 
4.56, thus implied that the mentioned aromatic system was linked to the carbonyl 

































Fig. 4.14: HMBC correlations in structure 88  
 
Compound 88 exhibited a pseudo-molecular ion [M-H]- peak at m/z 527 consistent 
with C30H24O9 molecular formula. Compound 88 has a specific rotation of -11.9 
and is chiral. Therefore, it must be either lophirone G ([α]D +113 in acetone) (Tih et 
al., 1990) or lophirone L ([α]D -6.4 in EtOH) (Anuradha et al., 2006) (Table 4.1). 
NMR data of 88 were identical to those reported for lophirone L (Anuradha et al., 
2006). Based on comparison of the NMR data, the structure of 88 was assigned 
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as lophirone L, which was previously isolated from the roots of O. squarrosa 
(Anuradha et al., 2006). 
 


























1D (1H, 13C, DEPT-135) and 2D (COSY, HSQC, HMBC) NMR spectra were used 
to determine the structure of syringaresinol (89). Observations in the mass 
spectrum in combination with 1H (Plate 21a), 1H,1H COSY (Plate 21b) and 13C 
(Plate 21c) NMR spectra of 89, indicated that 89 was a symmetrical dimeric 
molecule. The 1H NMR spectrum (Plate 21a) showed only one singlet at δH 6.69 
(4H) suggesting that the four aromatic protons are equivalent as pointed out in the 
proposed structure.  
 
The presence of a bis-tetrahydrofuran ring was signified by the 1H-1H interactions 
between the benzylic proton (H-7/H-7’) at δH 4.68 and H-8/H-8’ at δH 3.10 which 
were in turn interacting with CH2-9/9’ at δH 4.24 as observed in COSY spectra. The 
HMBC (Plate 21e) spectrum showed the presence of this ring by the correlations 
between H-8 and C-7, H-7 and C-9, H-9 and C-8, C-7. The linkage of the bis-
tetrahydrofuran ring to the aromatic ring was confirmed by the long-range 1H/13C 
correlations between H-7/H-7’ and C-1/C-1’, C-2/C-2’ and C-6/C-6’. The methoxy 
group protons were found to correlate to C-3 and 5 (δC 147.8) which in turn were 


































Fig. 4.15 : HMBC correlations in structure 89 
 
The molecular formula of 89 was found to be C22H26O8 by mass spectrometry 
which gave a pseudo-molecular ion peak [M+Na]+ at m/z = 441 in agreement with 
the proposed structure. The discussed correlations/interactions agree with the 
proposed structure thereby confirming 89 to be syringaresinol (El-Hassan et al., 
2003). 
 
Syringaresinol (89) is reported to be a major constituent of Lilac species (the 
common name for the genus Ryringa) (Deyama, 1983). Later the compound was 
reported to be isolated from Thymelaceae and Gmelina species. The glucosylated 
syringaresinol was reported to be isolated and fully characterized for the first time 
from Cressa cretica and Eucommia ulmoides (Deyama, 1983; Shahat et al., 2004). 
The compound is reported to posses strong cytotoxicity, anti-inflammatory and 
antioxidant activities (El-Desouky and Gamal-Eldeen, 2009). In another study, the 
compound inhibited proliferation of leukemic cells by induction of apoptosis and 
the cell arrest mechanism (Park et al., 2008). The compound was also found to 
inhibit the motility of Helicobacter pylori (Miyazawa et al., 2006). The first total 
































Fig. 4.16: Biosynthesis of syringaresinol (89) 
 
The compound is proposed to be biosynthesized (Fig. 4.16) from sinapyl alcohol, 
which undergoes dimerization to give syringaresinol (89) (Katayama and Ogaki, 
2001). This is the first report on the isolation of this type of lignan from Ochna 
species. 
 























The negative ion mass spectrum exhibited a pseudo-molecular ion peak [M-H]- at 
m/z 335, suggesting that 90 is a diterpene with the molecular formula of C20H32O4.  
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The infrared spectrum of this compound showed an absorption at 1710 cm-1 due to 
the carboxylic acid carbonyl group and the carboxylic acid O-H stretch was 
observed at 3200 cm-1 while the alcohol O-H stretch was observed at 3400 cm-1 
(Solomons and Fryhle, 2004).  
 
The 13C NMR spectrum (Plate 22c) of 90 showed the presence of 20 carbons and 
the DEPT-135 spectrum (Plate 22f) pointed out these are 5 quaternary carbons, 3 
methine, 10 methylene and 2 methyl carbons. 
 
The 1H NMR spectrum (Plate 22a) of 90 showed the presence of two tertiary 
methyl groups at δH 1.67 and 0.88. These chemical shifts are characteristic of the 
equatorial C-18 and axial C-20 methyl groups of a kaurane diterpene with a C-19 
axial carboxylic acid. The structure was further supported by 13C NMR resonances 
at δC 178.9 (C-19), 15.4 (C-20) and 26.7 (C-18), which are typical of the axial C-20 
and equatorial C-18 in diterpene with a C-19 axial carboxylic acid (Wang et al., 
2009). Other major features of the 1H and 13C NMR spectra were the presence of 
a hydroxy group at C-16 (δC 78.8) and two doublets centered at δH 3.23 and 3.13 
(J=11.0 Hz) typical for 17-methylene of a 16α,17-dihydroxy moiety 
(Harinantenaina et al., 2002). 16α,17-Dihydroxy-ent-kaurane has been reported to 
show resonances for these protons at δH 3.37 and 3.51 (J=12 Hz) and in that of 
16α,17-dihydroxy-ent-kauran-19-oic acid  at δH 3.32 and 3.43 (J=10.7 Hz) 
positions, comparable to the observed in 90 spectrum. Therefore, the isolated 
compound 90 was identified as 16α,17-dihydroxy-ent-kauran-19-oic acid (Hertz 
and Kulanthaivel, 1984; Wu et al., 1996). The 1H/13C correlations as observed in 



























Fig. 4.17: HMBC correlations in structure 90 
 
The compound has been isolated from various Helianthus species (Hertz and 
Kulanthaivel, 1984) and Annona species (Wu et al., 1996). It was reported that the 
compound exhibited significant activity against HIV replication with EC50 value of 
0.8 mg.mL-1 (Wu et al., 1996). The isolation of this compound from Ochna species 




Three new compounds [4,4’,7-tri-O-methylisocampylospermone A (85), 4”’-de-O-
methylafzelone A (86) and serrulone A (87)] were isolated from the roots of O. 
serrulata along with three simple isoflavonoids [irisolone 4’-methyl ether (81), 3',4'-
dimethoxy-6,7-methylenedioxyisoflavone (83), iriskumaonin 3’-methyl ether (84)], 
a diterpene of ent-kauranoic acid type [16α,17-dihydroxy-ent-kauran-19-oic acid 
(90)], a furofuran lignan [syringaresinol (89)] and biflavonoids [lophirone L (88), 
and a mixture of isocampylospermone A (61) and campylospermone A (62)]. This 
is the first report on the isolation of a furofuran lignan and a diterpene of ent-





4.4.1 Extraction and isolation 
 
Oven–dried (30 °C) and ground roots of O. serrulata (1.2 kg) were extracted with 
MeOH at room temperature for 48 h to yield 15 g of extract. Initial fractionation of 
the extract was done by running a short silica gel column eluting with 
EtOAc:hexanes mixtures with increasing polarities and finally washed with MeOH. 
Five fractions were obtained (R.1-R.5), the fifth being the MeOH wash. 
 
Compound 90 precipitated out when 850 mg of fraction R.2 was dissolved in 
MeOH. It was then washed further with MeOH to afford 10 mg of a white powder 
of 90. The filtrate was subjected to repeated silica gel chromatography with 
DCM:hexanes (1:1) to afford the isoflavonoids 81 (4.1 mg), 83 (5.0 mg) and 84 
(6.2 mg) and a novel biflavonoid 85 (4.2 mg). 
 
Silica gel column chromatography of fraction R.3 (1.2 g) followed by repeated 
purification on a chromatotron with DCM:EtOAc (1:1) yielded 8.1 mg of 36, 4.7 mg 
of 39, 4.1 mg of 50 and 18.0 mg of 76 and 4.0 mg of 90 as a white powder. 
 
Fraction R.4 (2.5 g) was subjected to silica gel column chromatography 
(DCM:EtOAc, 1:1) to obtain four fractions (R4.1-R4.4). R4.1 was purified further on 
a chromatotron with EtOAc:DCM (1:1) to afford 5.0 mg of an off-white solid (89). 
R4.2 was combined with the remaining R4.1 and subjected to purification 
procedure as above to yield 89 (1.5 mg), 86 (4.7 mg) as a yellow amorphous solid 
and 87 (5.1 mg). R4.3 was combined with R4.4 and repeatedly purified on a 
chromatotron with EtOAc:DCM (6:4) to afford 87 (1.1 mg), 88 (2.2 mg), 61 and 62 
(5.4 mg) as yellow non-crystalline solids. 
 
The flow diagram for the isolation of the compounds from the roots of O. serrulata 
is as given in Fig. 4.18 below. 
 
 111

















































   39
4.1 mg
   50
18 mg










   89
4.7 mg



















4.4.2 Physical data of the isolated compounds  
 
Irisolone 4’-methyl ether (81) was isolated as a white non-crystalline solid 
substance. 1H NMR (400 MHz, CDCl3): δH 7.79 (1H, s, H-2), 7.48 (2H, d, J2’,3’=8.8 
Hz, H-2’, 6’), 6.96 (2H, d, J5’,6’=8.8 Hz, H-3’,5’), 6.64 (1H, s, H-8), 6.07 (2H, s, 
OCH2O), 4.09 (3H, s, OMe), 3.85 (3H, s, OMe) (Plate 13a). 
13C NMR (100 MHz, 
CDCl3): δC 175.5 (C-4), 159.56 (C-4’), 152.8 (C-7), 151.9 (C-8a), 150.2 (C-2),141.7 
(C-5), 135.6 (C-6), 130.9 (C-2’, 6’), 125.4 (C-3), 124.1 (C-1’), 113.8 (C-4a), 113.9 
(C-3’, 5’), 102.1 (OCH2O), 93.2 (C-8), 61.2 (OMe), 55.3 (OMe) (Plate 13c). 
HRESIMS (positive ionization mode), m/z 349.0671 [M+Na]+ (calculated for 
C15H14NaO6 349.0688). 
 
3',4'-Dimethoxy-6,7-methylenedioxyisoflavone (83) was isolated as a white 
amorphous solid substance. 1H NMR (400 MHz, CDCl3): δH 7.96 (1H, s, H-2), 7.63 
(1H, s, H-5), 7.23 (1H, d, J2’,6’=2.1 Hz, H-2’), 7.06 (1H dd J5’,6’=8.4 Hz, J2’,6’=2.1 Hz, 
H-6’), 6.94 (1H, d J5’,6’=8.4 Hz, H-5’), 6.89 (1H, s, H-8), 6.12 (2H, s, OCH2O), 3.94 
(3H, s, OMe), 3.93 (3H, s, OMe), (Plate 14a). 13C NMR (100 MHz, CDCl3): δC 
175.4 (C-4), 153.5 (C-8a), 152.7 (C-7), 151.9 (C-2), 149.1 (C-4’), 148.9 (C-3’), 
146.3 (C-6), 124.6 (C-1’), 124.4 (C-3), 121.0 (C-6’), 119.6 (C-4a), 112.6 (C-2’), 
111.2 (C-5’), 102.8 (C-5), 102.4 (OCH2O), 97.8 (C-8), 56.0 (2xOMe) (Plate 14c). 
HRESIMS (positive ionization mode), m/z 349.0671 [M+Na]+ (calculated for 
C15H14NaO6 349.0688). 
 
Iriskumaonin 3’-methyl ether (84) isolated as a white amorphous solid 
substance. 1H NMR (400 MHz, CDCl3): δH 7.81 (1H, s, H-2), 7.21 (1H, d, J2’,6’=2.0 
Hz, H-2’), 7.02 (1H dd J5’,6’=8.3 Hz, J2’,6’=2.0 Hz, H-6’), 6.91 (1H, d J5’,6’=8.3 Hz, H-
5’), 6.65 (1H, s, H-8), 6.08 (2H, s, OCH2O), 4.10 (3H, s, OMe), 3.93 (3H, s, OMe), 
3.91 (3H, s, OMe) (Plate 15a). 13C NMR (100 MHz, CDCl3): δC 174.4 (C-4), 154.7 
(C-8a), 152.8 (C-7), 150.4 (C-2), 149.1 (C-4’), 148.7 (C-3’), 141.8 (C-5), 135.5 (C-
6), 125.4 (C-3), 124.6 (C-1’), 121.4 (C-6’), 113.8 (C-4a), 112.9 (C-2’), 111.1 (C-5’), 
102.2 (OCH2O), 93.2 (C-8), 61.3 (OMe), 56.0 (OMe), 55.9 (OMe) (Plate 15c). 
HRESIMS (positive ionization mode), m/z 379.0786 [M+Na]+ (calculated for 
C15H14NaO6 379.0794). 
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Isocampylospermone A (61) was isolated as a yellow amorphous solid 
substance in a mixture with campylospermone A  (62). 
 
Isocampylospermone A (61) 
1H NMR (400 MHz, CD3OD): δH 7.74 (2H, d, J6”,5"=8.7 Hz, H-5,5”), 7.02 (4H, d, 
J2’’’,3’’’=8.5 Hz, H-2’,6’,2”’,6”’), 6.77 (4H, d, J2’’’,3’’’=8.5 Hz, H-3’,5’,3”’,5”’),  6.49 (2H, 
dd, J8,6=2.2 Hz, J6,5 =8.7 Hz, H-6,6”), 6.20 (2H, d, J8,6=2.2 Hz, H-8,8”) (Plate 17a).
 
13C NMR (100 MHz, CD3OD): δC 192.7 (C-4,4”), 166.9 (C-7,7”), 165.2 (C-8a,8a”), 
159.8 (C-4’,4”’), 131.8 (C-5,5”), 130.9 (C-2’,6’, 2’”,6’”), 130.4 (C-1’,1”’), 116.6 (C-
3’,5’,3’”,5’”), 114.7 (C-4a,4a”), 112.1 (C-6,6”), 103.9 (C-8,8”), 83.8 (C-2,2”), 55.1 
(C-3,3”) (Plate 17c). 
 
Campylospermone A (62)  
1H NMR (400 MHz, CD3OD): δH  7.67 (2H, d, J6”,5”=8.6 Hz, H -5,5”), 6.90 (4H, d, 
J2’,3’=8.5 Hz, H-2”’,6”’,2’,6’), 6.76 (4H, d, J3’,2’=8.5 Hz, H-3’,5’,3”’,5”’), 6.48 (2H, dd, 
J8”,6”=2.2 Hz, J6”,5”=8.7 Hz, H- 6,6”), 6.25 (2H, d, J8,6=2.2 Hz, H-8), 5.85 (2H, d, 
J2,3=12.0 Hz, H-2,2”), 2.66 (2H, d, J2,3=12.0 Hz, 3,3”) (Plate 17a).
 13C NMR (100 
MHz, CD3OD): δC 193.9 (C- 4,4”),  166.8 (C-7,7”), 165.2 (C-8a,8a”), 159.6 (C-
4’,4”’), 130.2 (C-5,5”), 129.7 (C-1’,1”’), 130.4 (C-2’,6’, 2”’,6”’), 116.6 (C-3’,5’,3”’,5”’), 
115.8 (C-4a,4a”), 112.1 (C-6,6”), 103.9 (C-8,8”), 85.7 (C-2,2”), 52.6 (C-3,3”) (Plate 
17c). LRMS (negative ionization mode), m/z 509 [M-H]-. 
 
4,4’,7-Tri- O-methylisocampylospermone A (85) was isolated as yellow 
amorphous solid substance (Ichino et al., 2006). [α]21D= -101 (c 0.1, MeOH).
 1H 
NMR (500 MHz, (CD3)2CO): δH 7.80 (1H, d, J5,6=8.8 Hz, H-5), 7.77 (1H, d, 
J5”,6”=8.6 Hz, H-5”), 7.21 (4H, d, J2’,3’=8.5 Hz, H-2’,6’,2”’,6”’), 6.98 (4H, d, J2’,3’=8.5 
Hz, H-3’,5’), 6.97 (2H, d, J2’”,3’”=8.7 Hz, H-3”’,5”’), 6.65 (1H, dd, J6,8=2.3 Hz, 
J5,6=8.8 Hz, H-6), 6.59 (1H, dd, J6”,8”=2.1 Hz, J5”,6”=8.6 Hz, H-6”), 6.38 (1H, d, 
J6,8=2.3 Hz, H-8), 6.28 (1H, d, J6”,8”=2.2 Hz, H-8”), 4.99 (2H, d, H-2,2”), 3.84 (3H, s, 
OMe), 3.82 (6H, s, OMe), 3.72 (2H, d, H-3,3”) (Plate 16a). 13C NMR (125 MHz, 
(CD3)2CO): δC 190.7 (C-4), 190.5 (C-4”), 167.2 (C-7), 165.4 (C-7”), 164.3 (C-8a), 
164.3 (C-8a”), 161.6 (C-4’,4”’), 130.7 (C-2’, 6’, 2”’,6”’), 130.4 (C-1’), 130.3 (C-1”’), 
130.2 (C-5”), 129.7 (C-5), 115.2 (C-3’, 5’), 115.0 (C-3”’, 5”’), 114.7 (C-4a), 114.7 
(C-4a”), 111.6 (C-6”), 111.1 (C-6), 103.5 (C-8”), 101.6 (C-8), 82.8 (C-2), 82.6 (C-
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2”), 56.3 (OMe), 55.8 (OMe), 50.0 (C-3), 49.9 (C-3”), (Plate 16c). LRMS (negative 
ionization mode), m/z 551 [M-H]-. 
 
4”’-De- O-methylafzelone A (86) was isolated as a yellow powder (Pegnyemb et 
al., 2003). [α]22D= +89.3
 (c 0.4, MeOH). 1H NMR (400 MHz, CD3OD): δH 7.54 (1H, 
d, J5”, 6”=8.8 Hz, H-6”), 7.34 (2H, d, J3’,2’=8.4 Hz, H-2’,6’), 7.17 (2H, d, J3”’,2”’=8.3 Hz, 
H-2”’,6”’), 6.83 (2H, d, J3”’,2”’=8.3 Hz, H-3”’,5”’), 6.79 (2H, d, J3’,2’=8.4 Hz, H-3’,5’), 
6.29 (1H, d, J3”,5”=2.2 Hz, H-3”), 6.26 (1H, dd, J5”,6”=8.8 Hz, J3”,5”=2.2 Hz, H-5”), 
6.06 (1H, s H-8), 5.39 (1H, m, H-2), 5.75 (1H, d, Jβ,α=5.7 Hz, H-β), 5.22 (1H, d, 
Jβ,α=5.7 Hz, H-α), 3.15 (1H, m, H-3), 2.72 (1H, m, H-3) (Plate 18a).
 13C NMR (100 
MHz, CD3OD): δC 202.7 (C-4”), 198.5 (C-4), 170.3 (C-7), 167.5 (C-4”), 167.4 (C-
2”), 166.5 (C-8a), 160.2 (C-5), 159.5 (C-4”’), 159.2 (C-4’), 134.6 (C-6”), 131.9 (C-
1”’), 131.0 (C-1’), 129.2 (C-2’,6’), 128.9 (C-2”’,6”’), 116.8 (C-3’,5’), 116.5 (C-3”’,5”’), 
113.9 (C-1”), 109.6 (C-5”), 106.9 (C-6), 104.5 (C-4a), 103.9 (C-3”), 92.3 (C-β), 
91.5 (C-8), 81.0 (C-2), 55.2 (C-α), 44.0 (C-3) (Plate 18c). LRMS (positive 
ionization mode), m/z 549 [M+Na]+. 
 
Serrulone A (87) was isolated as a yellow solid. [α]21D= +55.9 (c 0.3, MeOH). 1H 
NMR (400 MHz, (CD3)2CO): δH 7.99 (1H, d, J5’,6’=8.9 Hz, H-6’), 7.46 (1H, d, 
J5”’,6”’=8.8 Hz, H-6”’), 7.39 (2H, d, J3,2=8.5 Hz, H-2,6), 7.20 (2H, d, J3”, 2”=8.5 Hz, H-
2”,6”), 6.83 (2H, d, J3,2=8.5 Hz, H-3,5), 6.59 (2H, d, J3”,2”=8.5 Hz, H-3”,5”), 6.3 (2H, 
dd, J5’,6’=8.9 Hz, J3’,5’=2.3 Hz, H-5’), 6.3 (2H, d, Jβ’,α’=8.8 Hz, H-β’), 6.18 (1H, d, 
J3’,5’=2.3, H-3’), 6.08 (1H, dd, J5”’,6”’=8.8 Hz, J3”’,5’”=2.2 Hz, H-5”’), 6.0 (1H, d, 
J3”’,5’”=2.2, H-3”’), 5.94 (1H, d, Jβ,α=5.7 Hz, H-β), 5.47 (1H, t, Jβ,α = 6.3 Hz, H-α), 
4.51 (1H, dd, Jβ’,α’ = 8.4, 7.5 Hz, H- α’) (Plate 19a).
 13C NMR (100 MHz, (CD3)2CO): 
δC 202.5 (C’), 201.1 (C), 167.1 (C-2’), 166.4 (C-4’), 166.2 (C-2”’), 165.7 (C-4”’), 
157.8 (C-4”), 157.7 (C-4), 133.9 (C-6”’), 133.4 (C-6’), 129.8 (C-1), 128.8 (C-1”), 
128.4 (C-2,6), 128.3 (C-2”,6”), 116.3 (C-5),116.1 (C-3), 116.1 (C-3”), 114.9 (C-5”), 
113.8 (C-1’”), 112.8 (C-1’), 108.9 (C-5’), 108.4 (C-5”’), 103.7 (C-3’), 103.2 (C-3”’), 
85.7 (C-β), 81.6 (C- β’), 61.4 (C- α’), 56.4 (C-α) (Plate 19c). LRMS (negative 




Lophirone L  (88) was isolated as a yellow powdery substance. [α]21D= -11.9 (c 
0.1, MeOH) (lit. -6.4 (EtOH) (Anuradha et al., 2006)). 1H NMR (400 MHz, CD3OD): 
δH 7.36 (6H, d, J2’,3’=8.5 Hz, H-2,6,2”,6”,6’,6”’), 6.79 (4H, d, J2’’,3’’=8.6 Hz, H-
3,5,3”,5”), 6.07 (2H, d, J5’,3’=2.2 Hz, H-3’,3”’), 6.03 (2H, dd, J5’,3’=2.2 Hz, J5’,6’=8.5 
Hz, H-5’,5”’), 5.39 (2H, dd, Jα,β=2.3, 5.3 Hz, H-β,β’), 4.56 (2H, dd, Jα,β=2.3, 5.3 Hz, 
H-α,α’) (Plate 20a). 13C NMR (100 MHz, CD3OD): δC 202.7 (C,C’), 166.7 (C-2’,2”’), 
166.5 (C-4’,4”’), 158.8 (C-4,4”), 133.9 (C-6’,6”’), 132.2 (C-1,1”), 129.4 (C-2,6,2”,6”), 
116.4 (C-3,5,3”,5”), 114.9 (C-1’,1”’), 109.0 (C-5’,5”’), 103.6 (C-3’,3”’), 85.4 (C-β,β’), 
59.9 (C-α,α’) (Plate 20c). LRMS (negative ionization mode), m/z 526 [M-H]-. 
 
Syringaresinol  (89) was isolated as a white solid. [α]21D= -54
 (c 0.2, MeOH) (lit. -
36, CHCl3) (Bryan and Fallon, 1976).
 1H NMR (500 MHz, (CD3)2CO): δH 6.69 (4H, 
s, H-2’,6’,2,6), 4.68 (2H, d, J7,8=4.3 Hz, H-7,7’), 4.24 (dd, 2H, J8,9=7.0, 15.8 Hz, H-
9,9’), 3.85 (2H, d, J8,9=3.8 Hz, H-9, 9’), 3.83 (12H, s, 4 x OMe), 3.10 (2H, m, H-
8’,8)  (Plate 21a). 13C NMR (125 MHz, (CD3)2CO): δC 147.8 (C-3,5,3’,5’), 135.4 (C-
4’,4), 132.3 (C-1’, 1), 103.7 (C-2’,6’, 2,6), 85.9 (C-7,7’), 71.5 (C-9,9’), 55.8 (4 x 
OMe), 54.5 (C-8,8’) (Plate 21c). LRMS (positive ionization mode), m/z 441 
[M+Na]+. 
 
16α,17-Dihydroxy- ent-kauran-19-oic acid  (90) was isolated as a white powder. 
[α]20D= -50.9 (c 0.2, DMSO) (lit. -53, MeOH, (Hsieh et al., 2004)).
 1H NMR (500 
MHz, (CD3)2SO): δH 3.23 (1H, d, J17a,b=11.0 Hz, H-17), 3.13 (1H, d, J17a,b=11.0 Hz, 
H-17), 2.5 (4H, m, H-1,15), 1.99 (1H, m, H-7), 1.91 (1H, m, H-13), 1.67 (5H, m, H-
12, 18), 1.44 (2H, m, H-11), 1.33 (4H, m, H-3,6), 1.26 (1H, m, H-9), 1.08 (2H, m, 
H-14), 0.98 (3H, m, H-2, 5), 0.88 (3H, s, H-20) (Plate 22a). 13C NMR (125 MHz, 
(CD3)2SO): δC 178.9 (C-19), 78.8 (C-16), 69.2 (C-17), 56.2 (C-2), 55.9 (C-5), 52.3 
(C-9), 43.2 (C-4), 42.9 (C-8), 41.7 (C-3), 40.5 (C-13), 40.4 (C-15), 39.5 (C-1), 37.8 
(C-7), 30.8 (C-10), 28.7 (C-14), 26.7 (C-18), 21.6 (C-12), 18.9 (C-6), 18.6 (C-
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The combined effects of the health-related challenges due to the rapidly growing 
population, the failure of modern medicine to provide effective treatment, chronic 
diseases and the emergence of the multi-drug resistant pathogens have led to the 
increased use of herbal medicines in recent years. It is of importance to establish 
a scientific basis for the use and validation of medicinal plants through biological 
screening.  
 
In this investigation, the major compounds extracted from O. serrulata were 
identified as biflavonoids, as was reported in Chapter 3 and 4. In this Chapter, a 
brief literature overview of the structure and biological activities of biflavonoids is 
presented, followed by a report on the antimalarial and cytotoxic activities of the 
compounds isolated in this investigation.  
 
5.2 Biflavonoids: An Overview of Structure and Biological 
Activities 
 
From the previous phytochemical studies on the genus Ochna as discussed in 
Chapter 2 of this thesis, it is clear that the genus is rich in biflavonoids (Khalivulla 




Normally flavonoids are composed of a C6-C3-C6 central skeleton with a total of 
15 carbons (Fig. 5.1). Different substituents can occur on the basic skeleton and 
thereby contribute to the diversity of flavonoids (Lia et al., 2007; Lin et al., 2001; 
López-Lázaro, 2002). 
 
Biflavonoids are typical polyphenolic flavonoid dimers (Fig. 5.1). The individual 
flavonoid units in these compounds are joined in a symmetrical or unsymmetrical 
manner and can either be identical or non-identical. In addition, there are two ways 
how the two flavonoid units are commonly linked; either through a C-C bond or C-
O-C bond. The bond connecting the two units may be at various positions, e.g. 3-
4’’’, 4’-4’’’, etc. In this class of compounds, remarkable diversity is expected due to 
the substitution of different functional groups such as hydroxy, methoxy and 
carbonyl groups and stereogenic centers that are positioned unpredictably on the 
main biflavonoid unit. This class of compounds are not broadly distributed and 
indeed, there are few plant species that have biflavonoids as major secondary 































Flavanoid Biflavanoid  
Fig. 5.1: General structures of flavonoids and biflavonoids 
 
The beginning of the isolation and characterization of biflavonoids was marked by 
Furukawa who extracted a yellow pigment from the leaves of the maidenhair tree, 
Ginko biloba L in 1929. The pigment was later recognized as a biflavonoid, 
ginkgetin (91) (Baker and Simmonds, 1940; Lin et al., 1997). The variety of 
biological activities, structural diversity and low toxicity shown by biflavonoids has 
resulted in an interest in this class of compounds (Ariyasena et al., 2004; Machado 





The biological activities observed for biflavonoids include antimicrobial (Jung et al., 
2006; Mbwambo et al., 2006; Weniger et al., 2006), anti-inflammatory (Banerjee et 
al., 2002; Chen et al., 2006; Kim et al., 1998; Lim et al., 2006; Park et al., 2006; 
Son et al., 2006; Suh et al., 2006b; Woo et al., 2006), antiviral (Lee et al., 2006; 
Ma et al., 2001), anticancer (Son et al., 2006; Yoon et al., 2006), anti-clotting (Lale 
et al., 1996), vasorelaxant (Dell'Agli et al., 2006; Kang et al., 2004) and other 
activities (Lee et al., 2006; Suh et al., 2006a; Suh et al., 2006b; Xu et al., 2001; 





































































Although a large number of biflavonoids have been isolated from plants, the 
assessment of their biological/pharmacological activities has not yet been given 
enough attention. A small number of biflavonoids have been investigated for 
different activities; these include ginkgetin (91), amentoflavone (92), isoginkgetin 
(93), morelloflavone (94), robustaflavone (95) and ochnaflavone (51).  
 
Ochnaflavone (51), a biflavonoid mainly isolated from members of the Ochnaceae, 
has shown anti-atherogenic activity. Atherogenesis is the formation of plaque 
made up of fatty materials which gradually constrict the arteries hence cause high 
blood pressure and cardiovascular diseases. The antiatherogenic activity of 51 is 
related to its ability to inhibit human vascular smooth muscle cell proliferation (Suh 


























Compounds 51, 91, 92 and 94 inhibit phospholipase A2 and cyclooxygenase-2 
enzymes activities thereby resulting into a decreased biosynthesis of the key 
mediators of inflammation (the prostaglandins) (Ariyasena et al., 2004; Chen et al., 
2006; Lim et al., 2006; Son et al., 2006; Yoon et al., 2006).  
 
In addition, biflavonoids like 51 are reported to suppress the activation of nuclear 
factor–κB (NF-κB), which is widely used by eukaryotic cells as a regulator of genes 
that control cell proliferation and cell survival. As such, in many tumours NF-κB is 
misregulated and so it remains active thereby turning on the gene expression, cell 
proliferation and protection against all conditions that would otherwise kill the cell. 
The suppression of NF-κB will result into downregulation of the gene expression 
and cell proliferation hence killing the particular cell (Banerjee et al., 2002; 
Jayaprakasam et al., 2000; Park et al., 2006; Suh et al., 2006b). 
 
Amentoflavone (92) has shown to have different mechanisms of activity against 
cancer cells. The compound inhibits the activity of topoisomerase enzymes and 
thereby impairs the winding and unwinding activity of DNA in the cell. This will 
consequently lead to cell death (Grynberg et al., 2002). Compound 92 also 
inhibited the activity of vascular endothelial growth factors (VEGF) thereby result in 
the death of the tumour cell by shutting down the vascular system (Tarallo et al., 
2011). Human cytochrome P450 enzymes are the main enzymes that are 
responsible for drug metabolism. However, highly reactive intermediate formed by 




mutation, in the presence of relevant gene this DNA adduct can initiate cancer 
(Goth-Goldstein et al., 2010). Amentoflavone (92) inhibits these enzymes with a 
nanomolar potency (von Moltke et al., 2004). The compound has shown to 
efficiently and specifically inhibit polymerization of amyloid peptides and thereby 
reduce the effects of Alzheimer’s disease as compared to the monoflavonoid 
apigenin which is less effective and less specific (Thapa et al., 2011). 
 
5.3 Results and Discussion 
 
5.3.1 Cytotoxicity activities 
 
The cytotoxicity assays for all compounds isolated from O. serrulata were 
performed at CSIR, Pretoria. The growth inhibitory effects of the compounds were 
tested in the 3-cell line panel consisting of TK10 (renal), UACC62 (melanoma) and 
MCF7 (breast) by sulforhodamine B (SRB) assay. The assay was first developed 
by Skehan and colleagues in 1990 in the NCI (USA) anticancer drug discovery 
program. The binding of the dye to proteins is pH dependent and therefore, the 
clonogenicity, drug-induced cytotoxicity and cell proliferation are measured by the 
assay which basically utilizes the capability of the sulforhodamine B dye (Acid Red 
52) to bind to the protein basic amino acid residues of the cells pretreated with 
trichloroacetic acid. Unbounding the dye from the protein amino acids of the cell is 
achieved by changing the pH to basic and therefore solubilize the dye that can be 
measured (Skehan et al., 1990).  
 
The obtained results are presented as dose-response curves for each cancer cell 
line. The dose-response curve is a plot of percentage growth versus concentration 
of the test compound. For each tested compound, three response parameters, 
GI50 (50% growth inhibition which signifies the growth inhibitory power of the test 
agent), TGI (which is the drug concentration resulting in total growth inhibition and 
signifies the cytostatic effect of the test agent) and LC50 (lethal concentration, 
killing 50% of the cells and signifies the cytotoxic effect of the test agent), were 




represent the concentration at which percentage growth is +50, 0 and -50, 
respectively. 
 
Four compounds, lophirone A (36), lophirone C (39), ochnaflavone (51) and 3’-O-
methylpsilosin (78), exhibited potent cytotoxic activity against the three mentioned 
cancer cells, the remaining compounds were only slightly active. 
 
Lophirone C (39) demonstrated higher cytotoxic activity against melanoma cancer 
cell lines (UACC62) than the other two cancer cell lines. Its activity against renal 
(TK10) and breast (MCF7) cancer cell lines was virtually the same. As shown in 
Fig. 5.2 and Table 5.1, the cytotoxic activity of 39 was concentration-dependent. 
 
 
Fig. 5.2: Dose-response curve of lophirone C (39) 
 
Table 5.1: Cytotoxic activity of 39 
Activities  TK10 (µM) UACC62 (µM) MCF7 (µM) 
GI50 18.39 N/A N/A 
TGI 35.63 11.67 30.35 





There are no published reports on the activity of lophirone C (39) prior to this work.  
A concentration-dependent cytotoxic activity of lophirone A (36) was observed 
(Table 5.2), the compound reached its optimum activity against the 3 cancer cell 
lines at a concentration of 72.45 µM as illustrated in Fig. 5.3 below. The compound 
was highly active against melanoma (UACC62) cancer cells, with lesser activity 
against breast (MCF7) and renal (TK10) cancer cells. 
 
 
Fig. 5.3: Dose-response curve of lophirone A (36) 
 
Table 5.2: Cytotoxic activity of 36 
Activities  TK10 (µM) UACC62 (µM) MCF7 (µM) 
GI50 36.14 16.78 23.19 
TGI 58.96 26.23 40.01 
LC50 131.29 35.59 62.25 
 
It was observed that the cytotoxic activity of lophirone A (36) correlated well with 
the reported activity of the compound. As described in Chapter 2 of this thesis, 36 
has been reported to be an inhibitor of Epstein-Barr virus and has shown inhibitory 





A higher selectivity was demonstrated by ochnaflavone (51), where the compound 
inhibited the growth of melanoma cancer cells only (UACC62). The activity of the 
compound against the mentioned cancer cells was concentration-dependent 
(Table 5.3 and Fig. 5.4). The growth inhibitory power of ochnaflavone (51) against 
renal and breast cancer cells was shown to be the same, the compound totally 
inhibited the growth of renal (TK10), melanoma (UACC62) and breast (MCF7) 
cancer cells at a concentration of 137.34, 12.91 and 137.34 µM, respectively. 
 
As described earlier in this Chapter, ochnaflavone (51) has shown a broad range 
of activities including anti-inflammatory, anticancer and anti-atherogenic activities. 
The observed cytotoxic activity of 51 correlates with the reported activity, however, 
the mechanism of the selectivity demonstrated by the compound needs to be 
investigated further. 
 
A C-glucosylated flavone, 3’-O-methylpsilosin (78) showed higher selectivity as 
shown in Table 5.4. The compound inhibited the growth melanoma cancer cells 
(UACC62) only at a concentration of 14.11 µM, comparable to that of 
ochnaflavone (51) (12.91 µM). There are no filed reports on the biological activity 






Fig. 5.4: Dose-response curve of ochnaflavone (51) 
 
Table 5.3: Cytotoxic activity of 51 
Activities  TK10 (µM) UACC62 (µM) MCF7 (µM) 
GI50 14.16 N/A 13.27 
TGI N/A 12.91 N/A 
LC50 N/A 25.16 N/A 
 
Table 5.4: Cytotoxic activity of 78 
Compound %GI TK10 %GI UACC62 %GI MCF7 
3’-O-methylpsilosin 8.02 -41.88 7.6 
Note: Fixed concentration (19.84 µM) of 3’-O-methylpsilosin (78) was used. 
 
Etoposide (21), a topoisomerase inhibitor that is used clinically for cancer 
treatment, was taken as a standard. It demonstrated almost the same level of 
cytotoxic activity against the three cancer cell lines (Fig. 5.5 and Table 5.5). The 
compound also exhibited a concentration-dependent activity, the sharp increment 






Fig. 5.5: Dose-response curve of etoposide (standard) 
 
Table 5.5: Cytotoxic activity of etoposide (standard) 
Activities  TK10 (µM) UACC62(µM) MCF7(µM) 
GI50 16.80 3.77 5.98 
TGI 65.48 74.06 N/A 
LC50 N/A N/A N/A 
 
All compounds [lophirone A (36) and C (39), ochnaflavone (51) and etoposide 
(21)] exhibited a concentration-dependant activity where, as their concentration 
increased their cytotoxic activities also increased. Lophirone C (38) showed a total 
growth inhibition (TGI) against renal (TK10), melanoma (UACC62) and breast 
(MCF7) cancer cells at 35.63 µM, 11.67 µM and 30.35 µM, respectively. Lophirone 
A (36) is less active and exhibited TGI against renal (TK10), melanoma (UACC62) 
and breast (MCF7) cancer cells at 58.96 µM, 26.23 µM and 40.01 µM, 
respectively.  
 
Higher selectivity was observed for ochnaflavone (51) and 3’-O-methylpsilosin (78) 
where only the growth of melanoma cancer cells (UACC62) was inhibited. 
Ochnaflavone (51) and 3’-O-methylpsilosin (78) showed TGI against melanoma 




To summarize, for the renal cancer cell line (TK10), the activity observed was 39 > 
36 > 51 > 78. For the melanoma cell line (UACC62) the activity was 39 > 51 > 78 > 
36 and for the breast cancer cell line (MCF7) the activity observed was 39 > 36 > 
51 >78. 
 
It is of interest to note the difference in cytotoxic activity of the four compounds 51, 
36, 39 and 78. Thus, whereas the structurally-related compounds 51 and 78 have 
shown comparable and virtually the same pattern of cytotoxic activities, compound 
39 has shown to be about as twice as active as 36.  
 
If the total growth inhibition (TGI) capacity of the compounds is compared with the 
standard [etoposide (21)], then, lophirone C (39) showed almost twice the activity 
of etoposide (21) and lophirone A (36) against renal cancer cell lines (TK10). 
Against melanoma cancer cells (UACC62), 39 and 51 showed virtually the same 
level of activity which was twice as much as that of 36 and almost seven times 
higher as compared to that of 21. The TGI of 21 and 51 against breast cancer cells 
(MCF7) were not determined but the activity of 36 and 39 against these cancer 
cells was virtually the same. 
 
To summarize, therefore, the trend in TGI (total growth inhibition) of the tested 
compounds against the renal cancer cell line (TK10) was 39 > 36 > 21, for a 
melanoma cell line (UACC62) it was observed that 39 > 51 > 36 > 21 and for a 
breast cancer cell line (MCF7) 39 > 36.  
 
5.3.2 Antimalarial activities 
 
With the exception of isocampylospermone A (61) and campylospermone A (62), 
the rest of the compounds isolated from the leaves, stem and roots of O. serrulata 
as reported in Chapter 3 and 4 of this thesis, have not been investigated for their 
antimalarial activity prior to this report. These two compounds (61 and 62)  are 
active against Plasmodium falciparum multidrug resistant strains (K1) at  0.16 and 
10.19 µM,  respectively, multidrug sensitive strains (FCR3) at 0.51 and 8.82 µM for 




The antimalarial tests for all compounds isolated from O. serrulata were performed 
by Prof. Robyn van Zyl at the Department of Pharmacy and Pharmacology, 
Faculty of Health Sciences, University of Witwatersrand, Johannesburg. The 
growth inhibitory effects of the compounds were evaluated against the 
chloroquine-resistant strains of Plasmodium falciparum (FCR-3). The Table below 
summarizes antimalarial activities of some of the compounds that showed 
moderate to weak activity. The rest of the compounds isolated from O. serrulata as 
reported in Chapter 3 and 4 of this thesis did not show any significant activity. 
 
The observed antimalarial activity of a mixture of isocampylospermone A (61) and 
campylospermone A (62) (64.31 µM) did not correlate with the reported activity of 
these two compounds (0.16 and 10.19 µM, respectively). The published activity is 
much higher than what has been observed here. However, individual pure 
compounds were used for the reported activity, while the mixture of the two 
compounds was used in this assay.  
 
Table 5.6 Antimalarial activity of the isolated compounds 
S/No Compound IC50 (µM) 
1 4,4’,7-tri-O-methylisocampylospermone A (85) 11.46 
2 Ochnaflavone (51) 17.25 
3 Serrulone A (87) 26.52 
4 Lophirone A (36) 29.78 
5 5-Deoxyurundeuvine C (76) 31.07 
6 Lophirone C (39) 35.31 
7 4”’-De-O-methylafzelone A (86) 38.43 
8 Afzelone B (50) 39.54 
9 Irisolone 4’-methyl ether (81) 40.72 
10 Syringaresinol (89) 42.66 
11 2”,3”-dihydroochnaflavone (54) 61.86 
12 Mixture of isocampylospermone A (61) and 
campylospermone A (62) 
64.31 




14 3’-O-methylpsilosin (78) 106.35 
15 16α,17-dihydroxy-ent-kauran-19-oic acid (90) 106.48 
 
It is important to note the difference in antimalarial activity of the structurally-
related 4,4’,7-tri-O-methylisocampylospermone A (85) with IC50 value of 11.46 µM 
and a mixture of isocampylospermone A (61) and campylospermone A (62) with 
IC50 value of 64.31 µM. 4,4’,7-Tri-O-methylisocampylospermone A (85) has a six-
fold higher antimalarial activity than a mixture of 61 and 62. None of the mentioned 
compounds showed any significant cytotoxic activity against the three tested 
cancer cells. 
 
With regards to a structure-activity relationship, it is difficult to make any 
conclusive remarks at this stage because no trend could be observed. For 
example, ochnaflavone (51), 2”,3” dihydroochnaflavone (54) and 3’-O-
methylpsilosin (78) are all flavones, but the antimalarial activity of 51 was found to 
be four times higher than that of 54 and six times higher than that of 78. In terms 
of the cytotoxic activity, 51 was comparable to 78, but 54 was less active against 
all the three cancer cells. 
 
The isomeric compounds, serrulone A (87) and lophirone L (88) exhibited 
completely different level of antimalarial activity. Compound 87 showed 
antimalarial activity at 26.52 µM, while 88 showed no significant activity. These 
compounds are stereoisomers and this indicates that relative and/or absolute 
configuration is important. On the other hand, lophirone C (39), serrulone A 87 and 
a 5-deoxyurundeuvine C (76) exhibited virtually the same activity against P. 
falciparum with IC50 values of 35.31 µM, 26.52 µM and 31.07 µM, respectively. 
 
The level of antimalarial activity of 4,4’,7-tri-O-methylisocampylospermone A (85) 
and ochnaflavone (51) is considered to be moderate, however the suitability of 
these compounds as antimalarial agents that can be used in the treatment of 
malaria will depend on toxicological, specificity and biodegradability properties of 







The observed cytotoxic activity of lophirone A (36) is comparable to the reported 
tumour growth inhibition activity reported for this compound. A literature search 
indicated that a 5-deoxy analogy of 4”’-de-O-methylafzelone A (86) have been 
patented for its anticancer activities by Japanese scientists (Hiroshi et al., 2009).  
 
4,4’,7-tri-O-methylisocampylospermone A (85) isolated from the roots of O. 
serrulata showed the highest antimalarial activity, whereas lophirone C (39) 
isolated from the stem and roots of the same plant showed potent cytotoxic activity 
against the mentioned three cancer cells. 
 
Unlike lophirone C (39), ochnaflavone (51) showed comparable activity in both 
tests, where higher selectivity was observed in cytotoxic tests. Higher selectivity 
was also shown by 3’-O-methylpsilosin (78), but 51 stands superior in that it 
showed consistency in its activity. The observed and reported biological activities 
of 51 were the motivation to synthesize compound 51 from commercially available 
starting materials; therefore, Chapter 6 of this thesis describes the synthesis of 
ochnaflavone (51). 
 
5.5 Materials and Methods 
 
Cytotoxicity tests were performed at the CSIR, South Africa in accordance with the 
protocol of the Drug Evaluation Branch, National Cancer Institute. Pure 
compounds were assayed in 3-cell line panel consisting of TK10 (renal), UACC62 
(melanoma) and MCF7 (breast).  
 
For screening experiment, the cells were inoculated in a 96-well microtiter plates 
at plating densities of 7-10 000 cells/well and were incubated for 24 h. After 24 hr 
one plate was fixed with trichloroacetic acid to represent a measurement of the cell 
population for each cell line at the time of drug addition (T0).The other plates with 
cells were treated with the compounds which were previously dissolved in DMSO 




drug addition serves as control. The blank contained complete medium without 
cells and etoposide was used as a standard. The plates were incubated for 48 hr 
after addition of the compounds.  
 
The optical density of the test well after 48 hr period of exposure to compound is 
T, the optical density at time zero is T0 and the control optical density is C. The 
TGI is the concentration of test drug where 100 x (T-T0)/(C-T0) = 0  
 
The results of five dose screening are reported as TGI (total growth inhibition). The 
biological activities of the compounds were categorised into 4: inactive (TGI > 50 
µg/ml or TGI >100µM), weak activity (15 µg/ml < TGI < 50 µg/ml or 30 µM < TGI 
<100 µM, moderate activity (6.25 µg/ml < TGI <15 µg/ml or 10 µM < TGI <30 µM 
and potent activity (TGI <6.25 µg/ml or TGI <10 µM). 
 
In vitro antimalarial tests as described in Chemaly et al.  were performed by Prof. 
Robyn van Zyl at the Department of Pharmacy and Pharmacology, Faculty of 
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6.1 General Introduction 
 
This chapter describes the synthesis of ochnaflavone (51), a non-symmetrical 
biflavone consisting of apigenin and luteolin moieties. The compound exhibits 
diverse biological activities including anticancer, anti-inflammatory and anti-HIV 
activities as described in Chapter 5 of this thesis. Based on the broad range of 
biological activities and the observed selectivity in the cytotoxicity tests (as 
reported in Chapter 5), the decision was made to synthesize the compound.  
 
The total synthesis of ochnaflavone has not been reported, although Okigawa et 
al. (1976) have published the preparation of the pentamethyl ether of this 
compound. Therefore, the aim of this Chapter is to report the first total synthesis of 
ochnaflavone (51) using an approach different from that of Okigawa et al. 
 
6.1.1 Ochnaflavone  
 
Ochnaflavone (51) is present in the leaves and stems of plants belonging to the 
family Ochnaceae (Kang et al., 2005). Most biflavones consist of an interflavone 
linkage between ring B of one moiety and the ring A of the other flavone moiety 
(AB type), between two A rings (AA type), or between two C rings (3,3”-CC type); 
but the most rare biflavones are the ones with the inter-flavone linkage through the 
two B rings. Ochnaflavone (51) has an ether link between an apigenin and luteolin 
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moieties (Sagrera et al., 2011). Ochnaflavone (51) contains a diaryl ether 
functionality which is widely found in biologically active molecules and natural 
products (Evans et al., 2001; Nicolau et al., 1999). This structural feature is part of 
various significant pharmaceuticals with antibiotic activities, such as vancomycin, 
teicoplanin, the antiviral peptide K-13 and the antitumoral bouvardin (Bigot et al., 
2000; Nicolaou et al., 2002; Theil, 1999; Zhu, 1997). 
 
Ochnaflavone (51) has diverse biological activities such as anticancer, anti-
inflammatory and anti-HIV activities, as discussed in Chapter 5 of this thesis. The 
broad range of biological activities, the observed cytotoxicity activity and the 
absence of a filed report on the synthesis of 51 have sparked interest in 
synthesizing this compound (Chang et al., 1994; Lee et al., 1995; Moon et al., 
2006; Reutrakul et al., 2007; Son et al., 2006; Suh et al., 2006a; Suh et al., 2006b; 













The two most important features of the synthesis of ochnaflavone (51) are the 
formation of the diaryl ether linkage and the assembly of the flavone nucleus. In 
the next paragraphs, different synthetic methods employed in the synthesis of 
diaryl ethers and flavones will be discussed 
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6.2 Synthesis of Diaryl Ethers 
 
The most logical approach to the synthesis of 51 is to start with the preparation of 
the diaryl ether. This functionality is present in many other natural products, 
therefore it is not surprising that a great amount of research has been focused on 
the development and improvement of methods used to form diaryl ethers. In the 
next paragraphs, the most important methods to form diaryl ethers will be 
discussed. 
  
6.2.1 Ullmann condensation 
 
The Ullmann ether synthesis is a variation of the Ullmann reaction where phenolic 
compound is coupled with an electron-deficient aryl halide in the presence of a 
copper compound, the reaction is named after Fritz Ullmann. Recently, there have 
been extensive research efforts to develop copper-based catalysts in cross-
coupling reactions of aryl halides with various nucleophiles so as to replace the 
traditional Ullmann-type reaction conditions. These traditional copper-based 
reactions typically involve the coupling of an aromatic halide with an amine 
(Goldberg reactions) or phenol (Ullmann reactions) for the synthesis of an aryl 
amine and an aryl ether, respectively, as illustrated in Scheme 6.1  (Kunz et al., 
2003). 
 
The terminology “Ullmann condensation” usually describes the copper-catalyzed 
reactions of aromatic halides with phenol salts or anilines for the synthesis of aryl 
ethers and amines. On the other hand, “Ullmann coupling” refers to reactions 
aiming at synthesizing biaryls from aromatic halides. 
 
These reactions have offered a foundation for the preparation of diaryl ethers but 
typical Ullmann’s reaction conditions experience the disadvantages of high 
reaction temperatures, the use of toxic solvents (e.g. hexamethylphosphoramide) 
and also intolerance to a wide variety of functional groups. The major weakness of 
the classical Ullmann reaction comes from inconsistent products obtained from the 
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use of different copper sources (Amberg et al., 1993; Capdevielle and Maumy, 



































Ullmann, 1905  
 
Scheme 6.1: Examples of Ullmann and Goldberg coupling reactions  
 
Therefore, palladium-based catalysts were developed, however, due to the high 
costs associated with palladium-based catalyst systems, the past decade has 
seen the development of a multitude of copper catalysts for Ullmann-type O-
arylation reactions (Boger and Yohannes, 1989; Chang et al., 2008; Chen et al., 
2008; Naidu et al., 2008). 
 
Applications of Ullmann condensation in synthesis: 
In 1991, D. L. Boger and group utilized the intramolecular Ullmann condensation 
reaction to form a 15-membered macrocyclic ring of a cytotoxic natural product, 
combretastatin D-2. The iodo-part of the molecule was cyclized with the phenolic-
part of the molecule 103 to form diaryl ether 104 which was later demethylated to 
yield combretastatin D-2 (Boger et al., 1991). The compound has unusual meta 
and para-cyclophane subunits, the cyclization was mediated by methyl copper as 
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Scheme 6.2: Intramolecular Ullmann synthesis of 104 as reported by Boger  
et al., 1991 
 
(+)-Diepoxin δ (105), a highly oxygenated anticancer natural product, was 
synthesized in the Wipf laboratory. The key step in the synthesis of 105 was the 
building of the diaryl ether linkage which was accomplished via Ullmann 
condensation of phenolic compound (106) and 1-iodo-8-methoxynaphthalene 
(107). The condensation of the two precursors was carried out in refluxing pyridine 















Scheme 6.3: Intermolecular Ullmann synthesis of 105 as reported by Wipf 
and Jung, 2000  
 
6.2.2 Nucleophilic aromatic substitution (S NAr) reactions 
 
An older method for synthesis of diaryl ethers is the use of nucleophilic aromatic 
substitution (SNAr) reactions. This involves the direct nucleophilic coupling of a 
phenol to an electron-deficient aromatic system. This method is simple to use and 
has been applied in the synthesis of vancomycin, piperazinomycin, the 
combretastatins and other natural products. Nucleophilic coupling of phenols to 
different electron-deficient aryl frameworks has been known for some time, but the 
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application of this reaction method in the synthesis of diaryl ether-containing 
natural products has recently stimulated the development of modifications 
(Beugelmans et al., 1994a; Beugelmans et al., 1994b).  
 
Applications of nucleophilic aromatic substitution in synthesis: 
The construction of vancomycin and other diaryl ether natural products utilizes the 
intramolecular SNAr macrocyclization. The Boger group illustrated the simplicity of 
the SNAr macrocyclization in the synthesis of the important fragment of the 
antitumor agents deoxybouvardin and RA-VII (Carrington et al., 1999). Compound 
108 was successfully cyclized to the 14-membered macrocycle 109 in 50 - 60% 
yields, where sodium hydride was used to initiate ring cyclization as illustrated in 


















108 109  
 
Scheme 6.4: Intramolecular S NAr synthesis of 109 as reported by Carrington  
et al., 1999 
 
Caesium fluoride has also been used in SNAr conditions for initiating 
intramolecular ring cyclization as shown in Scheme 6.5 . Compound 110 was 
successfully ring cyclized to 111, which is a derivative of the natural product 





















110 111  
 
Scheme 6.5: Intramolecular S NAr synthesis of 111 as reported by Rao  et al., 
1997 
 
6.2.3 Other methods 
 
Other methods have also been developed and one method involves the 
application of the Diels-Alder reaction. Good yields of diaryl ether were obtained 
by the cycloaddition reaction between a substituted aryloxy-1,3-butadiene and 
acetylenic electrophile, followed by aromatization. Scheme 6.6  indicates an 
example of the stated reaction where diene 112 was reacted with methyl 
propiolate and the resulting product was oxidized with DDQ to yield diaryl ether 










2. DDQ, benzene, 64%
1. CH CO2CH3
112 113  
 
Scheme 6.6: Synthesis of 113 by Diels-Alder reaction as reported by Olsen  et 
al., 1995, Sawyer, 2000 
 
Chan and Evans showed that diaryl ethers can also be prepared at room 
temperature using copper(II) acetate as catalyst and triethylamine as a base. The 
diaryl ether 116 is formed from a phenol 115 and an arylboronic acid 114 as 








114 115 116  
 
Scheme 6.7: Synthesis of 116 as reported by Chan  et al., 1998, Evans  et al., 
1998 
 
6.3 Synthesis of Flavones 
 
The interesting biological activities of flavones have resulted into intense synthetic 
efforts towards the synthesis of various flavones. There are a number of methods 
reported for the synthesis of flavones. 
 
6.3.1 The Baker-Venkataraman method 
 
The Baker-Venkataraman approach involves the conversion of 2’-
hydroxyacetophenone (117) to an ester 118 by acylation, followed by a 
rearrangement via an intramolecular Claisen condensation in the presence of 
potassium hydroxide (a base) and pyridine to give a diketone 119.  From the 
diketone, a flavone 120 is expected to be obtained under rather harsh conditions 
either by treating with concentrated sulfuric acid or heating with glacial acetic acid 
as in Scheme 6.8  (Baker, 1933; Ganguly et al., 2005). 
 


















Scheme 6.8: Synthesis of flavones by Baker-Venkataraman Method 
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Proposed mechanism for diketone formation in Baker-Venkataraman Method 
The first step is the removal of a hydrogen atom from acetophenone to form an 
enolate. The formed enolate attacks the ester carbon forming a cyclic alkoxide 
which finally opens up into a phenolate and protonation by acid gives the phenol 




































Scheme 6.9: Proposed mechanism for diketone formation  
 
Modification of the Baker-Venkataraman method for flavone synthesis  
The modification of the Baker-Venkataraman method of synthesizing flavones was 
published by Ganguly and co-workers (2005). In the presence of a base catalyst 
(DBU) and pyridine, the mixture of 2’,4’-dihydroxyacetophenone (121) and benzoyl 
chloride (122) were heated to 80-90 °C as shown in Scheme 6.10  to yield the 
respective flavone (Ganguly et al., 2005). However, in an excess benzoyl chloride, 
the phenolic group of the formed β-diketone (Baker-Venkataraman product) 
undergoes esterification followed by rearrangement to a triketone; 























Scheme 6.10: Synthesis of flavones by Ganguly’s method 
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6.3.2 The Konstanecki – Robinson method 
 
In this method, o-hydroxyaryl ketones (125) are converted to chromones and/ or 
coumarins with aliphatic acid anhydrides in the presence of the sodium salt of the 
corresponding acid. On the other hand, if an aromatic acid anhydride (126) is used 
in the presence of the salt of the corresponding acid 127, a flavone 128 is formed 
as shown in Scheme 6.11  (Ellis, 1977; Nakanishi, 1974). The method for the 
formation of chromones and coumarins is called the Robinson method and for the 
formation of flavones, is called the Von Konstanecki method (Hepworth et al., 





















Scheme 6.11: Synthesis of flavones by the Von Konstanecki method 
 
Modifications of the Von Konstanecki method for flavone synthesis 
The synthesis of flavones has been modified over the years; one of the primary 
modifications has been substituting the carboxylate salt with other bases. While 
Kohn and Low demonstrated that catalytic amounts of triethylamine allowed for the 
reaction to be run at 160 °C (Kohn and Low, 1944), Looker and co-workers went 
further by using amines as solvents and thus reduce the reaction temperatures. 
They found that the reactions could be run at the refluxing temperature of the 
amines (Looker et al., 1978). 
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Processes involved:  1:    Enolization;  2:  Acylation 
 
Scheme 6.12: Mechanism of flavones synthesis by the Von Konstanecki 
method 
 
Another group that contributed to the modification of this method is Grover and 
coworkers, they showed that the reaction proceed well even when potassium 
carbonate is used as a base. They also showed that the reaction can be 
performed with refluxing acetone as a solvent and so reduce greatly the 
temperature at which the reaction proceeds (Grover et al., 1963). 
 
6.3.3 Oxidative ring cyclization of chalcones 
 
Another methodology most commonly used to prepare flavones involves the 
cyclization of substituted 2-hydroxychalcones, obtained by an aldol condensation 
reaction between a 2’-hydroxyacetophenone and an aldehyde. These cyclizations 
have been carried out under numerous conditions such as using iodine in 
DMSO/triethyleneglycol/pyridine and heat. It has been demonstrated that the role 
of DMSO/triethyleneglycol/pyridine in these reactions is to act as an oxidative 
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agent as well as a medium of energy transfer (Gupta et al., 2000). The use of mild 
conditions such as ferric chloride in absolute ethanol has also been reported, 
iron(III) in these reactions acts as oxidizing agent facilitating the 2-
hydroxychalcone ring closure. Catalysts such as CuCl2, SeO2 and silica have 
shown to be effective in catalyzing 2-hydroxychalcone ring cyclization. DDQ, a 
strong oxidant, which has been used for dehydrogenating reactions, have been 
reported to be effective in dehydrating flavanones to flavones and also ring 
cyclizing 2-hydroxychalcones. Since DDQ decomposes in water, the reactions are 
reported to be carried out in refluxing dry dioxane (Gupta et al., 2000; Huang et al., 
2003; Imafuku et al., 1987; Kabalka and Mereddy, 2005; Mavel et al., 2006; 
Miyake et al., 2003; Zambare et al., 2009). 
 
6.4 Previous Syntheses of Ether-linked Biflavones 
 
The only report on the synthesis of an ether-linked biflavone was provided by 
Okigawa in 1976. The group synthesized 5,5”,7,7”,4’-pentamethoxyochnaflavone 
(129) by Baker-Vankataraman rearrangement. In their method, 5,5”,7,7”,4’-
pentamethoxyochnaflavone (129) was obtained from dibenzoic acid 130 as a 
starting material that was converted to the diester. The obtained ester underwent 
rearrangement in the presence of a base to yield β–diketone (131).  This was 
followed by ring closure when treated with concentrated sulfuric acid to yield 
5,5”,7,7”,4’-pentamethoxyochnaflavone (129) as illustrated in Scheme 6.13  


























Scheme 6.13: Synthesis of 129  by Baker-Vankataraman method 
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6.5 Retrosynthetic Analysis of Ochnaflavone (51) 
 
Although Okigawa and group reported the synthesis of the 
pentamethoxyochnaflavone (129), there are no filed reports on the total synthesis 
of ochnaflavone (51) and therefore in this Chapter the total synthesis of the 
compound will be reported. It was our aim to synthesize 51 by first generating the 
ether linkage between the two aromatic aldehydes to obtain diaryl ether 132, 
followed by base-catalyzed aldol condensation with 2’-hydroxy-4’,6’-
dimethoxyacetophenone (133) to form a pentamethoxy dimeric chalcone 134. The 
oxidative ring cyclization of 134 was expected to yield 5,5”,7,7”,4’-
pentamethoxyochnaflavone (129), followed by demethylation of 129 to yield 51 as 










































Scheme 6.14: Retrosynthesis of 51  
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6.6 Results and Discussion 
 
6.6.1 Synthesis of diaryl ether (132) 
 
The synthetic approach to diaryl ether 132 is illustrated in Scheme 6.15 . This 
compound could be obtained from the Ullmann condensation and other applicable 
reactions but as stated earlier, these reactions require harsh conditions and result 
into mixtures of products. On the other hand, a base-initiated intermolecular 
nucleophilic aromatic substitution reaction was used. The reaction between 
isovanillin (135) and p-fluorobenzaldehyde (136) in a heated DMF gave diaryl 





















Scheme 6.15: Synthesis of 132  by intermolecular nucleophilic aromatic 
substitution  
 
The 1H NMR spectrum (Plate 23a) of the diaryl ether 132 showed the presence of 
two singlets at δH 9.94 and 9.93, typical for aldehydes and a para-substituted 
aromatic system could be identified by the presence of two doublets with coupling 
of 8.8 Hz at δH 7.89 and 7.06, each one integrating to two protons. Methoxy 
protons were observed at δH 3.92 and an ABX aromatic system was present (δH 
7.89dd, 7.68d and 7.38d). 
 
The 13C NMR spectrum (Plate 23b) showed the presence of 13 signals, with two 
carbonyls at δC 190.5 and 190.0 and a methoxy carbon at δC 55.9. Three signals 
due to oxygen linked aromatic carbons were observed at δC 162.8, 156.9 and 
143.4, consistent with the structure. Signals due to p-substituted and o,p-
disubstituted aromatic rings were observed in their normal resonance regions. 
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6.6.2 Synthesis of 2’-hydroxy-4’,6’-dimethoxyacetophenone (133) 
 




Commercially available 1,3,5-trihydroxybenzene (137) was methylated by using 
methyl iodide under basic condition in acetone for 6 h as indicated in Scheme 
6.16 to yield 1,3,5-trimethoxybenzene (138) in 89% yield as a white solid. The 1H 
NMR spectrum (Plate 24a) of the product showed the presence of only two peaks 
“accounted to” the three equivalent aromatic protons and nine equivalent methoxy 
protons for the three methoxy groups. The signal for the aromatic protons was 
observed at δH 6.11 (3H, s) and the three methoxy groups were observed at δH 
3.79 (9H, s). The presence of the three methoxy groups indicated that compound 
138 was successfully methylated in the three respective positions. 
 
This was followed by acylation, where 138 was acetylated by using acetyl chloride, 
anhydrous zinc chloride and dry dichloromethane for 6 h as indicated in Scheme 
6.16. The white solid 2’,4’,6’-trimethoxyacetophenone (139) was obtained in 70% 
yield.  
 
The 1H NMR spectrum (Plate 25a) of 139 showed the presence of four peaks, 
being a singlet for the two equivalent aromatic protons observed at δH 6.05 (2H, s), 
the methoxy groups at δH 3.75 (3H, s) and 3.72 (6H, s) and a methyl group at δH 
2.38 (3H, s). The observed methyl group indicated that the acylation reaction was 
successful. 
 
Selective deprotection of the methoxy group ortho to the carbonyl in 139 was 
performed by using boron tribromide in dry DCM under nitrogen as per Scheme 
6.16. The deprotected product, 133 obtained here showed the same NMR features 




Selective methylation of 2’,4’,6’-trihydroxyacetophenone (140) was accomplished 
by using methyl iodide and potassium carbonate in refluxing acetone as shown in 
Scheme 6.16 . 2’-Hydroxy-4’,6’-dimethoxyacetophenone (133) was isolated as a 
white solid in 50% yield. The methylation reaction occurred via the nucleophilic 
substitution reaction (SN2) of the phenoxide ion and methyl iodide. 
 
The 1H NMR spectrum (Plate 26a) of 133 showed two singlets at δH 3.83 (3H) and 
δH 3.79 (3H) due to the two methoxy groups at C-4 and C-6, respectively. The 
phenolic proton signal was observed as a sharp singlet at δH 13.99, the 
appearance of this deshielded phenolic proton signal supported the presence of a 
hydroxy group at the C-2’ position. The peaks corresponding to the aromatic ring 
appeared at δH 6.02 and δH 5.89 due to the two meta-coupled protons.  
 
The 13C NMR spectrum (Plate 26b) displayed nine different signals resulting from 
ten carbons, the signals for two methoxy carbons were overlapping at δC 55.5. The 
signal due to carbonyl carbon was observed at δC 203.1 and oxygen-linked 
aromatic signals were observed at δC 167.5, 166.1 and 162.9. Other aromatic 































Scheme 6.16: The two synthetic routes to 133  
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6.6.3 Synthesis of a dimeric chalcone 134 by Claisen-Schmidt condensation 
 
The Claisen-Schmidt condensation of 2-hydroxy-4,6-dimethoxyacetophenone 
(133) with diaryl ether 132 under basic condition (KOH) in EtOH proceeded 






















133 134  
 
Scheme 6.17: Synthesis of 134 by Claisen-Schmidt condensation 
 
The dimeric chalcone was obtained as a yellow powder, its structure was 
confirmed by the 1H, 13C NMR and MS. The presence of hydroxy groups at the two 
C-2 positions was supported by appropriately deshielded phenolic proton signals 
at δH 14.34 and 14.31 (1H, s) in its 
1H  NMR spectrum.  
 
The 1H NMR spectrum (Plate 27a) of 134 displayed five singlets at δH 3.92, 3.89, 
3.85, 3.83 and 3.83 each integrating for 3H due to the methoxy groups. The m-
coupled protons of the two A-rings appeared at δH 5.97 (1H, d, J = 2.3 Hz), 6.12 
(1H, d, J = 2.3 Hz), 6.10 (1H, d, J = 2.3 Hz) and δH 5.93 (1H, d, J = 2.3 Hz). The 
three aromatic protons of the ABX-ring were observed at δH 7.05 (1H, d, J = 8.6 
Hz), 7.33 (1H, d, J = 2.0 Hz) and δH 7.42 (1H, dd, J = 8.6 and 2.0 Hz). The para-
substituted aromatic ring was confirmed to be present due to the presence of 
doublet signals at δH 7.59 (2H, d, J = 8.6 Hz) and 7.00 (2H, d, J = 8.6 Hz). The α,β- 
protons of the one chalcone moiety appeared as two doublets at δH 7.85 and 7.78 
with the characteristic trans coupling of 15.6 Hz. However the two protons of the 
second chalcone moiety overlap and appear as a broad singlet at δH 7.73. 
 
The 13C NMR spectrum (Plate 27b) of 134 showed the presence of 30 signals. The 
signals for the methoxy carbons were observed from δC 56.1 to 55.6. The 
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presence of a chalcone moiety was confirmed by signals at δC 141.7 (C-β2), 
141.4(C-β1), 126.2 (C-α1,α2); low field due to the anisotropic effect of the carbonyl.  
The [M+H]+ peak observed at m/z 611.1920 is consistent with the molecular 
formula C35H32O10 (calc. 611.1917). 
 
6.6.4 Oxidative cyclization of a dimeric chalcone 134 to biflavone 129  
 
The last but one step in the synthesis of ochnaflavone (51) involves ring 
cyclization of the above synthesized dimeric chalcone 134 into 5,7,4’,5”,7”-
pentamethoxyochnaflavone (129) as indicated previously in Scheme 6.14 . The 
cyclization of 134 into the corresponding biflavone 129 was initially carried out by 
using a catalytic amount of iodine in DMSO at 130 - 140 °C. However, at this 
specified temperature, the reaction resulted into decomposition of the starting 
material. Alternatively, the same reaction was repeated under microwave 
conditions to decrease the time in which 134 is exposed to a high temperature, 
however, 134 still decomposed (Menezes et al., 2009). The same conditions 
(DMSO/I2) were repeated at various temperatures. It was observed that at lower 
temperatures, longer time was taken for the reaction to complete and it also 
resulted into an un-isolatable mixture of products. The cyclization reaction was 
repeated, but this time using DDQ in refluxing dry dioxane (101 °C), the starting 
material decomposed, but when the temperature of the reaction was lowered to 80 
°C, it was observed that the reaction resulted in a mixture of products as shown in 
Table 6.1 (Imafuku et al., 1987). At this point, it was established that the dimeric 
chalcone decomposes at temperatures exceeding 100 °C. It was also observed 
that while ring cyclization of most chalcones reported in literature to yield flavones, 
DMSO is regarded as a suitable solvent, it was not the case for ether-linked 
dimeric chalcone 134. 
 
Oxalic acid as a catalyst in absolute ethanol at 80 °C as described by Zambare et 
al, did not yield the desired compound and instead a biflavanone 141 was 
obtained in 25% yield (Zambare et al., 2009). When the reaction was left to 
continue for 72 h the starting materials could still be observed on TLC, this was 
due to the inter-convertibility of the two compounds through the equilibrium 
existing between the chalcone and flavanone and therefore prevents further 
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conversion of the dimeric chalcone to biflavanone (Andrzej and Cecylia, 1992; 
Bathélémy et al., 2008; González et al., 2002). 
 
The 1H NMR spectrum (Plate 28a) of 141 indicated that the two deshielded 
phenolic protons characterized by singlets at δH 12 – 14 were no longer present 
and this indicated that the ring closure reaction was successful. The presence of 
one para-substituted system was characterized by the protons doublet signals at 
δH 7.40 and 6.98 each integrating to two protons. The ABX aromatic spin system 
was easily identified due to the presence of the coupling signals at δH 7.26dd, 
7.16d and 7.06d. The meta-coupled protons were observed at δH 6.16, 6.14, 6.11 
and 6.10 each integrating for one proton. Singlets due to the five methoxy groups 
were observed at δH 3.90 (6H), 3.87 (3H) and 3.83 (6H). The presence of the two 
flavanone systems was confirmed by the ABX spin system at δH 3.02 (m) and 2.8 
(m) for H-3, H-3” and 5.37 (m) for H-2, H-2”. 
 
The dimeric chalcone 134 was then subjected to a ring cyclization reaction in the 
presence of a catalytic amount of iodine in heated (80 °C) pyridine to yield the 
desired product (129) in 70% yield as shown in Scheme 6.18  and Table 6.1 . The 
characteristic signals of the hydrogen-bonded phenolic protons (δH 12 – 14) and 
the trans-alkene protons were not observed in the 1H NMR spectrum (Plate 29a) 
indicating that ring closure reaction was successful. The formation of 129 was 
further supported by the presence of two singlet signals at δH 6.59 and 6.55, each 
integrating to one proton, of the typical flavone unit. The four meta-coupled 
aromatic protons were shifted down field to δH 6.54, 6.51, 6.36 and 6.35 in 129 
from δH 6.12, 6.10, 5.97 and 5.93 in the dimeric chalcone 134. The spectrum 
showed the presence of one ABX aromatic spin system, one para-substituted 
aromatic ring and five methoxy groups.  
 
The 13C NMR spectrum (Plate 29b) showed the presence of two carbonyls at δC 
177.5 and 177.4. Peaks for nine oxygen bonded aromatic carbons were also 
observed at δC 164.0, 164.0, 160.9, 160.35, 160.3, 159.8, 159.7, 159.6 and 154.1.  
The five methoxy groups were observed at δC 56.4 (2xOCH3), 56.1 (OCH3), 55.7 
(OCH3) and δC 55.7 (OCH3) consistent to the structure of 129.  
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temp./cond. Products  
% yield 
1 134 DMSO/I2 130-140 
°C a 0 
2 134 DMSO/I2 80-90 
°C b 
0 
3 134 DMSO/I2 
130-140 °C 
Microwave,5 min a 
0 
4 134 Dry dioxane/DDQ Reflux (101 °C) a 0 
5 134 Dry dioxane/DDQ 80-90 °C b 
0 
6 134 EtOH/oxalic acid 
80-90 °C 141 25 
7 134 Pyridine/I2 80 
°C 129 70% 




































Scheme 6.18: Oxidative ring cyclization of dimeric chalcone 134 
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6.6.5 Deprotection of 129 by using BBr 3 in dry DCM 
 
Ochnaflavone (51) was obtained as a yellow solid after purification of the reaction 
mixture obtained from the reaction of boron tribromide and 129 in dry DCM as 
illustrated in Scheme 6.19 . The product obtained had the same NMR spectra as 























Rt. 48 hrs, 60%
 
 




In this Chapter, the synthesis of a biflavone (ochnaflavone) with an ether linkage 
between apigenin and luteolin moieties is described. The synthesis of 
ochnaflavone (51) was carried out successfully from 2’-hydroxy-4’,6’-
dimethoxyacetophenone (100) and diaryl ether 132. Base-catalyzed aldol 
condensation of 132 and 133 resulted in the formation of the dimeric chalcone 
134, which underwent oxidative cyclization in iodine/pyridine to give the 
pentamethoxy dimeric flavone 129. Biflavone 129 was then deprotected by using 
boron tribromide in dry DCM to yield ochnaflavone (51). In the oxidative ring 
cyclization of the dimeric chalcone 134 several methods were employed, including 
iodine in DMSO, DDQ in dry dioxane and iron(III) chloride in absolute ethanol, but 
none of these reactions were successful. However, it was found that oxalic acid in 
absolute ethanol produced biflavanone 141 as the sole product, whereas reaction 
with iodine in pyridine gave the desired product 129 as a major product. This 
Chapter therefore successfully describes the synthesis of a rare type of ether-
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linked natural biflavone (ochnaflavone) with anti-cancer, antitumor, anti-




6.8.1 General materials and methods 
 
Anhydrous solvents used for the reactions reported in this Chapter was collected 
from the PURE SOLVTM – MD (Multiple Dispensing System) system manufactured 
by Innovative Technology Inc. Reagents were bought from Sigma Aldrich and 
other materials and methods are as described in the experimental section, 
Chapter 3 of this thesis. 
 
















To a solution of isovanillin (135) (500 mg, 3.29 mmol) and anhydrous potassium 
carbonate (681 mg, 4.93 mmol) in 15 ml of dry DMF under nitrogen, 448 mg (3.61 
mmol) of p-fluorobenzaldehyde (136) were added. The mixture was heated at 80 
°C with stirring until the starting material was co nsumed (monitored by TLC). After 
all the starting material was consumed, the reaction was left to cool to room 
temperature, 20 ml of cold water was added, followed by extraction with 3 X 20 mL 
CHCl3. The obtained organic layer was dried over anhydrous magnesium sulfate 
and the solvent was removed in vacuo. The residue obtained was purified by silica 
gel column chromatography with EtOAc:hexanes (3:7) as eluent to yield 748 mg 
(89%) of 132 as a light yellow solid. 
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1H NMR (400 MHz, CDCl3): δH 9.94 and 9.93 (2H, s, 2HCO), 7.89 (2H, d, J2’’,3’’ = 
8.8 Hz, H-3’’,5’’), 7.89 (1H, dd,  J5’,6’ = 8.5 Hz, J2’,6’ 2.0 Hz, H-6’), 7.69 (1H, d, J2’,6’ = 
2.0 Hz, H-2’), 7.38 (1H, d, J5’,6’ = 8.5 Hz, H-5’), 7.06 (2H, d, J3’’,2’’ = 8.8 Hz, H-2”,6”), 
3.91 (3H, s, OCH3) (Plate 23a).  
 
13C NMR (100 MHz, CDCl3): δC 190.6 (C-1), 190.0 (C-1”’), 162.6 (C-1”), 156.9 (C-
4’), 143.4 (C-3’), 131.9 (C-3”,5”,4”), 130.9 (C-1’), 129.5 (C-6’), 122.3 (C-2’), 116.3 
(C-2”,6”), 113.4 (C-5’), 55.9 (OCH3) (Plate 23b). 
 






To a stirred mixture of 1.9 g (13.88 mmol) of potassium carbonate and 500 mg 
(3.97 mmol) of phloroglucinol (137) in 25 mL acetone, 1.97 g (13.88 mmol) of 
methyl iodide was added. The reaction was left to stir for 6 h while monitoring by 
TLC. The reaction was left to cool to room temperature after completion of the 
reaction and then 30 mL of cold distilled water was added followed by extraction 
with 3 X 30 mL CHCl3. The chloroform extract was washed once with dilute 
hydrochloric acid, dried over anhydrous magnesium sulfate and the solvent 
removed in vacuo. The resulting crude mixture was purified by silica gel column 
chromatography with EtOAc:hexanes (1:9) to afford 558 mg (89%) of 138 as a 
white solid.  
 















In a round-bottomed flask containing 442 mg (3.24 mmol) of anhydrous zinc 
chloride, 15 mL of DCM were added. The system was then flushed with nitrogen, 
followed by cooling the solution in an ice bath. A solution of acetyl chloride (305 
mg (3.89 mmol)) in 5 mL DCM was added drop wise over 10 minutes. This was 
followed by addition of 138 (512 mg, 3.24 mmol)) dissolved in 5 mL DCM to the 
reaction mixture, the addition rate was adjusted so the solution did not boil 
excessively. After addition was complete, the ice bath was removed and the 
reaction was allowed to reach room temperature. After stirring for an additional 15 
minutes at room temperature, the reaction mixture was poured carefully and 
slowly, with stirring, into a beaker containing ice and 6M HCl. At this stage 139 
precipitated out as a white solid which was collected by filtration to give 476 mg 
(70%) of 139. 
 
1H NMR (400 MHz, CDCl3): δH 6.05 (2H, s, H-3’, 5’), 3.75 (3H, s, OCH3), 3.72 (6H, 
s, 2xOCH3), 2.38 (3H, s, CH3) (Plate 25a). 
 











Two different procedures were used to synthesize 133, the first being selective 
demethylation of 2’,4’,6’-trimethoxyacetophenone (139) and the second is 
selective methylation of 2’,4’,6’-trihydroxyacetophenone (140). 
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Method 1: 
A solution of 805 mg (3.214 mmol) boron tribromide in 5 mL dry DCM was slowly 
added with a syringe to a stirred solution of 139 (450 mg, 2.14 mmol) in 10 mL dry 
DCM under nitrogen. After complete addition of BBr3, the reaction mixture was left 
at room temperature for 12 hrs and then poured into 50 mL ice water. The mixture 
was then shaken with ice water to hydrolyse the excess BBr3 and boron 
complexes. The product was extracted with 3 X 20 mL DCM. The obtained organic 
layers were dried over anhydrous magnesium sulfate and the solvent was 
removed in vacuo to obtain a dry crude reaction mixture. Purification by a silica gel 
column chromatography with EtOAc:hexanes (1:9), yielded 336 mg (80%) of 2’-
hydroxy-4’,6’-dimethoxyacetophenone (133) as a white solid. 
 
Method 2: 
To a well-stirred mixture of 2,4,6-trihydroxyacetophenone (140) (500 mg, 2.97 
mmol) and methyl iodide (1.06 g, 7.43 mmol) in 20 mL acetone, 1.02 g (7.43 
mmol) of anhydrous potassium carbonate  was added. The reaction mixture was 
refluxed for 5 hours while monitoring by TLC until all the starting material was 
consumed. The reaction mixture was left to cool and 40 mL of cold acidified 
distilled water was added, followed by extraction with 3 X 20 mL CHCl3. The 
obtained organic layer was dried over anhydrous magnesium sulfate and solvent 
removed in vacuo. The residue was purified by silica gel column chromatography 
with EtOAc:hexanes (1:9) to afford 291 mg (50%) of 2’-hydroxy-4’,6’-
dimethoxyacetophenone (133) as a white solid. 
 
1H NMR (400 MHz, CDCl3): δH 13.99 (1H, s, OH), 6.02 (1H, d, J3’,5’ = 2.1 Hz, H-3’), 
5.89 (1H, d, J3’,5’ = 2.1 Hz, H-5’), 3.83 (3H, s, OCH3), 3.79 (3H, s, OCH3), 2.58 (3H, 
s, CH3) (Plate 26a).  
 
13C NMR (100 MHz, CDCl3): δC 203.1 (C-2), 167.5 (C-2’), 166.1 (C-6’), 162.9 (C-
4’), 105.9 (C-1’), 93.5 (C-3’), 90.6 (C-5’), 55.5 (2xOCH3), 32.9 (C-1) (Plate 26b). 
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To a solution of 404 mg (1.55 mmol) of diaryl ether 132 in EtOH (50 mL), 620 mg 
(3.16 mmol) of 2’-hydroxy-4’,6’-dimethoxyacetophenone (133) was added. The 
solution was cooled in an ice bath followed by addition of powdered 353 mg (6.31 
mmol) of KOH. After overnight stirring, the reaction mixture was diluted with ice 
cold water (50 mL) and acidified with 6 M HCl. The formed 134 precipitated out as 
yellow solids and was filtered off under reduced pressure, washed with water. Dry 
yellow solids of 134 (772 mg, 80%) were obtained.  
 
1H NMR (400 MHz, CDCl3): δH 14.34 (OH), 14.31 (OH), 7.85 (1H, d, Jα1,β1 = 15.7 
Hz, H-β2), 7.79 (1H, d, Jα2,β2 = 15.7 Hz, H-α2), 7.73 (2H, s, H-α1, β1), 7.59 (2H, d, 
J2,3 = 8.5 Hz, H-2, 6A2), 7.42 (1H, dd, J5,6 = 8.2 Hz, J2,6 = 2.0 Hz, H-6A1), 7.33 (1H, 
d, J2,6 = 2.0 Hz, H-2A1), 7.05 (1H, d, J5,6 = 8.2, 2.0 Hz, H-5A1), 7.0 (2H, d, J2,3 = 8.5 
Hz, H-3, 5A2), 6.12 (1H, d, J3,5  = 2.2 Hz, H-5B1), 6.10 (1H, J3,5  = 2.2 Hz, H-5B2), 
5.97 (1H, d, J3,5  = 2.2 Hz, H-3B1), 5.94 (1H, d, J3,5  = 2.2 Hz, H-3B2), 3.9 (3H, s, 
OCH3), 3.89 (3H, s, OCH3), 3.85 (3H, s, OCH3), 3.83 (6H, s, 2xOCH3) (Plate 27a). 
 
13C NMR (100 MHz, CDCl3): δC 192.5 (C=O), 192.3 (C=O), 168.4 (C-6B1,B2), 
166.2 (C-2B1,B2), 162.5 (C-4B1,B2), 159.4 (C-4A2), 153.1 (C-4A1), 144.6 (C-3A1), 
141.8 (C-β2), 141.4 (C-β1), 130.3 (C-2,6A2), 130.0 (C-1A2), 129.2 (C-1A1), 126.9 
(C-6A1), 126.2 (C-α1,α2), 120.2 (C-2A1), 117.4 (C-3,5A2), 112.9 (C-5A1), 106.4 (C-
1B1), 106.3 (C-1B2), 93.9 (C-3B1,B2), 91.3 (C-5B1), 91.2 (C-5B2), 56.1 (OCH3), 
55.8 (2xOCH3), 55.6 (2xOCH3) (Plate 27b). 
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To a mixture of oxalic acid (10 mol%) and 134 (400 mg, 0.65 mmol), 20 mL of 
absolute ethanol was added. The stirred reaction mixture was heated at 80 °C for 
72 h while monitoring the reaction by TLC. The reaction mixture was then cooled 
to room temperature and the solvent evaporated under reduced pressure. This 
was followed by extraction using 50 mL of water and 3 X 30 mL DCM and the 
organic layer collected was dried over anhydrous magnesium sulfate. DCM was 
removed in vacuo and the resulting residue was purified by silica gel column 
chromatography with EtOAc:hexanes (1:1) to afford 100 mg (25%) of the 
biflavanone 141 as a light yellow solid. 
 
1H NMR (400 MHz, CDCl3): δH 7.40 (2H, d, J2”’,3”’ = 8.5 Hz, H-2”’, 6”’), 7.26 (1H, dd, 
J5’,6’ = 8.5 Hz, J2’,6’ = 2.0 Hz, H-6’), 7.16 (1H, d, J2’,6’ = 2.0 Hz, H-2’), 7.06 (1H, d, 
J5’,6’ = 8.5 Hz, H-5’), 6.99 (2H, d, J2”’,3”’ = 8.5 Hz, H-3”’, 5”’), 6.16 (1H, d, J6,8 = 2.2 
Hz, H-6), 6.14 (1H, d, J6”,8” = 2.0 Hz, H-6”), 6.10 (2H, d, J6,8 = 2.0 Hz, H-8, 8”), 5.37 
(2H, m, H-2, 2”), 3.9 (6H, s, 2OMe), 3.87 (3H, s, OMe), 3.83 (6H, s, 2OMe), 3.02 
(2H, m, H-2, 2”), 2.8 (2H, m, H-3, 3”) (Plate 28a). 
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To a stirred solution of dimeric chalcone 134 (600 mg, 0.98 mmol) in 15 mL 
pyridine, 498 mg (1.96 mmol) of iodine was added and the mixture was heated to 
80 °C while stirring for 24 h. The reaction was lef t to cool to room temperature and 
a cold solution of sodium thiosulfate was added to the reaction mixture until all 
excess iodine was consumed. This was followed by extraction with 3 X 30 mL 
DCM, the obtained organic layer was washed with 30 mL of water and dried over 
anhydrous magnesium sulfate. The solvent was removed in vacuo and the crude 
reaction mixture was purified by silica gel column chromatography with 
EtOAc:hexanes (8:2)  to obtain 129 (417 mg, 70%) as yellow solid subtance. 
 
1H NMR (400 MHz, CDCl3): δH 7.82 (2H, d, J2”’,3”’ = 8.8 Hz, H-2”’, 6”’), 7.73 (1H, dd, 
J5’,6’ = 8.7 Hz, J2’,6’ = 2.3 Hz, H-6’), 7.61 (1H, d, J2’,6’ = 2.3 Hz, H-2’), 7.12 (1H, d, 
J5’,6’ = 8.7 Hz, H-5’), 7.02 (2H, d, J2”’,3”’ = 8.8 Hz, H-3”’, 5”’), 6.54 (1H, d, J6,8 = 2.2 
Hz, H-6), 6.51 (1H, d, J6”,8” = 2.4 Hz, H-6”), 6.36 (1H, d, J6,8 = 2.2 Hz, H-8), 6.35 
(1H, d, J6”,8” = 2.4 Hz, H-6”), 6.59 (1H, s, H-3), 6.55 (1H, s, H-3”), 3.94 (3H, s, 
OMe), 3.93 (3H, s, OMe), 3.89 (3H, s, OMe), 3.88 (3H, s, OMe), 3.87 (3H, s, OMe) 
(Plate 29a).  
 
13C NMR (100 MHz, CDCl3): δC 177.5 (C=O), 177.4 (C=O),164.0 (C-7”), 164.0 (C-
7), 160.9 (C-5,5”), 160.3 (C-2), 160.3 (C-2”), 159.8 (C-4”’), 159.7 (C-8a), 159.6 (C-
8a”), 154.0 (C-4’), 143.8 (C-3’), 127.7 (C-2”’,6”’), 125.8 (C-1”’), 124.7 (C-6’), 124.0 
(C-1’), 119.8 (C-2’), 116.6 (C-3”’, 5”’), 113.0 (C-5’), 109.2 (C-4a”), 109.1 (C-4a), 
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108.2 (C-3, 3”), 96.2 (C-6), 96.1 (C-6”), 92.8 (C-8”, 8), 56.4 (2xOCH3), 56.1 
(OCH3), 55. 7 (2xOCH3) (Plate 29b). 
 


























A solution of boron tribromide (206 mg, 0.82 mmol) in 5 mL dry DCM was slowly 
added with a syringe to a stirred solution of 40 mg (0.07 mmol) 129 in 10 mL DCM 
under nitrogen. After complete addition of BBr3, the reaction mixture was left to stir 
at room temperature for 72 h and then poured into 30 mL ice water. The mixture 
was then shaken to hydrolyse the excess BBr3 and boron complexes; a phenolic 
product was obtained by extraction with 3 X 20 mL EtOAc. The obtained organic 
layer was dried over anhydrous magnesium sulfate and the solvent was removed 
in vacuo to obtain a dry crude reaction mixture. Purification of the reaction mixture 
by a silica gel column chromatography with MeOH:CHCl3 (1:9) afforded 21.2 mg 
(60%) of 51 as yellow solids. 
 
1H NMR (400 MHz, (CD3)2CO): δH 12.95 (5-OH), 12.94 (5”-OH), 8.08 (2H, d, J2”’,3”’ = 
8.9 Hz, H-2”’, 6”’), 7.903 (1H, dd, J(5’,6’) = 8.5 Hz, J2’,6’ = 2.1 Hz, H-6’), 7.89 (1H, d, 
J2’,6’ = 2.1 Hz, H-2’), 7.29 (1H, d, J5’,6’ = 8.5 Hz, H-5’), 7.16 (2H, d, J2”’,3”’ = 8.9 Hz, 
H-3”’, 5”’), 6.73 (2H, s, H-3, 3”), 6.56 (1H, d, J6,8 = 2.0 Hz, H-6), 6.55 (1H, d, J6”,8” = 
2.4 Hz, H-6”), 6.28 (1H, d, J6,8 = 2.0 Hz, H-8), 6.27 (1H, d, J6”,8” = 2.0 Hz, H-8”) 
(Plate 30a). 
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13C NMR (100 MHz, (CD3)2CO): δC 182.2 (C-4), 182.2 (C-4”),164.2 (C-7”), 164.18 
(C-7), 163.5 (C-2), 163.1 (C-2”), 162.5 (C-5, 5”), 161.1 (C-4”’), 157.9 (C-8a, 8a”), 
154.1 (C-4’), 142.4 (C-3’), 128.3 (C-2”’,6”’), 125.4 (C-1”’), 123.6 (C-1’), 120.7 (C-
2’), 118.1 (C-5’), 116.6 (C-3”’, 5”’), 104.3 (C-4a), 104.52 (C-4a”), 104.5 (C-3”), 
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Conclusion and recommendations 
 
This thesis reports the phytochemical investigations of stem, leaves and roots of 
O. serrulata belonging to the family Ochnaceae. The Zulu people use the root 
decoction of this plant commonly known as fynblaarrooihout (Afr.), umbomvane 
(Zulu) or iliTye (Xhosa) for the treatment of bone diseases and gangrenous 
proctitis (Hutchings et al., 1996; Hutchings and Van Staden, 1994). The study is 
comprised of the isolation and identification of the compounds from the EtOAc and 
MeOH extracts of the plant, followed by subsequent screening of the isolated 
compounds for their cytotoxic and antimalarial activities and the synthesis of the 
most cytotoxic compound. 
 
Four new compounds [two dimeric chalcones (5-deoxyurundeuvine C and 
serrulone A and two biflavonoids (4,4’,7-tri-O-methylisocampylospermone A and 
4”’-de-O-methylafzelone A)] were isolated along with 18 known compounds 
namely, one rearranged biflavonoid (lophirone A), five biflavonoid derivatives 
(afzelone B, ochnaflavone, 2”,3”-dihydroochnaflavone, isocampylospermone A 
and campylospermone A), two dimeric chalcones (lophirone C and lophirone L), 
two C-glucosylated flavones (psilosin and 3’-O-methylpsilosin), a cyanoglucoside, 
(2’,4’-dihydroxyphenyl)acetic acid, methyl (2’,4’-dihydroxyphenyl)acetate, 
epicatechin, three isoflavonoid derivatives (irisolone 4’-methyl ether, iriskumaonin 
3’-methyl ether, 3',4'-dimethoxy-6,7-dioxymethyleneisoflavone), a furofuran lignan 
(syringaresinol) and a diterpene (16α,17-dihydroxy-ent-kauran-19-oic acid) from 
the pulverized extracts of the stem, leaves and roots of O. serrulata. The structural 
elucidation of these compounds was achieved by a combination of spectroscopic 
methods (1H, 1H,1H COSY, HSQC, HMBC, DEPT-135, 90, NOESY, 13C NMR, 
mass spectrometry and infrared spectroscopy). 
 
 174
The isolation of psilosin, 3’-O-methylpsilosin, syringaresinol and 16α,17-dihydroxy-
ent-kauran-19-oic acid from Ochna species is reported for the first time in this 
thesis. 
 
Four compounds exhibited promising cytotoxic activities; the most potent 
compound was lophirone C with a total growth inhibition (TGI) against renal 
(TK10), melanoma (UACC62) and breast (MCF7) cancer cells at 35.63 µM, 11.67 
µM and 30.35 µM, respectively. Lophirone A exhibited TGI against the same 
cancer cells at 58.96 µM, 26.23 µM and 40.01 µM, respectively. Ochnaflavone and 
3’-O-methylpsilosin inhibited the growth of melanoma cancer cells (UACC62) only, 
where both compounds showed TGI against melanoma (UACC62) cancer cells at 
12.91 µM and 14.11 µM, respectively. 
 
A new biflavonoid (4,4’,7-tri-O-methylisocampylospermone A) showed moderate 
activity against chloroquine-resistant strains of Plasmodium falciparum (FCR-3) 
with IC50 of 11.46 µM, followed by ochnaflavone (17.25 µM). Weakly active 
compounds were serrulone A (26.52 µM), lophirone A (29.78 µM), 5-
deoxyurundeuvine C (31.07 µM), lophirone C (35.31 µM), 4”’-de-O-methylafzelone 
A (38.43 µM), afzelone B (39.54 µM), irisolone 4’-methyl ether (40.72 µM) and 
syringaresinol (42.66 µM) 
 
This is the first report on the isolation and antimalarial activity of 4,4’,7-tri-O-
methylisocampylospermone A, structural modification of this compound is 
recommended for further studies to enhance its activity. Ochnaflavone and 
lophirone C can further be developed as new anticancer drug leads and structural 
modifications may improve their activity. 
 
Ochnaflavone, an ether-linked biflavone consisting of apigenin and luteolin 
moieties, was synthesized in this study. Oxidative ring cyclization of a 2,2”-
dihydroxy dimeric chalcone in iodine and heated pyridine was utilized to obtain the 
biflavone. The use of the described method for synthesis of the ether-linked 
dimeric flavone reported here can be extended to the synthesis of other 
compounds with a diaryl ether functionality. This functionality has been found to be 
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an important structural feature that plays a significant role in enhancing biological 
activity of a given molecule. 
 
The study supports the notion that biologically-active compounds and potential 
pharmaceuticals can be isolated from African medicinal plants. As was found for 
other Ochnaceae species, the majority of the compounds isolated from the plant 
were biflavonoids. Many of these compounds have been isolated only from this 
family and they may be used as chemotaxonomical markers for the family. 
 
To conclude, the main objectives of this study (to isolate, characterize, evaluate 
the biological activities of the compounds present in O. serrulata and synthesize 
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Plate 12a: 1H NMR Spectrum of (2 Z)-[(4R,5R,6S)-6-(β-D-glucopyranosyloxy)-4,5-

































































Plate 12b: COSY NMR Spectrum of (2 Z)-[(4R,5R,6S)-6-(β-D-glucopyranosyloxy)-4,5-
























































Plate 12c: 13C NMR Spectrum of (2 Z)-[(4R,5R,6S)-6-(β-D-glucopyranosyloxy)-4,5-


































Plate 12d: HSQC NMR Spectrum of (2 Z)-[(4R,5R,6S)-6-(β-D-glucopyranosyloxy)-4,5-


























































Plate 12e: DEPT -90 and 135  NMR Spectrum of (2 Z)-[(4R,5R,6S)-6-(β-D-glucopyranosyloxy)-4,5-


























3 2 1' 7 3',4',6 2' 5' 5 4
6'




Plate 12g: NOESY NMR Spectrum of (2 Z)-[(4R,5R,6S)-6-(β-D-glucopyranosyloxy)-4,5-
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